Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	json	split
In contrast to the purely enhancer - dependent effect of cytokines such as TNF on the activity of the HIV regulatory region ( LTR), we observed that okadaic acid ( OKA) activates HIV transcription through both the enhancer, responding to the factor NF - kappa B, and the promoter domain of the LTR.	cytokines,57,66,Gene/Protein	TNF,75,78,Gene/Protein	HIV regulatory region,102,123,Gene/Protein	LTR,126,129,Gene/Protein	NF - kappa B,249,261,Gene/Protein	promoter domain,271,286,Gene/Protein	LTR,294,297,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""HIV regulatory region"", ""start_span"": 102, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 249, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""promoter domain"", ""start_span"": 271, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 294, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	train
Our results suggest that SP1 phosphorylation induced by OKA, a selective inhibitor of the serine - threonine phosphatase PP2A, facilitates the formation of a transcription complex involving general transcription factors, HIV Tat, and Sp1 proteins.	SP1,25,28,Gene/Protein	serine - threonine phosphatase,90,120,Gene/Protein	PP2A,121,125,Gene/Protein	transcription complex,158,179,Gene/Protein	transcription factors,198,219,Gene/Protein	HIV Tat,221,228,Gene/Protein	Sp1 proteins,234,246,Gene/Protein	"[{""token"": ""SP1"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""serine - threonine phosphatase"", ""start_span"": 90, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""transcription complex"", ""start_span"": 158, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 198, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""HIV Tat"", ""start_span"": 221, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 proteins"", ""start_span"": 234, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
Whereas the Jak kinases Jak1 and Jak3 and the signal transducer and activator of transcription proteins Stat3 and Stat5 are activated in normal T cells in response to IL - 2, this signaling pathway was constitutively activated in HTLV - I - transformed cells.	Jak kinases,12,23,Gene/Protein	Jak1,24,28,Gene/Protein	Jak3,33,37,Gene/Protein	transcription proteins,81,103,Gene/Protein	Stat3,104,109,Gene/Protein	Stat5,114,119,Gene/Protein	IL - 2,167,173,Gene/Protein	"[{""token"": ""Jak kinases"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""transcription proteins"", ""start_span"": 81, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
The proximal promoter contains a region termed CLEO ( - 54 to - 31) that consists of a purine - rich element abutting an activator protein - 1 ( AP - 1) - like site, as well as an upstream nuclear factor - kappa B ( NF - kappa B) site ( - 85 to - 76) and a CK - 1 element ( - 101 to - 92).	proximal promoter,4,21,Gene/Protein	CLEO,47,51,Gene/Protein	- 54 to - 31,54,66,Gene/Protein	purine - rich element,87,108,Gene/Protein	- 85 to - 76,237,249,Gene/Protein	CK - 1 element,257,271,Gene/Protein	- 101 to - 92,274,287,Gene/Protein	"[{""token"": ""proximal promoter"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CLEO"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""- 54 to - 31"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""purine - rich element"", ""start_span"": 87, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""- 85 to - 76"", ""start_span"": 237, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""CK - 1 element"", ""start_span"": 257, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""- 101 to - 92"", ""start_span"": 274, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
The specificity of CIITA for three major MHC class II genes, DR, DQ and DP, is mediated by its remaining C - terminal residues ( amino acids 317 - 1130).	CIITA,19,24,Gene/Protein	MHC class II genes,41,59,Gene/Protein	DR,61,63,Gene/Protein	DQ,65,67,Gene/Protein	DP,72,74,Gene/Protein	C - terminal residues,105,126,Gene/Protein	amino acids 317 - 1130,129,151,Gene/Protein	"[{""token"": ""CIITA"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II genes"", ""start_span"": 41, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""DR"", ""start_span"": 61, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""DQ"", ""start_span"": 65, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""DP"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal residues"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 317 - 1130"", ""start_span"": 129, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
Adhesion of human monocytes to P - selectin, the most rapidly expressed endothelial tethering factor, increased the secretion of monocyte chemotactic protein - 1 ( MCP - 1) and tumor necrosis factor - alpha ( TNF - alpha) by the leukocytes when they were stimulated with platelet - activating factor.	P - selectin,31,43,Gene/Protein	endothelial tethering factor,72,100,Gene/Protein	monocyte chemotactic protein - 1,129,161,Gene/Protein	MCP - 1,164,171,Gene/Protein	tumor necrosis factor - alpha,177,206,Gene/Protein	TNF - alpha,209,220,Gene/Protein	platelet - activating factor,271,299,Gene/Protein	"[{""token"": ""P - selectin"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""endothelial tethering factor"", ""start_span"": 72, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemotactic protein - 1"", ""start_span"": 129, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 177, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""platelet - activating factor"", ""start_span"": 271, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
Moreover, tethering by P - selectin specifically enhanced nuclear translocation of nuclear factor - kappa B ( NF - kappa B), a transcription factor required for expression of MCP - 1, TNF - alpha, and other immediate - early genes.	P - selectin,23,35,Gene/Protein	nuclear factor - kappa B,83,107,Gene/Protein	NF - kappa B,110,122,Gene/Protein	transcription factor,127,147,Gene/Protein	MCP - 1,175,182,Gene/Protein	TNF - alpha,184,195,Gene/Protein	immediate - early genes,207,230,Gene/Protein	"[{""token"": ""P - selectin"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 83, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 127, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early genes"", ""start_span"": 207, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
The data indicate that PKC - epsilon and, to a lesser extent PKC - alpha but not - zeta, can regulate the transcription factors AP - 1 and nuclear factor of activated T cells ( NF - AT - 1).	PKC - epsilon,23,36,Gene/Protein	PKC - alpha,61,72,Gene/Protein	- zeta,81,87,Gene/Protein	transcription factors,106,127,Gene/Protein	AP - 1,128,134,Gene/Protein	factor of activated T cells,147,174,Gene/Protein	NF - AT - 1,177,188,Gene/Protein	"[{""token"": ""PKC - epsilon"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""PKC - alpha"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""- zeta"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 106, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""factor of activated T cells"", ""start_span"": 147, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - 1"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Coexpression of HMG I / Y and Oct - 2 in cell lines lacking Oct - 2 results in high levels of HLA - DRA gene expression, and in vitro DNA - binding studies reveal that HMG I / Y stimulates Oct - 2A binding to the HLA - DRA promoter.	HMG I / Y,16,25,Gene/Protein	Oct - 2,30,37,Gene/Protein	Oct - 2,60,67,Gene/Protein	HLA - DRA gene,94,108,Gene/Protein	I / Y,172,177,Gene/Protein	Oct - 2A,189,197,Gene/Protein	HLA - DRA promoter,213,231,Gene/Protein	"[{""token"": ""HMG I / Y"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA gene"", ""start_span"": 94, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""I / Y"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA promoter"", ""start_span"": 213, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
We further demonstrate that Tax induction of nuclear c - Rel expression is activated by the RelA ( p65) subunit of NF - kappa B, which activates transcription of the c - rel gene through an intrinsic kappa B enhancer element.	Tax,28,31,Gene/Protein	c - Rel,53,60,Gene/Protein	RelA,92,96,Gene/Protein	p65,99,102,Gene/Protein	NF - kappa B,115,127,Gene/Protein	c - rel gene,166,178,Gene/Protein	kappa B enhancer element,200,224,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""c - rel gene"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""kappa B enhancer element"", ""start_span"": 200, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
TNF - alpha, therefore, emerges as the main factor responsible for a second phase of NF - kappa B regulation, controlling both translocation of p65 and c - rel, and new mRNA synthesis for c - rel and p105 / p50.	TNF - alpha,0,11,Gene/Protein	NF - kappa B,85,97,Gene/Protein	p65,144,147,Gene/Protein	c - rel,152,159,Gene/Protein	mRNA,169,173,Gene/Protein	c - rel,188,195,Gene/Protein	p105 / p50,200,210,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 188, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""p105 / p50"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
GM - kappa B defines a binding site for NF - kappa B, and GC - box defines a binding site for three ( A1, A2, B) constitutive proteins.	GM - kappa B,0,12,Gene/Protein	NF - kappa B,40,52,Gene/Protein	GC - box,58,66,Gene/Protein	A1,102,104,Gene/Protein	A2,106,108,Gene/Protein	B,110,111,Gene/Protein	constitutive proteins,113,134,Gene/Protein	"[{""token"": ""GM - kappa B"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""GC - box"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""A1"", ""start_span"": 102, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""A2"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 110, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""constitutive proteins"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The NR2 hybrid allowed us to exclude three candidate genes for AGS: hepatic nuclear factor 3 beta ( HNF3 beta), paired box 1 ( PAX1), and cystatin C ( CST3) as shown by their localization outside of the deletion.	candidate genes,43,58,Gene/Protein	hepatic nuclear factor 3 beta,68,97,Gene/Protein	HNF3 beta,100,109,Gene/Protein	paired box 1,112,124,Gene/Protein	PAX1,127,131,Gene/Protein	cystatin C,138,148,Gene/Protein	CST3,151,155,Gene/Protein	"[{""token"": ""candidate genes"", ""start_span"": 43, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""hepatic nuclear factor 3 beta"", ""start_span"": 68, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""HNF3 beta"", ""start_span"": 100, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""paired box 1"", ""start_span"": 112, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""PAX1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""cystatin C"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""CST3"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
The NS - Meg cells were positive for alpha - naphthyl acetate esterase and periodic acid - Schiff ( PAS) staining and for surface CD4, CD7, CD13, CD34, CD41a, and glycophorin A antigens.	alpha - naphthyl acetate esterase,37,70,Gene/Protein	CD4,130,133,Gene/Protein	CD7,135,138,Gene/Protein	CD13,140,144,Gene/Protein	CD34,146,150,Gene/Protein	CD41a,152,157,Gene/Protein	glycophorin A antigens,163,185,Gene/Protein	"[{""token"": ""alpha - naphthyl acetate esterase"", ""start_span"": 37, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CD7"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""CD13"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""CD41a"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""glycophorin A antigens"", ""start_span"": 163, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
In this paper, we report that cross - linking of CD28 ( but not CD2, CD5, LFA - 1, or CD7) leads to an elevation of c - jun mRNA, with only minimal activation of c - fos expression.	CD28,49,53,Gene/Protein	CD2,64,67,Gene/Protein	CD5,69,72,Gene/Protein	LFA - 1,74,81,Gene/Protein	CD7,86,89,Gene/Protein	c - jun mRNA,116,128,Gene/Protein	c - fos,162,169,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 1"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CD7"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""c - jun mRNA"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Constitutive NF - kappa B was not maintained by autocrine action of cytokines TNF, interleukin 6, interleukin 10, granulocyte - macrophage colony - stimulating factor or macrophage colony - stimulating factor, since neutralizing antibodies did not reduce constitutive DNA - binding activity.	NF - kappa B,13,25,Gene/Protein	cytokines,68,77,Gene/Protein	TNF,78,81,Gene/Protein	interleukin 6,83,96,Gene/Protein	interleukin,98,109,Gene/Protein	granulocyte - macrophage colony - stimulating factor,114,166,Gene/Protein	macrophage colony - stimulating factor,170,208,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 6"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""interleukin"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 114, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""macrophage colony - stimulating factor"", ""start_span"": 170, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
Removal of the carboxy terminus enables ERP to interact with a variety of ets - binding sites including the E74 site, the IgH enhancer pi site, and the lck promoter ets site, suggesting a carboxy - terminal negative regulatory domain.	carboxy terminus,15,31,Gene/Protein	ERP,40,43,Gene/Protein	ets - binding sites,74,93,Gene/Protein	E74 site,108,116,Gene/Protein	IgH enhancer pi site,122,142,Gene/Protein	lck promoter ets site,152,173,Gene/Protein	carboxy - terminal negative regulatory domain,188,233,Gene/Protein	"[{""token"": ""carboxy terminus"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ERP"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ets - binding sites"", ""start_span"": 74, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""E74 site"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer pi site"", ""start_span"": 122, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""lck promoter ets site"", ""start_span"": 152, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""carboxy - terminal negative regulatory domain"", ""start_span"": 188, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
We focused our studies on the role of Pit - 1 and of PR as potential transcriptional regulators, since the POU domain protein Pit - 1 is essential in the control of pituitary PRL expression, and progesterone induces decidual transformation of the endometrial stroma, a differentiation process during which the decidual PRL gene is activated.	Pit - 1,38,45,Gene/Protein	PR,53,55,Gene/Protein	transcriptional regulators,69,95,Gene/Protein	POU domain protein,107,125,Gene/Protein	Pit - 1,126,133,Gene/Protein	PRL,175,178,Gene/Protein	PRL gene,319,327,Gene/Protein	"[{""token"": ""Pit - 1"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 69, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""POU domain protein"", ""start_span"": 107, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Pit - 1"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""PRL"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""PRL gene"", ""start_span"": 319, ""end_span"": 327, ""type"": ""Gene/Protein""}]"	train
NF - kappa B ( P65 or P65 / P50 heterodimer) bound to the P sequence in electrophoretic mobility shift assays ( EMSA) and activated transcription through the P sequence when expression plasmids were cotransfected with P sequence - driven reporter plasmids in Jurkat T cells.	NF - kappa B,0,12,Gene/Protein	P65,15,18,Gene/Protein	P65 / P50 heterodimer,22,43,Gene/Protein	P sequence,58,68,Gene/Protein	P sequence,158,168,Gene/Protein	expression plasmids,174,193,Gene/Protein	P sequence - driven reporter plasmids,218,255,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""P65"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""P65 / P50 heterodimer"", ""start_span"": 22, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""expression plasmids"", ""start_span"": 174, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""P sequence - driven reporter plasmids"", ""start_span"": 218, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Wild - type and chimeric HLF proteins also bound closely related sites identified previously for bZIP proteins of both the proline - and acidic amino acid - rich ( PAR) and C / EBP subfamilies; however, E2A - HLF proteins were significantly less tolerant of certain deviations from the HLF consensus binding site.	chimeric HLF proteins,16,37,Gene/Protein	bZIP proteins,97,110,Gene/Protein	proline,123,130,Gene/Protein	PAR,164,167,Gene/Protein	C / EBP subfamilies,173,192,Gene/Protein	E2A - HLF,203,212,Gene/Protein	HLF consensus binding site,286,312,Gene/Protein	"[{""token"": ""chimeric HLF proteins"", ""start_span"": 16, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""bZIP proteins"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""proline"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""PAR"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP subfamilies"", ""start_span"": 173, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 203, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""HLF consensus binding site"", ""start_span"": 286, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
Although no qualitative difference was observed between specific granules and gelatinase granules with respect to cytochrome b558 and Mac - 1, stimulation of the neutrophil with FMLP resulted in a selective mobilization of the least dense peroxidase - negative granules, ie, gelatinase granules, which, in concert with secretory vesicles, furnish the plasma membrane with Mac - 1 and cytochrome b558.	gelatinase,78,88,Gene/Protein	cytochrome b558,114,129,Gene/Protein	Mac - 1,134,141,Gene/Protein	FMLP,178,182,Gene/Protein	gelatinase,275,285,Gene/Protein	Mac - 1,372,379,Gene/Protein	cytochrome b558,384,399,Gene/Protein	"[{""token"": ""gelatinase"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""cytochrome b558"", ""start_span"": 114, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 1"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""FMLP"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""gelatinase"", ""start_span"": 275, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 1"", ""start_span"": 372, ""end_span"": 379, ""type"": ""Gene/Protein""}, {""token"": ""cytochrome b558"", ""start_span"": 384, ""end_span"": 399, ""type"": ""Gene/Protein""}]"	train
We demonstrate that the staphylococcal superantigens toxic shock syndrome toxin - 1 ( TSST - 1) and staphylococcal enterotoxin A ( SEA) activate HIV - 1 - LTR - driven transcription of chloramphenicol acetyl transferase in the human monocytic cell line THP - 1.	staphylococcal superantigens,24,52,Gene/Protein	toxic shock syndrome toxin - 1,53,83,Gene/Protein	TSST - 1,86,94,Gene/Protein	staphylococcal enterotoxin A,100,128,Gene/Protein	SEA,131,134,Gene/Protein	HIV - 1 - LTR,145,158,Gene/Protein	chloramphenicol acetyl transferase,185,219,Gene/Protein	"[{""token"": ""staphylococcal superantigens"", ""start_span"": 24, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""toxic shock syndrome toxin - 1"", ""start_span"": 53, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""TSST - 1"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal enterotoxin A"", ""start_span"": 100, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""SEA"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 - LTR"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl transferase"", ""start_span"": 185, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
In contrast, FK506 or EGTA ( Ca2 + chelator) similarly affected the formation of kappa B - like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins ( c - Rel, p65, p50, and p49).	kappa B - like site binding complexes,81,118,Gene/Protein	antibodies,153,163,Gene/Protein	human Rel family proteins,176,201,Gene/Protein	c - Rel,204,211,Gene/Protein	p65,213,216,Gene/Protein	p50,218,221,Gene/Protein	p49,227,230,Gene/Protein	"[{""token"": ""kappa B - like site binding complexes"", ""start_span"": 81, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""human Rel family proteins"", ""start_span"": 176, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""p49"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Site B ( nt 4519 to 4545) specifically bound four distinct nuclear protein complexes: a ubiquitous factor, a T - cell - specific factor, a B - cell - specific factor, and the monocyte / macrophage - and B - cell - specific transcription factor PU. 1 / Spi - 1.	Site B,0,6,Gene/Protein	nt 4519 to 4545,9,24,Gene/Protein	nuclear protein complexes,59,84,Gene/Protein	ubiquitous factor,88,105,Gene/Protein	T - cell - specific factor,109,135,Gene/Protein	B - cell - specific factor,139,165,Gene/Protein	monocyte / macrophage - and B - cell - specific transcription factor,175,243,Gene/Protein	"[{""token"": ""Site B"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""nt 4519 to 4545"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""nuclear protein complexes"", ""start_span"": 59, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous factor"", ""start_span"": 88, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific factor"", ""start_span"": 109, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific factor"", ""start_span"": 139, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""monocyte / macrophage - and B - cell - specific transcription factor"", ""start_span"": 175, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Pretreatment of cells with protein tyrosine kinase inhibitors and the dominant negative allele of c - Raf - 1 ( Raf 301) inhibited I kappa B alpha degradation, NF - kappa B binding, and transactivation of kappa B reporter constructs by hypoxia.	tyrosine kinase,35,50,Gene/Protein	dominant negative allele,70,94,Gene/Protein	c - Raf - 1,98,109,Gene/Protein	Raf 301,112,119,Gene/Protein	I kappa B alpha,131,146,Gene/Protein	NF - kappa B,160,172,Gene/Protein	kappa B reporter constructs,205,232,Gene/Protein	"[{""token"": ""tyrosine kinase"", ""start_span"": 35, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative allele"", ""start_span"": 70, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""c - Raf - 1"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Raf 301"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 160, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""kappa B reporter constructs"", ""start_span"": 205, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
Most importantly, we show a Tax - dependent correlation between expression of NFKB2 ( p100) and processing to the DNA binding NFKB2 ( p52) form, induction of c - Rel, and trans - activation of NF - kappa B - mediated gene expression.	Tax,28,31,Gene/Protein	NFKB2,78,83,Gene/Protein	p100,86,90,Gene/Protein	NFKB2,126,131,Gene/Protein	p52,134,137,Gene/Protein	c - Rel,158,165,Gene/Protein	NF - kappa B,193,205,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
In clonogenetic fetal calf serum - supplemented ( FCS +) or - nonsupplemented ( FCS -) culture treated with saturating levels of interleukin - 3 ( IL - 3) granulocyte - macrophage colony - stimulating factor ( GM - CSF) and erythropoietin ( Ep) ( combined with c - kit ligand in FCS ( -) - culture conditions), RA induces a dramatic dose - dependent shift from erythroid to granulomonocytic colony formation, the latter colonies being essentially represented by granulocytic clones.	interleukin - 3,129,144,Gene/Protein	IL - 3,147,153,Gene/Protein	granulocyte - macrophage colony - stimulating factor,155,207,Gene/Protein	GM - CSF,210,218,Gene/Protein	erythropoietin,224,238,Gene/Protein	Ep,241,243,Gene/Protein	c - kit,261,268,Gene/Protein	"[{""token"": ""interleukin - 3"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 155, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 224, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""Ep"", ""start_span"": 241, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""c - kit"", ""start_span"": 261, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
Furthermore, R24 treatment resulted in translocation of c - rel, but little or no NF kappa B p50 or p65, from the cytoplasm to the nucleus and an increase of NF kappa B binding complexes containing c - rel and p50.	R24,13,16,Gene/Protein	c - rel,56,63,Gene/Protein	NF kappa B p50,82,96,Gene/Protein	p65,100,103,Gene/Protein	NF kappa B binding complexes,158,186,Gene/Protein	c - rel,198,205,Gene/Protein	p50,210,213,Gene/Protein	"[{""token"": ""R24"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B p50"", ""start_span"": 82, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B binding complexes"", ""start_span"": 158, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 210, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
By assaying CAT enzyme activity across a 24 - h PRL induction time course, we were able to assign G1 vs. S phase PRL responses of the IRF - 1 gene to different regions of the IRF - 1 5 ' - flanking and promoter DNA.	CAT enzyme,12,22,Gene/Protein	PRL,48,51,Gene/Protein	PRL,113,116,Gene/Protein	IRF - 1 gene,134,146,Gene/Protein	IRF - 1,175,182,Gene/Protein	5 ' - flanking,183,197,Gene/Protein	promoter DNA,202,214,Gene/Protein	"[{""token"": ""CAT enzyme"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""PRL"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""PRL"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 gene"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""promoter DNA"", ""start_span"": 202, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
Two multicopy basal enhancer motifs within the SCMV MIE enhancer, namely, 11 copies of the 16 - bp cyclic AMP response element ( CRE) and 3 copies of novel 17 - bp serum response factor ( SRF) binding sites referred to as the SNE ( SRF / NFkappaB - like element), as well as four classical NFkappaB sites within the HCMV version, contribute to TPA responsiveness in transient assays in monocyte and T - cell types.	multicopy basal enhancer motifs,4,35,Gene/Protein	MIE enhancer,52,64,Gene/Protein	cyclic AMP response element,99,126,Gene/Protein	CRE,129,132,Gene/Protein	SNE,226,229,Gene/Protein	SRF / NFkappaB - like element,232,261,Gene/Protein	NFkappaB sites,290,304,Gene/Protein	"[{""token"": ""multicopy basal enhancer motifs"", ""start_span"": 4, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""MIE enhancer"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP response element"", ""start_span"": 99, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""SNE"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""SRF / NFkappaB - like element"", ""start_span"": 232, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB sites"", ""start_span"": 290, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	train
In particular, Tax is capable of modulating the expression or activity of various host transcription factors, including members of the NF - kappa B / Rel and CREB / ATF families, as well as the cellular factors HEB - 1 and p67SRF.	Tax,15,18,Gene/Protein	transcription factors,87,108,Gene/Protein	NF - kappa B / Rel,135,153,Gene/Protein	CREB / ATF families,158,177,Gene/Protein	cellular factors,194,210,Gene/Protein	HEB - 1,211,218,Gene/Protein	p67SRF,223,229,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 87, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF families"", ""start_span"": 158, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""cellular factors"", ""start_span"": 194, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""HEB - 1"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""p67SRF"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
This contrasts with induction of c - fos by both CD40 and sIg, which is PKC independent and indicates that CD40 is capable of signaling through PKC or a closely related kinase.	c - fos,33,40,Gene/Protein	CD40,49,53,Gene/Protein	sIg,58,61,Gene/Protein	PKC,72,75,Gene/Protein	CD40,107,111,Gene/Protein	PKC,144,147,Gene/Protein	kinase,169,175,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""sIg"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
We now show that in EBV - transformed B lymphocytes most of TRAF1 or TRAF3 and 5% of TRAF2 are associated with LMP1 and that most of LMP1 is associated with TRAF1 or TRAF3.	TRAF1,60,65,Gene/Protein	TRAF3,69,74,Gene/Protein	TRAF2,85,90,Gene/Protein	LMP1,111,115,Gene/Protein	LMP1,133,137,Gene/Protein	TRAF1,157,162,Gene/Protein	TRAF3,166,171,Gene/Protein	"[{""token"": ""TRAF1"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""TRAF1"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
The Rel / NF - kappa B proteins, p50, p52, p65, c - Rel, and RelB, constitute a family of transcription factors involved in the positive regulation of a variety of genes during the immune response.	Rel / NF - kappa B proteins,4,31,Gene/Protein	p50,33,36,Gene/Protein	p52,38,41,Gene/Protein	p65,43,46,Gene/Protein	c - Rel,48,55,Gene/Protein	RelB,61,65,Gene/Protein	transcription factors,90,111,Gene/Protein	"[{""token"": ""Rel / NF - kappa B proteins"", ""start_span"": 4, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 90, ""end_span"": 111, ""type"": ""Gene/Protein""}]"	train
In this study, we isolated the genomic DNA for human IRF - 2 gene, determined the intron - exon structure of the human IRF - 2 gene, mapped the major transcription initiation site, identified a number of potential regulatory elements in the 5 ' - flanking region, and localized the IRF - 2 gene on human chromosome 4.	genomic DNA,31,42,Gene/Protein	human IRF - 2 gene,47,65,Gene/Protein	human IRF - 2 gene,113,131,Gene/Protein	major transcription initiation site,144,179,Gene/Protein	5 ' - flanking region,241,262,Gene/Protein	IRF - 2 gene,282,294,Gene/Protein	human chromosome 4,298,316,Gene/Protein	"[{""token"": ""genomic DNA"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""human IRF - 2 gene"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""human IRF - 2 gene"", ""start_span"": 113, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""major transcription initiation site"", ""start_span"": 144, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 241, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 2 gene"", ""start_span"": 282, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 4"", ""start_span"": 298, ""end_span"": 316, ""type"": ""Gene/Protein""}]"	train
The promoter region lacked a TATA box but contained potential binding sites for the transcriptional factors including two Sp1, CRE, Myb and NFkB located at positions - 153, - 178, - 286, - 875, and - 1011, respectively.	promoter region,4,19,Gene/Protein	TATA box,29,37,Gene/Protein	transcriptional factors,84,107,Gene/Protein	Sp1,122,125,Gene/Protein	CRE,127,130,Gene/Protein	Myb,132,135,Gene/Protein	NFkB,140,144,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional factors"", ""start_span"": 84, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Myb"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NFkB"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
Constitutive binding of further factor proteins to DNA, such as JunD, c - Fos and FosB, was detected in several patients whereas the localisation and DNA binding of other factors such as c - Jun, RelA / p65 and c - Rel was unaltered.	factor proteins,32,47,Gene/Protein	JunD,64,68,Gene/Protein	c - Fos,70,77,Gene/Protein	FosB,82,86,Gene/Protein	c - Jun,187,194,Gene/Protein	RelA / p65,196,206,Gene/Protein	c - Rel,211,218,Gene/Protein	"[{""token"": ""factor proteins"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""FosB"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""RelA / p65"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
Furthermore both childrens ' T cells were unable to produce the cytokines IL - 2, interferon - gamma ( IFN - gamma), IL - 4 and tumor necrosis factor - alpha ( TNF - alpha).	cytokines,64,73,Gene/Protein	IL - 2,74,80,Gene/Protein	interferon - gamma,82,100,Gene/Protein	IFN - gamma,103,114,Gene/Protein	IL - 4,117,123,Gene/Protein	tumor necrosis factor - alpha,128,157,Gene/Protein	TNF - alpha,160,171,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 82, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 128, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
These results suggest that phosphorylated pRB is constitutively expressed in MM cells and that IL - 6 further shifts pRB from its dephosphorylated to its phosphorylated form, thereby promoting MM cell growth via two mechanisms; by decreasing the amount of E2F bound by dephosphorylated pRB due to reduced dephosphorylated pRB, thereby releasing growth arrest; and by upregulating IL - 6 secretion by MM cells and related IL - 6 - mediated autocrine tumor cell growth.	phosphorylated pRB,27,45,Gene/Protein	IL - 6,95,101,Gene/Protein	pRB,117,120,Gene/Protein	dephosphorylated pRB,269,289,Gene/Protein	dephosphorylated pRB,305,325,Gene/Protein	IL - 6,380,386,Gene/Protein	IL - 6,421,427,Gene/Protein	"[{""token"": ""phosphorylated pRB"", ""start_span"": 27, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""pRB"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""dephosphorylated pRB"", ""start_span"": 269, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""dephosphorylated pRB"", ""start_span"": 305, ""end_span"": 325, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 380, ""end_span"": 386, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 421, ""end_span"": 427, ""type"": ""Gene/Protein""}]"	train
p38 and p63 may provide a docking site for Grb2, thereby linking Grb2 SH3 - binding proteins SOS1, SLP - 76, and p120 to downstream signalling events.	p38,0,3,Gene/Protein	p63,8,11,Gene/Protein	Grb2,43,47,Gene/Protein	Grb2 SH3 - binding proteins,65,92,Gene/Protein	SOS1,93,97,Gene/Protein	SLP - 76,99,107,Gene/Protein	p120,113,117,Gene/Protein	"[{""token"": ""p38"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""p63"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Grb2 SH3 - binding proteins"", ""start_span"": 65, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""SOS1"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""p120"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
In this study, we characterize an essential upstream IL - 2 response element that contains both consensus and non - consensus GAS motifs, two putative Ets binding sites ( EBS), one of which overlaps the consensus GAS motif, and a GATA motif, which overlaps the non - consensus GAS motif.	IL - 2 response element,53,76,Gene/Protein	consensus and non - consensus GAS motifs,96,136,Gene/Protein	Ets binding sites,151,168,Gene/Protein	EBS,171,174,Gene/Protein	consensus GAS motif,203,222,Gene/Protein	GATA motif,230,240,Gene/Protein	non - consensus GAS motif,261,286,Gene/Protein	"[{""token"": ""IL - 2 response element"", ""start_span"": 53, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""consensus and non - consensus GAS motifs"", ""start_span"": 96, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Ets binding sites"", ""start_span"": 151, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""consensus GAS motif"", ""start_span"": 203, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""GATA motif"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""non - consensus GAS motif"", ""start_span"": 261, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
The proximal region in PFP9a20 contained two potential Sp1 binding sites ( GC box and GT box) and one Ets binding site ( EBS).	proximal region,4,19,Gene/Protein	PFP9a20,23,30,Gene/Protein	Sp1 binding sites,55,72,Gene/Protein	GC box,75,81,Gene/Protein	GT box,86,92,Gene/Protein	Ets binding site,102,118,Gene/Protein	EBS,121,124,Gene/Protein	"[{""token"": ""proximal region"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""PFP9a20"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 binding sites"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""GC box"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GT box"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Ets binding site"", ""start_span"": 102, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
In contrast, engagement of the TCR by class II MHC / superantigen, either with or without CD28 ligation, resulted in the induction of NF - AT, AP - 1, and NF - kappaB as well as IL - 2 production.	TCR,31,34,Gene/Protein	class II MHC / superantigen,38,65,Gene/Protein	CD28,90,94,Gene/Protein	NF - AT,134,141,Gene/Protein	AP - 1,143,149,Gene/Protein	NF - kappaB,155,166,Gene/Protein	IL - 2,178,184,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""class II MHC / superantigen"", ""start_span"": 38, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Similar to expression of IL - 2, we demonstrated that recombinant vascular - cell adhesion molecule - 1, when co - immobilized with anti - CD3 mAb, significantly enhanced the induction of transcription factors NF - AT, AP - 1, and NF - kappa B as determined by electromobility shift assays.	IL - 2,25,31,Gene/Protein	recombinant vascular - cell adhesion molecule - 1,54,103,Gene/Protein	anti - CD3 mAb,132,146,Gene/Protein	transcription factors,188,209,Gene/Protein	NF - AT,210,217,Gene/Protein	AP - 1,219,225,Gene/Protein	NF - kappa B,231,243,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""recombinant vascular - cell adhesion molecule - 1"", ""start_span"": 54, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 mAb"", ""start_span"": 132, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 188, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 219, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 231, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Analysis of the expression of genes reported to regulate cytokine - induced proliferation demonstrated that both IL - 2 and IL - 12 induce c - myc mRNA accumulation in NK and T cells, whereas only IL - 2 induces bcl - 2 expression.	genes,30,35,Gene/Protein	cytokine,57,65,Gene/Protein	IL - 2,113,119,Gene/Protein	IL - 12,124,131,Gene/Protein	c - myc mRNA,139,151,Gene/Protein	IL - 2,197,203,Gene/Protein	bcl - 2,212,219,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""c - myc mRNA"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Our data provide the first demonstration that IL - 12 - mediated activation of T and NK cells does not involve expression of members of the immediate - early activation genes family ( egr - 1, c - fos, and junB), AP - 1 transcriptional activity, or bcl - 2 expression.	IL - 12,46,53,Gene/Protein	immediate - early activation genes family,140,181,Gene/Protein	egr - 1,184,191,Gene/Protein	c - fos,193,200,Gene/Protein	junB,206,210,Gene/Protein	AP - 1,213,219,Gene/Protein	bcl - 2,249,256,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early activation genes family"", ""start_span"": 140, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""egr - 1"", ""start_span"": 184, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 249, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
We show here that the plasma cell - specific repressor function, designated SIR ( suppressor of immune response genes), does not act directly on the transcription of class II genes, but instead on the transcription of the AIR - 1 gene, whose product, the class II transactivator ( CIITA), is fundamental for the regulation of the constitutive and inducible expression of MHC class II genes.	SIR,76,79,Gene/Protein	suppressor of immune response genes,82,117,Gene/Protein	class II genes,166,180,Gene/Protein	AIR - 1 gene,222,234,Gene/Protein	class II transactivator,255,278,Gene/Protein	CIITA,281,286,Gene/Protein	MHC class II genes,371,389,Gene/Protein	"[{""token"": ""SIR"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""suppressor of immune response genes"", ""start_span"": 82, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""class II genes"", ""start_span"": 166, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""AIR - 1 gene"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""class II transactivator"", ""start_span"": 255, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 281, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II genes"", ""start_span"": 371, ""end_span"": 389, ""type"": ""Gene/Protein""}]"	train
Effects of IL - 10 and IL - 4 on LPS - induced transcription factors ( AP - 1, NF - IL6 and NF - kappa B) which are involved in IL - 6 regulation.	IL - 10,11,18,Gene/Protein	IL - 4,23,29,Gene/Protein	transcription factors,47,68,Gene/Protein	AP - 1,71,77,Gene/Protein	NF - IL6,79,87,Gene/Protein	NF - kappa B,92,104,Gene/Protein	IL - 6,128,134,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The use of the protein tyrosine kinase ( PTK) - specific inhibitor herbimycin A dramatically decreased cellular proliferation without altering the activity of the human immunodeficiency virus - 1 long terminal repeat ( HIV - 1 LTR), a promoter largely dependent on the binding of nuclear factor kappa B ( NF - kappa B).	protein tyrosine kinase,15,38,Gene/Protein	PTK,41,44,Gene/Protein	human immunodeficiency virus - 1 long terminal repeat,163,216,Gene/Protein	HIV - 1 LTR,219,230,Gene/Protein	promoter,235,243,Gene/Protein	nuclear factor kappa B,280,302,Gene/Protein	NF - kappa B,305,317,Gene/Protein	"[{""token"": ""protein tyrosine kinase"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""human immunodeficiency virus - 1 long terminal repeat"", ""start_span"": 163, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 280, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 305, ""end_span"": 317, ""type"": ""Gene/Protein""}]"	train
By using 70Z / 3 - derived pre - B - cell lines either lacking or expressing human CD14 ( the LPS receptor), it was observed that expression of human CD14 imparted responsiveness to LPS but not to OspA or spirochetal lipopeptides ( assessed by induction of NF - kappa B and expression of surface immunoglobulin M).	human CD14,77,87,Gene/Protein	LPS receptor,94,106,Gene/Protein	human CD14,144,154,Gene/Protein	OspA,197,201,Gene/Protein	spirochetal lipopeptides,205,229,Gene/Protein	NF - kappa B,257,269,Gene/Protein	surface immunoglobulin M,288,312,Gene/Protein	"[{""token"": ""human CD14"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LPS receptor"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""human CD14"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""OspA"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""spirochetal lipopeptides"", ""start_span"": 205, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 257, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""surface immunoglobulin M"", ""start_span"": 288, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
The transcription factor, Nuclear Factor of Activated T cells ( NFAT) is a major target for p21ras and calcium signalling pathways in the IL - 2 gene and is induced by p21ras signals acting in synergy with calcium / calcineurin signals.	transcription factor,4,24,Gene/Protein	Nuclear Factor of Activated T cells,26,61,Gene/Protein	NFAT,64,68,Gene/Protein	p21ras,92,98,Gene/Protein	IL - 2 gene,138,149,Gene/Protein	p21ras,168,174,Gene/Protein	/ calcineurin,214,227,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Nuclear Factor of Activated T cells"", ""start_span"": 26, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""/ calcineurin"", ""start_span"": 214, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
Constitutively active MAPKK - 1 fully activates ERK - 2 and the transcription factor Elk - 1, but does not substitute for activated p21ras and synergize with calcium / calcineurin signals to induce NFAT.	MAPKK - 1,22,31,Gene/Protein	ERK - 2,48,55,Gene/Protein	transcription factor,64,84,Gene/Protein	Elk - 1,85,92,Gene/Protein	p21ras,132,138,Gene/Protein	/ calcineurin,166,179,Gene/Protein	NFAT,198,202,Gene/Protein	"[{""token"": ""MAPKK - 1"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ERK - 2"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 64, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Elk - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""/ calcineurin"", ""start_span"": 166, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
In NK3. 3 cells, IL - 2 induced comparable formation of c - fos promoter sis - inducible element IFN - gamma - activated sequence - binding complexes containing STAT3 alone with complexes containing STAT3 and STAT1 alpha, while in preactivated primary NK cells, it preferentially induced complexes containing STAT3 and STAT1 alpha.	IL - 2,17,23,Gene/Protein	c - fos promoter sis - inducible element IFN - gamma - activated sequence - binding complexes,56,149,Gene/Protein	STAT3,161,166,Gene/Protein	STAT3,199,204,Gene/Protein	STAT1 alpha,209,220,Gene/Protein	STAT3,309,314,Gene/Protein	STAT1 alpha,319,330,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""c - fos promoter sis - inducible element IFN - gamma - activated sequence - binding complexes"", ""start_span"": 56, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 309, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 319, ""end_span"": 330, ""type"": ""Gene/Protein""}]"	train
Cytokines that bind to the interleukin - 2 ( IL - 2) receptor common gamma chain ( gamma c), including IL - 2, IL - 4, IL - 7, IL - 9, and IL - 15, are important for the growth and differentiation of T and B lymphocytes, natural killer cells, macrophages, and monoctyes.	Cytokines,0,9,Gene/Protein	gamma c,69,76,Gene/Protein	IL - 2,103,109,Gene/Protein	IL - 4,111,117,Gene/Protein	IL - 7,119,125,Gene/Protein	IL - 9,127,133,Gene/Protein	IL - 15,139,146,Gene/Protein	"[{""token"": ""Cytokines"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""gamma c"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
To define the activation of the STAT5 homologues and lower molecular weight variant in human monocytes and monocytes differentiated into macrophages by culture in macrophage - CSF ( M - CSF), we measured the GM - CSF induced tyrosine phosphorylation of STAT5A, STAT5B, and any lower molecular weight STAT5 isoforms.	STAT5 homologues,32,48,Gene/Protein	macrophage - CSF,163,179,Gene/Protein	M - CSF,182,189,Gene/Protein	GM - CSF,208,216,Gene/Protein	STAT5A,253,259,Gene/Protein	STAT5B,261,267,Gene/Protein	STAT5 isoforms,300,314,Gene/Protein	"[{""token"": ""STAT5 homologues"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""macrophage - CSF"", ""start_span"": 163, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""STAT5A"", ""start_span"": 253, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 261, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""STAT5 isoforms"", ""start_span"": 300, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	train
Whereas 94 - kD STAT5A was clearly tyrosine phosphorylated and bound to the enhancer element, the gamma response region ( GRR), of the Fc gamma RI gene, substantially less tyrosine phosphorylated STAT5B bound to the immobilized GRR element.	94 - kD STAT5A,8,22,Gene/Protein	enhancer element,76,92,Gene/Protein	gamma response region,98,119,Gene/Protein	GRR,122,125,Gene/Protein	Fc gamma RI gene,135,151,Gene/Protein	STAT5B,196,202,Gene/Protein	GRR element,228,239,Gene/Protein	"[{""token"": ""94 - kD STAT5A"", ""start_span"": 8, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""enhancer element"", ""start_span"": 76, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""gamma response region"", ""start_span"": 98, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""GRR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RI gene"", ""start_span"": 135, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GRR element"", ""start_span"": 228, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Both IL - 13 and IL - 4 induced phosphorylation of IL - 4 STAT ( STAT6) but not STAT1, STAT3, or STAT5.	IL - 13,5,12,Gene/Protein	IL - 4,17,23,Gene/Protein	IL - 4 STAT,51,62,Gene/Protein	STAT6,65,70,Gene/Protein	STAT1,80,85,Gene/Protein	STAT3,87,92,Gene/Protein	STAT5,97,102,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 STAT"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	train
The involvement of members of the PEBP2 / CBF family in chromosome translocations associated with acute myeloid leukemia, and in the transcriptional regulation of the myeloid - specific genes encoding for myeloperoxidase, elastase, and the colony - stimulating factor receptor, highlights the relevance of the regulation of the CD36 gene promoter in monocytic cells by members of the PEBP2 / CBF family.	PEBP2 / CBF family,34,52,Gene/Protein	myeloid - specific genes,167,191,Gene/Protein	myeloperoxidase,205,220,Gene/Protein	elastase,222,230,Gene/Protein	colony - stimulating factor receptor,240,276,Gene/Protein	CD36 gene promoter,328,346,Gene/Protein	PEBP2 / CBF family,384,402,Gene/Protein	"[{""token"": ""PEBP2 / CBF family"", ""start_span"": 34, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""myeloid - specific genes"", ""start_span"": 167, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""myeloperoxidase"", ""start_span"": 205, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""elastase"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""colony - stimulating factor receptor"", ""start_span"": 240, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""CD36 gene promoter"", ""start_span"": 328, ""end_span"": 346, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 / CBF family"", ""start_span"": 384, ""end_span"": 402, ""type"": ""Gene/Protein""}]"	train
The immediate - early gene egr - 1 encodes a transcription factor ( EGR1) that links B - cell antigen receptor ( BCR) signals to downstream activation events through the regulation of previously unidentified target genes.	immediate - early gene,4,26,Gene/Protein	egr - 1,27,34,Gene/Protein	transcription factor,45,65,Gene/Protein	EGR1,68,72,Gene/Protein	B - cell antigen receptor,85,110,Gene/Protein	BCR,113,116,Gene/Protein	target genes,208,220,Gene/Protein	"[{""token"": ""immediate - early gene"", ""start_span"": 4, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""egr - 1"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""EGR1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""B - cell antigen receptor"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""BCR"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
We have previously shown that a DNA - binding factor specific to adult hematopoietic cells ( polypryrimidine - binding factor, PYBF) binds to a pyrimidine - rich region 1 kb upstream from the human delta - globin - encoding gene ( HBD).	DNA - binding factor,32,52,Gene/Protein	polypryrimidine - binding factor,93,125,Gene/Protein	PYBF,127,131,Gene/Protein	pyrimidine - rich region,144,168,Gene/Protein	1 kb upstream,169,182,Gene/Protein	human delta - globin - encoding gene,192,228,Gene/Protein	HBD,231,234,Gene/Protein	"[{""token"": ""DNA - binding factor"", ""start_span"": 32, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""polypryrimidine - binding factor"", ""start_span"": 93, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""PYBF"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""pyrimidine - rich region"", ""start_span"": 144, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""1 kb upstream"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""human delta - globin - encoding gene"", ""start_span"": 192, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
In the locus control region ( LCR) of the beta - globin locus, in vivo footprints on NF - E2 ( or AP - 1) and GATA - 1 motifs remained the same regardless of whether the fetal or the adult globin genes are expressed.	locus control region,7,27,Gene/Protein	LCR,30,33,Gene/Protein	beta - globin locus,42,61,Gene/Protein	NF - E2,85,92,Gene/Protein	AP - 1,98,104,Gene/Protein	GATA - 1 motifs,110,125,Gene/Protein	adult globin genes,183,201,Gene/Protein	"[{""token"": ""locus control region"", ""start_span"": 7, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin locus"", ""start_span"": 42, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1 motifs"", ""start_span"": 110, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""adult globin genes"", ""start_span"": 183, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Galectin - 3 is a beta - galactoside - binding lectin previously designated as epsilon BP ( IgE - binding protein), CBP35, Mac - 2, L - 29, and L - 34, and its expression has been associated with various physiological and pathological processes, including cell growth, tumor transformation, and metastasis.	beta - galactoside - binding lectin,18,53,Gene/Protein	epsilon BP,79,89,Gene/Protein	IgE - binding protein,92,113,Gene/Protein	CBP35,116,121,Gene/Protein	Mac - 2,123,130,Gene/Protein	L - 29,132,138,Gene/Protein	L - 34,144,150,Gene/Protein	"[{""token"": ""beta - galactoside - binding lectin"", ""start_span"": 18, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""epsilon BP"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IgE - binding protein"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CBP35"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""L - 29"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""L - 34"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
We previously demonstrated that both synthetic ( Exosurf) and modified natural surfactant ( Survanta) downregulated endotoxin - stimulated inflammatory c ytokine mRNA levels and protein products ( tumor necrosis factor - alpha [ TNF], interleukin - 1 - beta [ IL - 1], interleukin - 6 [ IL - 6]) in human alveolar macrophages.	inflammatory c ytokine mRNA,139,166,Gene/Protein	protein products,178,194,Gene/Protein	tumor necrosis factor - alpha,197,226,Gene/Protein	interleukin - 1 - beta,235,257,Gene/Protein	IL - 1,260,266,Gene/Protein	interleukin - 6,269,284,Gene/Protein	IL - 6,287,293,Gene/Protein	"[{""token"": ""inflammatory c ytokine mRNA"", ""start_span"": 139, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""protein products"", ""start_span"": 178, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 197, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1 - beta"", ""start_span"": 235, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 260, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 269, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
In combination with TNF - alpha, IL - 10 stimulated activating protein - 1 ( AP - 1) and nuclear factor ( NF) - kappa B binding activities and cooperated to increase HIV - 1 steady - state mRNA levels and enhance long terminal repeat - directed transcription through activation of the NF - kappa B binding sites, suggesting the IL - 10 effect occurs at least in part at the transcriptional level.	TNF - alpha,20,31,Gene/Protein	IL - 10,33,40,Gene/Protein	activating protein - 1,52,74,Gene/Protein	AP - 1,77,83,Gene/Protein	long terminal repeat,213,233,Gene/Protein	NF - kappa B binding sites,285,311,Gene/Protein	IL - 10,328,335,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""activating protein - 1"", ""start_span"": 52, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 213, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding sites"", ""start_span"": 285, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 328, ""end_span"": 335, ""type"": ""Gene/Protein""}]"	train
We show that an inhibitor of protein phosphatases ( PPs) PP1 / PP2A, calyculin A, induces ( i) phosphorylation of STAT3 on serine and threonine residues, ( ii) inhibition of STAT3 tyrosine phosphorylation and DNA binding activity, and ( iii) relocation of STAT3 from the nucleus to the cytoplasm.	protein phosphatases,29,49,Gene/Protein	PPs,52,55,Gene/Protein	PP1 / PP2A,57,67,Gene/Protein	calyculin A,69,80,Gene/Protein	STAT3,114,119,Gene/Protein	STAT3,174,179,Gene/Protein	STAT3,256,261,Gene/Protein	"[{""token"": ""protein phosphatases"", ""start_span"": 29, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""PPs"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""PP1 / PP2A"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""calyculin A"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 256, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
IL - 10 - activated STAT1 could bind to the GAS - motif sequence in the promoter region of the Fcgamma receptor, but not to that in the promoter region of the COX - 2 gene, whereas IFN - gamma - activated STAT1 and STAT5 could bind to both sequences.	IL - 10 - activated STAT1,0,25,Gene/Protein	GAS - motif sequence,44,64,Gene/Protein	Fcgamma receptor,95,111,Gene/Protein	promoter region,136,151,Gene/Protein	COX - 2 gene,159,171,Gene/Protein	IFN - gamma - activated STAT1,181,210,Gene/Protein	STAT5,215,220,Gene/Protein	"[{""token"": ""IL - 10 - activated STAT1"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""GAS - motif sequence"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Fcgamma receptor"", ""start_span"": 95, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""COX - 2 gene"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - activated STAT1"", ""start_span"": 181, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
After up to 90 min exposure time ELISA, EMSA ( electromobility shift assay) and RT - PCR were used to measure protein tyrosine kinase activity, protein activity of NF - kappaB and cytokine ( IL - 1beta, IL - 6, TNF - alpha) specific mRNA levels in BEAS - 2B cells.	protein tyrosine kinase,110,133,Gene/Protein	NF - kappaB,164,175,Gene/Protein	cytokine,180,188,Gene/Protein	IL - 1beta,191,201,Gene/Protein	IL - 6,203,209,Gene/Protein	TNF - alpha,211,222,Gene/Protein	mRNA,233,237,Gene/Protein	"[{""token"": ""protein tyrosine kinase"", ""start_span"": 110, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 211, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
The consequent decrease in the nuclear levels of c - Jun and JunD leads to diminished binding of c - Jun / c - Fos and JunD / c - Fos heterodimers to the AP - 1 consensus sequence in the TNF promoter and, thus, to decreased transactivation of the TNF gene.	c - Jun,49,56,Gene/Protein	JunD,61,65,Gene/Protein	c - Jun / c - Fos,97,114,Gene/Protein	JunD / c - Fos heterodimers,119,146,Gene/Protein	AP - 1 consensus sequence,154,179,Gene/Protein	TNF promoter,187,199,Gene/Protein	TNF gene,247,255,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun / c - Fos"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""JunD / c - Fos heterodimers"", ""start_span"": 119, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 consensus sequence"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""TNF promoter"", ""start_span"": 187, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""TNF gene"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
One of the putative targets of calcineurin is the pre - existing, cytosolic component of the nuclear factor of activated T cells ( NFATp; also referred to as NFAT1), which is one of several transcription factors required for the expression of interleukin 2.	calcineurin,31,42,Gene/Protein	cytosolic component,66,85,Gene/Protein	nuclear factor of activated T cells,93,128,Gene/Protein	NFATp,131,136,Gene/Protein	NFAT1,158,163,Gene/Protein	transcription factors,190,211,Gene/Protein	interleukin 2,243,256,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic component"", ""start_span"": 66, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 93, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 190, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 243, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
Inhibition of the NF - kappaB pathway by overexpression of a dominant - active inhibitor of NF - kappaB abolished CD40 - induced up - regulation of both the Bfl - 1 and Bcl - x genes and also eliminated the ability of CD40 to rescue Fas - induced cell death.	NF - kappaB,18,29,Gene/Protein	NF - kappaB,92,103,Gene/Protein	CD40,114,118,Gene/Protein	Bfl - 1,157,164,Gene/Protein	Bcl - x,169,176,Gene/Protein	CD40,218,222,Gene/Protein	Fas,233,236,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Bfl - 1"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - x"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Instead, we propose that ligation of a distinct inhibitory receptor leads to the recruitment of SHP1 via its SH2 domains, activation of SHP1 and subsequently inhibition of TCR signals if the inhibitory receptor is juxtaposed to the TCR.	inhibitory receptor,48,67,Gene/Protein	SHP1,96,100,Gene/Protein	SH2 domains,109,120,Gene/Protein	SHP1,136,140,Gene/Protein	TCR,172,175,Gene/Protein	inhibitory receptor,191,210,Gene/Protein	TCR,232,235,Gene/Protein	"[{""token"": ""inhibitory receptor"", ""start_span"": 48, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domains"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory receptor"", ""start_span"": 191, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
DN constructs of myeloid differentiation protein, IRAK, TNF receptor - associated factor 6, and NF - kappaB - inducing kinase, when coexpressed with TLR2, abrogate TLR2 - mediated NF - kappaB activation.	myeloid differentiation protein,17,48,Gene/Protein	IRAK,50,54,Gene/Protein	TNF receptor - associated factor 6,56,90,Gene/Protein	NF - kappaB - inducing kinase,96,125,Gene/Protein	TLR2,149,153,Gene/Protein	TLR2,164,168,Gene/Protein	NF - kappaB,180,191,Gene/Protein	"[{""token"": ""myeloid differentiation protein"", ""start_span"": 17, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IRAK"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""TNF receptor - associated factor 6"", ""start_span"": 56, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - inducing kinase"", ""start_span"": 96, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
In the present study, we have identified a cellular context ( the interleukin - 2 [ IL - 2] - dependent HT - 2 line) in which the EPO stimulation of the EPOR fails to support cellular proliferation, STAT - 5 induction, or MAPK activation, despite efficient phosphorylation of the EPOR and JAK2 and inhibition of apoptosis after withdrawal of IL - 2.	EPO,130,133,Gene/Protein	EPOR,153,157,Gene/Protein	STAT - 5,199,207,Gene/Protein	MAPK,222,226,Gene/Protein	EPOR,280,284,Gene/Protein	JAK2,289,293,Gene/Protein	IL - 2,342,348,Gene/Protein	"[{""token"": ""EPO"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""EPOR"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 5"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""EPOR"", ""start_span"": 280, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 289, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 342, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor - associated proteins TRADD and receptor - interacting protein ( RIP) but does not induce apoptosis or require RIP for NF - kappaB activation.	Epstein - Barr virus oncoprotein latent membrane protein 1,4,62,Gene/Protein	tumor necrosis factor receptor - associated proteins,75,127,Gene/Protein	TRADD,128,133,Gene/Protein	receptor - interacting protein,138,168,Gene/Protein	RIP,171,174,Gene/Protein	RIP,217,220,Gene/Protein	NF - kappaB,225,236,Gene/Protein	"[{""token"": ""Epstein - Barr virus oncoprotein latent membrane protein 1"", ""start_span"": 4, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor receptor - associated proteins"", ""start_span"": 75, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""receptor - interacting protein"", ""start_span"": 138, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 225, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Transcription factors USF1 and USF2 up - regulate gene expression ( i. e., HIV - 1 long terminal repeats) via interaction with an E box on their target promoters, which is also a binding site for c - Myc.	Transcription factors,0,21,Gene/Protein	USF1,22,26,Gene/Protein	USF2,31,35,Gene/Protein	HIV - 1 long terminal repeats,75,104,Gene/Protein	E box,130,135,Gene/Protein	binding site,179,191,Gene/Protein	c - Myc,196,203,Gene/Protein	"[{""token"": ""Transcription factors"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""USF1"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""USF2"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeats"", ""start_span"": 75, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""E box"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
The signaling events that link FGF receptor - 1 engagement and NF - kappaB activation in Jurkat are probably distinct from the CD28 costimulation pathway, since FGF - 1 - induced Rel / kappaB binding proteins do not contain significant levels of c - Rel and are not identical with the CD28 response complex.	FGF receptor - 1,31,47,Gene/Protein	NF - kappaB,63,74,Gene/Protein	CD28,127,131,Gene/Protein	FGF - 1,161,168,Gene/Protein	Rel / kappaB binding proteins,179,208,Gene/Protein	c - Rel,246,253,Gene/Protein	CD28 response complex,285,306,Gene/Protein	"[{""token"": ""FGF receptor - 1"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""FGF - 1"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""Rel / kappaB binding proteins"", ""start_span"": 179, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response complex"", ""start_span"": 285, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
We conclude that ( 1) HTLV - I infection per se does not result in a constitutive phosphorylation of the Jak3, STAT3, and STAT5 proteins; ( 2) malignant transformation in at least some cases of ATLL does not require the constitutive, but may require IL - 2 - induced, activation of the IL - 2R Jak / STAT pathway; and ( 3) there are major differences in T - cell immortalization mechanism ( s) which appear to involve SHP - 1 and target molecules for rapamycin and RAD.	Jak3,105,109,Gene/Protein	STAT3,111,116,Gene/Protein	STAT5,122,127,Gene/Protein	IL - 2,250,256,Gene/Protein	IL - 2R,286,293,Gene/Protein	Jak / STAT,294,304,Gene/Protein	SHP - 1,418,425,Gene/Protein	"[{""token"": ""Jak3"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 250, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 286, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""Jak / STAT"", ""start_span"": 294, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""SHP - 1"", ""start_span"": 418, ""end_span"": 425, ""type"": ""Gene/Protein""}]"	train
The transcription factor NF - kappaB has been shown to play a role in protecting cells against death mediated by TNF We show here that NF - kappaB also has a role in regulating Fas / APO - 1 / CD95 - mediated death, a major pathway of peripheral T cell death.	transcription factor,4,24,Gene/Protein	NF - kappaB,25,36,Gene/Protein	TNF,113,116,Gene/Protein	NF - kappaB,135,146,Gene/Protein	Fas,177,180,Gene/Protein	APO - 1,183,190,Gene/Protein	CD95,193,197,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 135, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""APO - 1"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Whereas IL - 4 appears to repress functional IL - 12 signaling through inhibition of IL - 12R beta 2 expression, IFN - gamma in the mouse, and IFN - alpha in the human appear to induce IL - 12R beta 2 expression and promote IL - 12 responsiveness.	IL - 4,8,14,Gene/Protein	IL - 12,45,52,Gene/Protein	IL - 12R beta 2,85,100,Gene/Protein	IFN - gamma,113,124,Gene/Protein	IFN - alpha,143,154,Gene/Protein	IL - 12R beta 2,185,200,Gene/Protein	IL - 12,224,231,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12R beta 2"", ""start_span"": 85, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12R beta 2"", ""start_span"": 185, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Selective activation of STAT1alpha at the IFN - gamma receptor is achieved by specific interaction between a cytosolic tyrosine motif including Y440 in the IFN - gamma receptor alpha - chain and the SH2 domain of STAT1alpha.	STAT1alpha,24,34,Gene/Protein	IFN - gamma receptor,42,62,Gene/Protein	cytosolic tyrosine motif,109,133,Gene/Protein	Y440,144,148,Gene/Protein	IFN - gamma receptor alpha - chain,156,190,Gene/Protein	SH2 domain,199,209,Gene/Protein	STAT1alpha,213,223,Gene/Protein	"[{""token"": ""STAT1alpha"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma receptor"", ""start_span"": 42, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic tyrosine motif"", ""start_span"": 109, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Y440"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma receptor alpha - chain"", ""start_span"": 156, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""STAT1alpha"", ""start_span"": 213, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Type I interferons ( IFN - alpha and IFN - beta) and type II interferon ( IFN - gamma) inhibit induction of these genes by IL - 4 and IL - 13.	Type I interferons,0,18,Gene/Protein	IFN - alpha,21,32,Gene/Protein	IFN - beta,37,47,Gene/Protein	type II interferon,53,71,Gene/Protein	IFN - gamma,74,85,Gene/Protein	IL - 4,123,129,Gene/Protein	IL - 13,134,141,Gene/Protein	"[{""token"": ""Type I interferons"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""type II interferon"", ""start_span"": 53, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
Th1 cells produce IL - 2 and IFN - gamma, whereas Th2 cells produce IL - 4, IL - 5, IL - 6, IL - 10, and IL - 13.	IL - 2,18,24,Gene/Protein	IFN - gamma,29,40,Gene/Protein	IL - 4,68,74,Gene/Protein	IL - 5,76,82,Gene/Protein	IL - 6,84,90,Gene/Protein	IL - 10,92,99,Gene/Protein	IL - 13,105,112,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
In the present study we investigated the possible involvement of the mitogen - activated protein kinase family members extracellular - regulated kinase 1 / 2 ( ERK1 / 2) and c - Jun N - terminal kinase ( JNK) in mediating IL - 6 gene expression in human monocytes, in particular their role in enhancing NF - kappa B activity.	mitogen - activated protein kinase family,69,110,Gene/Protein	extracellular - regulated kinase 1 / 2,119,157,Gene/Protein	ERK1 / 2,160,168,Gene/Protein	Jun N - terminal kinase,178,201,Gene/Protein	JNK,204,207,Gene/Protein	IL - 6,222,228,Gene/Protein	NF - kappa B,303,315,Gene/Protein	"[{""token"": ""mitogen - activated protein kinase family"", ""start_span"": 69, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""extracellular - regulated kinase 1 / 2"", ""start_span"": 119, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""ERK1 / 2"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""Jun N - terminal kinase"", ""start_span"": 178, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 303, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
The E2A - HLF fusion gene, generated by t ( 17; 19) ( q22; p13) in acute lymphoblastic leukemia ( ALL), encodes a chimeric transcription factor in which the trans - activating domains of E2A are fused to the DNA - binding and dimerization domains of hepatic leukemic factor ( HLF).	E2A - HLF fusion gene,4,25,Gene/Protein	chimeric transcription factor,114,143,Gene/Protein	trans - activating domains,157,183,Gene/Protein	E2A,187,190,Gene/Protein	DNA - binding and dimerization domains,208,246,Gene/Protein	hepatic leukemic factor,250,273,Gene/Protein	HLF,276,279,Gene/Protein	"[{""token"": ""E2A - HLF fusion gene"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""chimeric transcription factor"", ""start_span"": 114, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""trans - activating domains"", ""start_span"": 157, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding and dimerization domains"", ""start_span"": 208, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""hepatic leukemic factor"", ""start_span"": 250, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 276, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Furthermore, the phosphorylation status of TRAF2 had significant effects on the ability of the protein to bind to CD40, as evidenced by our observations that the CD40 cytoplasmic domain interacted preferentially with underphosphorylated TRAF2 and that phosphatase treatment significantly enhanced the binding of TRAF2 to CD40.	TRAF2,43,48,Gene/Protein	CD40,114,118,Gene/Protein	CD40 cytoplasmic domain,162,185,Gene/Protein	TRAF2,237,242,Gene/Protein	phosphatase,252,263,Gene/Protein	TRAF2,312,317,Gene/Protein	CD40,321,325,Gene/Protein	"[{""token"": ""TRAF2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD40 cytoplasmic domain"", ""start_span"": 162, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 252, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 312, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 321, ""end_span"": 325, ""type"": ""Gene/Protein""}]"	train
Overexpression of wild - type Grf40 in Jurkat cells induced a significant increase of SLP - 76 - dependent interleukin ( IL) - 2 promoter and nuclear factor of activated T cell ( NF - AT) activation upon T cell receptor ( TCR) stimulation, whereas the COOH - terminal SH3 - deleted Grf40 mutant lacked any recognizable increase in IL - 2 promoter activity.	wild - type Grf40,18,35,Gene/Protein	nuclear factor of activated T cell,142,176,Gene/Protein	NF - AT,179,186,Gene/Protein	T cell receptor,204,219,Gene/Protein	TCR,222,225,Gene/Protein	COOH - terminal SH3 - deleted Grf40 mutant,252,294,Gene/Protein	IL - 2 promoter,331,346,Gene/Protein	"[{""token"": ""wild - type Grf40"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cell"", ""start_span"": 142, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 204, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal SH3 - deleted Grf40 mutant"", ""start_span"": 252, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 331, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	train
Specific inhibitors of p70 ( S6) - kinase ( rapamycin), and Gi protein ( pertussis toxin), prevented induction of IL - 10 production by gp41 in monocytes, while inhibitors of the phosphatidylinositol 3 - kinase ( PI 3 - kinase) ( wortmannin) and mitogen - activated protein kinase ( MAPK) pathway ( PD 98059) did not.	Gi protein,60,70,Gene/Protein	pertussis toxin,73,88,Gene/Protein	IL - 10,114,121,Gene/Protein	gp41,136,140,Gene/Protein	phosphatidylinositol 3 - kinase,179,210,Gene/Protein	PI 3 - kinase,213,226,Gene/Protein	MAPK,283,287,Gene/Protein	"[{""token"": ""Gi protein"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""pertussis toxin"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""gp41"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 179, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 213, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Thus HIV - 1 gp41 - induced IL - 10 up - regulation in monocytes may not involve NF - kappaB, MAPK, or PI 3 - kinase activation, but rather may operate through activation of adenylate cyclase and pertussis - toxin - sensitive Gi / Go protein to effect p70 ( S6) - kinase activation.	gp41,13,17,Gene/Protein	IL - 10,28,35,Gene/Protein	NF - kappaB,81,92,Gene/Protein	MAPK,94,98,Gene/Protein	PI 3 - kinase,103,116,Gene/Protein	adenylate cyclase,174,191,Gene/Protein	pertussis - toxin - sensitive Gi / Go protein,196,241,Gene/Protein	"[{""token"": ""gp41"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""adenylate cyclase"", ""start_span"": 174, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""pertussis - toxin - sensitive Gi / Go protein"", ""start_span"": 196, ""end_span"": 241, ""type"": ""Gene/Protein""}]"	train
Functional studies using human endothelial cells demonstrated that overexpression of CBP rescued cAMP inhibition of NF - kappaB - mediated transcription and transcription mediated by a chimeric protein, GAL4 - p65 ( 286 - 551), which contained the GAL4 DNA binding domain fused to the carboxyl - terminal region of p65 ( amino acids 286 - 551).	CBP,85,88,Gene/Protein	NF - kappaB,116,127,Gene/Protein	chimeric protein,185,201,Gene/Protein	GAL4 DNA binding domain,248,271,Gene/Protein	carboxyl - terminal region,285,311,Gene/Protein	p65,315,318,Gene/Protein	amino acids 286 - 551,321,342,Gene/Protein	"[{""token"": ""CBP"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""chimeric protein"", ""start_span"": 185, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 DNA binding domain"", ""start_span"": 248, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl - terminal region"", ""start_span"": 285, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 315, ""end_span"": 318, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 286 - 551"", ""start_span"": 321, ""end_span"": 342, ""type"": ""Gene/Protein""}]"	train
To further explore the ramifications of CD19 signaling, the current study examined whether phosphorylation of Elk - 1, activation of activator protein - 1 ( AP - 1), or activation of nuclear factor - kappaB ( NF - kappaB) transcription factors occurred following CD19 cross - linking.	CD19,40,44,Gene/Protein	Elk - 1,110,117,Gene/Protein	activator protein - 1,133,154,Gene/Protein	AP - 1,157,163,Gene/Protein	NF - kappaB,209,220,Gene/Protein	transcription factors,222,243,Gene/Protein	CD19,263,267,Gene/Protein	"[{""token"": ""CD19"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Elk - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 133, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 222, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
Functional analyses of DNA fragments containing the TATA element and the identification of a DNase I - hypersensitive chromatin site ( HS 1) in close proximity to the TATA box suggest that the identified TATA motif is important for elk - 1 transcription in vivo.	DNA fragments,23,36,Gene/Protein	TATA element,52,64,Gene/Protein	DNase I - hypersensitive chromatin site,93,132,Gene/Protein	HS 1,135,139,Gene/Protein	TATA box,167,175,Gene/Protein	TATA motif,204,214,Gene/Protein	elk - 1,232,239,Gene/Protein	"[{""token"": ""DNA fragments"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""TATA element"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""DNase I - hypersensitive chromatin site"", ""start_span"": 93, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""HS 1"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""TATA motif"", ""start_span"": 204, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""elk - 1"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Treatment of T lymphocytes with IFN - alpha, IL - 2, IL - 12, and IL - 15 upregulated IL - 2Ralpha, c - myc, and pim - 1 gene expression.	IFN - alpha,32,43,Gene/Protein	IL - 2,45,51,Gene/Protein	IL - 12,53,60,Gene/Protein	IL - 15,66,73,Gene/Protein	IL - 2Ralpha,86,98,Gene/Protein	c - myc,100,107,Gene/Protein	pim - 1 gene,113,125,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Ralpha"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""pim - 1 gene"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
Interestingly, Nmi lacks an intrinsic transcriptional activation domain; instead, Nmi enhances the association of CBP / p300 coactivator proteins with Stat1 and Stat5, and together with CBP / p300 can augment IL - 2 - and IFNgamma - dependent transcription.	Nmi,15,18,Gene/Protein	transcriptional activation domain,38,71,Gene/Protein	Nmi,82,85,Gene/Protein	CBP / p300 coactivator proteins,114,145,Gene/Protein	Stat1,151,156,Gene/Protein	Stat5,161,166,Gene/Protein	CBP / p300,186,196,Gene/Protein	"[{""token"": ""Nmi"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activation domain"", ""start_span"": 38, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Nmi"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300 coactivator proteins"", ""start_span"": 114, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
These include Fc epsilonRII ( CD23), 15 - lipoxygenase, IL - 1 receptor antagonist ( IL - 1ra), and type I and type II IL - 1 receptors ( IL - 1R).	Fc epsilonRII,14,27,Gene/Protein	CD23,30,34,Gene/Protein	15 - lipoxygenase,37,54,Gene/Protein	IL - 1 receptor antagonist,56,82,Gene/Protein	IL - 1ra,85,93,Gene/Protein	type I and type II IL - 1 receptors,100,135,Gene/Protein	IL - 1R,138,145,Gene/Protein	"[{""token"": ""Fc epsilonRII"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""15 - lipoxygenase"", ""start_span"": 37, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor antagonist"", ""start_span"": 56, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1ra"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""type I and type II IL - 1 receptors"", ""start_span"": 100, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1R"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
However, suppression of IL - 1R gene expression by IFN - gamma and IL - 10 was associated with decreased tyrosine phosphorylation and nuclear translocation of the IL - 4 / IL - 13 - inducible transcription factor, Stat6, suggesting a potential mechanism by which IFN - gamma and IL - 10 may mediate their suppressive effects.	IL - 1R gene,24,36,Gene/Protein	IFN - gamma,51,62,Gene/Protein	IL - 10,67,74,Gene/Protein	IL - 4 / IL - 13 - inducible transcription factor,163,212,Gene/Protein	Stat6,214,219,Gene/Protein	IFN - gamma,263,274,Gene/Protein	IL - 10,279,286,Gene/Protein	"[{""token"": ""IL - 1R gene"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 / IL - 13 - inducible transcription factor"", ""start_span"": 163, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 214, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 263, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 279, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
In UCSD - AML1, we have also identified fusion transcripts between the ecotropic viral insertion site I ( EVI1) gene in 3q26 and GR6 and between EVI1 and Ribophorin I that maps 30 kb telomeric to GR6 in 3q21.	fusion transcripts,40,58,Gene/Protein	3q26,120,124,Gene/Protein	GR6,129,132,Gene/Protein	EVI1,145,149,Gene/Protein	Ribophorin I,154,166,Gene/Protein	GR6,196,199,Gene/Protein	3q21,203,207,Gene/Protein	"[{""token"": ""fusion transcripts"", ""start_span"": 40, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""3q26"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""GR6"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""EVI1"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""Ribophorin I"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""GR6"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""3q21"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
All fusions splice the 5 ' ends of the 3q21 genes into exon 2 of the EVI1 gene, an event that is similar to the normal intergenic splicing of MDS1 - EVI1 and to those previously documented in leukemias with t ( 3; 21) and t ( 3; 12), in which acute myelogenous leukemia 1 - EVI1 fusions and ETV6 - EVI1 fusions, respectively, occur.	5 ' ends,23,31,Gene/Protein	3q21 genes,39,49,Gene/Protein	exon 2,55,61,Gene/Protein	EVI1,69,73,Gene/Protein	MDS1 - EVI1,142,153,Gene/Protein	myelogenous leukemia 1 - EVI1 fusions,249,286,Gene/Protein	ETV6 - EVI1 fusions,291,310,Gene/Protein	"[{""token"": ""5 ' ends"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""3q21 genes"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""exon 2"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""EVI1"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""MDS1 - EVI1"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""myelogenous leukemia 1 - EVI1 fusions"", ""start_span"": 249, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""ETV6 - EVI1 fusions"", ""start_span"": 291, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
Recently, we demonstrated that the DSE are also cAMP - responsive elements ( CRE), since they mediated activation signals elicited by cholera toxin ( Ctx), a potent activator of the cAMP - dependent protein kinase A ( PKA) signal transduction pathway.	DSE,35,38,Gene/Protein	cAMP - responsive elements,48,74,Gene/Protein	CRE,77,80,Gene/Protein	cholera toxin,134,147,Gene/Protein	Ctx,150,153,Gene/Protein	protein kinase A,199,215,Gene/Protein	PKA,218,221,Gene/Protein	"[{""token"": ""DSE"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - responsive elements"", ""start_span"": 48, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""cholera toxin"", ""start_span"": 134, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Ctx"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 199, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
We describe here a heterodimeric binding complex of NF - kappaB subunits ( c - Rel and p65) which is identical to the one obtained using the HIV - LTR - kappaB site as recognition sequence and different from the one ( c - Rel and p50) observed with nuclear extracts from Mo T - lymphoid HTLV - II infected cells.	heterodimeric binding complex,19,48,Gene/Protein	NF - kappaB subunits,52,72,Gene/Protein	c - Rel,75,82,Gene/Protein	p65,87,90,Gene/Protein	HIV - LTR - kappaB site,141,164,Gene/Protein	c - Rel,218,225,Gene/Protein	p50,230,233,Gene/Protein	"[{""token"": ""heterodimeric binding complex"", ""start_span"": 19, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 52, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""HIV - LTR - kappaB site"", ""start_span"": 141, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 230, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
Further, Vpr suppresses expression of IL - 2, IL - 10, IL - 12, TNF alpha and IL - 4, all of which are NF - kappa B - dependent.	Vpr,9,12,Gene/Protein	IL - 2,38,44,Gene/Protein	IL - 10,46,53,Gene/Protein	IL - 12,55,62,Gene/Protein	TNF alpha,64,73,Gene/Protein	IL - 4,78,84,Gene/Protein	NF - kappa B,103,115,Gene/Protein	"[{""token"": ""Vpr"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	train
AIDS - C patients showed low IL - 2 and high IL - 4, IL - 10, and IgE concentratios; conversely, AIDS - GR patients showed high IL - 2 and low IL - 4 and IgE concentrations.	IL - 2,29,35,Gene/Protein	IL - 4,45,51,Gene/Protein	IL - 10,53,60,Gene/Protein	IgE,66,69,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 4,143,149,Gene/Protein	IgE,154,157,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Anti - intercellular adhesion molecule - 1 ( ICAM - 1) and anti - P - selectin antibodies ( monoclonal antibodies [ mAbs]) attenuated phase - 1 neutrophil adhesion, consistent with roles for constitutively expressed ICAM - 1 and enhanced surface expression of preformed P - selectin.	Anti - intercellular adhesion molecule - 1,0,42,Gene/Protein	ICAM - 1,45,53,Gene/Protein	anti - P - selectin antibodies,59,89,Gene/Protein	monoclonal antibodies,92,113,Gene/Protein	mAbs,116,120,Gene/Protein	ICAM - 1,216,224,Gene/Protein	P - selectin,270,282,Gene/Protein	"[{""token"": ""Anti - intercellular adhesion molecule - 1"", ""start_span"": 0, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""anti - P - selectin antibodies"", ""start_span"": 59, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibodies"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""mAbs"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""P - selectin"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	train
Such genes disclose a common element within their promoters, defined Interferon Stimulated Response Element ( ISRE), which binds a nuclear factor ( s) translocated from the cytoplasm to the nucleus ( ISGF3) after the binding of interferon ( IFN) to the specific receptor.	promoters,50,59,Gene/Protein	Interferon Stimulated Response Element,69,107,Gene/Protein	ISRE,110,114,Gene/Protein	nuclear factor,131,145,Gene/Protein	ISGF3,200,205,Gene/Protein	interferon,228,238,Gene/Protein	IFN,241,244,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Interferon Stimulated Response Element"", ""start_span"": 69, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""ISRE"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 228, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
We have previously identified new binding sites for transcription factors downstream of the transcription start site ( nt 465 to 720): three AP - 1 sites ( I, II, and III), an AP3 - like motif ( AP3 - L), a downstream binding factor ( DBF) site, and juxtaposed Sp1 sites.	transcription factors,52,73,Gene/Protein	transcription start site,92,116,Gene/Protein	nt 465 to 720,119,132,Gene/Protein	AP - 1 sites,141,153,Gene/Protein	AP3 - like motif,176,192,Gene/Protein	AP3 - L,195,202,Gene/Protein	juxtaposed Sp1 sites,250,270,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 52, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 92, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""nt 465 to 720"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sites"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - like motif"", ""start_span"": 176, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""juxtaposed Sp1 sites"", ""start_span"": 250, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Virus production occurred with slightly delayed kinetics for viruses containing combined mutations in the AP - 1 ( III), AP3 - L, and DBF sites and in the AP3 - L and DBF - sites, whereas viruses mutated in the AP - 1 ( I, II, III) and AP3 - L sites and in the AP - 1 ( I, II, III), AP3 - L, and DBF sites exhibited a severely defective replicative phenotype.	AP3 - L,121,128,Gene/Protein	DBF sites,134,143,Gene/Protein	AP3 - L,155,162,Gene/Protein	DBF - sites,167,178,Gene/Protein	AP3 - L sites,236,249,Gene/Protein	AP3 - L,283,290,Gene/Protein	DBF sites,296,305,Gene/Protein	"[{""token"": ""AP3 - L"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""DBF sites"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""DBF - sites"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L sites"", ""start_span"": 236, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L"", ""start_span"": 283, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""DBF sites"", ""start_span"": 296, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
Both Sp1 and Sp3 bound to the 5 ' portion of this region, whereas a PMA - inducible factor ( PIF) mainly bound to its 3 ' portion and bound to the Sp binding motifs as well.	Sp1,5,8,Gene/Protein	Sp3,13,16,Gene/Protein	5 ' portion,30,41,Gene/Protein	PMA - inducible factor,68,90,Gene/Protein	PIF,93,96,Gene/Protein	3 ' portion,118,129,Gene/Protein	Sp binding motifs,147,164,Gene/Protein	"[{""token"": ""Sp1"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""Sp3"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""5 ' portion"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""PMA - inducible factor"", ""start_span"": 68, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""PIF"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""3 ' portion"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""Sp binding motifs"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
This pattern of STAT protein phosphorylation is identical to IL - 10 receptor activation on normal cells and similar to IFN - alpha ( STAT1 and STAT3) and IFN - gamma ( STAT1) receptor activation in CLL.	STAT protein,16,28,Gene/Protein	IL - 10 receptor,61,77,Gene/Protein	IFN - alpha,120,131,Gene/Protein	STAT1,134,139,Gene/Protein	STAT3,144,149,Gene/Protein	IFN - gamma,155,166,Gene/Protein	STAT1,169,174,Gene/Protein	"[{""token"": ""STAT protein"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 receptor"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
During myelopoiesis, which includes the development of granulocytic and monocytic lineages, transcription factors from several families are active, including AML1 / CBF beta, C / EBP, Ets, c - Myb, HOX, and MZF - 1.	transcription factors,92,113,Gene/Protein	AML1 / CBF beta,158,173,Gene/Protein	C / EBP,175,182,Gene/Protein	Ets,184,187,Gene/Protein	c - Myb,189,196,Gene/Protein	HOX,198,201,Gene/Protein	MZF - 1,207,214,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""AML1 / CBF beta"", ""start_span"": 158, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""c - Myb"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""HOX"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""MZF - 1"", ""start_span"": 207, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
In DNA - protein binding studies, we detected the binding of transcription factors GABP alpha and - beta to a dyad symmetry element ( DSE) of the distal enhancer, which is formed by palindromic binding sites of Ets - like factors.	transcription factors,61,82,Gene/Protein	GABP alpha and - beta,83,104,Gene/Protein	dyad symmetry element,110,131,Gene/Protein	DSE,134,137,Gene/Protein	distal enhancer,146,161,Gene/Protein	palindromic binding sites,182,207,Gene/Protein	Ets - like factors,211,229,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 61, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""GABP alpha and - beta"", ""start_span"": 83, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""dyad symmetry element"", ""start_span"": 110, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""DSE"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer"", ""start_span"": 146, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""palindromic binding sites"", ""start_span"": 182, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""Ets - like factors"", ""start_span"": 211, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
However, IL - 10 did not affect IFN - gamma - induced tyrosine phosphorylation of STAT - 1alpha or alter STAT - 1alpha binding to the IFN - gamma response element ( IRE) in the ICAM - 1 promoter.	IL - 10,9,16,Gene/Protein	IFN - gamma,32,43,Gene/Protein	STAT - 1alpha,82,95,Gene/Protein	STAT - 1alpha,105,118,Gene/Protein	IFN - gamma response element,134,162,Gene/Protein	IRE,165,168,Gene/Protein	ICAM - 1 promoter,177,194,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 1alpha"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 1alpha"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma response element"", ""start_span"": 134, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""IRE"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 177, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
The core of the promoter ( positions - 42 to + 11) is recognized by the lymphoid cell - specific transcription factors Ets - 1, LEF1, and AML1 as well as by CREB / ATF - 1, as is demonstrated in gel shift and footprinting experiments.	promoter,16,24,Gene/Protein	positions - 42 to + 11,27,49,Gene/Protein	lymphoid cell - specific transcription factors,72,118,Gene/Protein	Ets - 1,119,126,Gene/Protein	LEF1,128,132,Gene/Protein	AML1,138,142,Gene/Protein	CREB / ATF - 1,157,171,Gene/Protein	"[{""token"": ""promoter"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""positions - 42 to + 11"", ""start_span"": 27, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""lymphoid cell - specific transcription factors"", ""start_span"": 72, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""LEF1"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF - 1"", ""start_span"": 157, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
The IL - 4 receptor ( IL - 4R) in B cells is composed of two chains, the IL - 4 - binding IL - 4Ralpha chain, which is shared with the IL - 13R, and the IL - 2Rgamma ( gammac) chain, which is shared with IL - 7R, IL - 9R, and IL - 15R.	IL - 4 receptor,4,19,Gene/Protein	IL - 4R,22,29,Gene/Protein	IL - 4 - binding IL - 4Ralpha chain,73,108,Gene/Protein	IL - 13R,135,143,Gene/Protein	IL - 7R,204,211,Gene/Protein	IL - 9R,213,220,Gene/Protein	IL - 15R,226,234,Gene/Protein	"[{""token"": ""IL - 4 receptor"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - binding IL - 4Ralpha chain"", ""start_span"": 73, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7R"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9R"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15R"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
CsA neither inhibits the processing of the NF - kappa B1 precursor p105 to p50, nor does it ` ` stabilize ' ' the C - terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.	NF - kappa B1 precursor,43,66,Gene/Protein	p105,67,71,Gene/Protein	p50,75,78,Gene/Protein	p105,138,142,Gene/Protein	I kappa B gamma,144,159,Gene/Protein	p105,186,190,Gene/Protein	mature p50,205,215,Gene/Protein	"[{""token"": ""NF - kappa B1 precursor"", ""start_span"": 43, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""mature p50"", ""start_span"": 205, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Whereas T cells from young subjects stimulated with cross - linked anti - CD3epsilon mAb OKT3 plus PMA or with the lectin PHA plus PMA demonstrated considerable increases in c - Fos protein expression, the expression of c - Fos but not c - Jun was markedly reduced in stimulated T cells from certain elderly subjects.	cross - linked anti - CD3epsilon mAb,52,88,Gene/Protein	OKT3,89,93,Gene/Protein	lectin,115,121,Gene/Protein	PHA,122,125,Gene/Protein	c - Fos,174,181,Gene/Protein	c - Fos,220,227,Gene/Protein	c - Jun,236,243,Gene/Protein	"[{""token"": ""cross - linked anti - CD3epsilon mAb"", ""start_span"": 52, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""OKT3"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 220, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Total mRNA was extracted from T cells, and using RT - PCR, changes in the production of IL - 2 and RA receptors ( RAR) - alpha, beta, gamma mRNA were determined.	mRNA,6,10,Gene/Protein	IL - 2,88,94,Gene/Protein	RA receptors,99,111,Gene/Protein	RAR,114,117,Gene/Protein	alpha,121,126,Gene/Protein	beta,128,132,Gene/Protein	gamma mRNA,134,144,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""RA receptors"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""alpha"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""beta"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""gamma mRNA"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
ALY is a ubiquitously expressed, nuclear protein that specifically associates with the activation domains of LEF - 1 and AML - 1 ( CBF alpha2, PEBP2 alpha ( B), which is another protein component of the TCR alpha enhancer complex.	ALY,0,3,Gene/Protein	activation domains,87,105,Gene/Protein	LEF - 1,109,116,Gene/Protein	AML - 1,121,128,Gene/Protein	CBF alpha2,131,141,Gene/Protein	PEBP2 alpha,143,154,Gene/Protein	TCR alpha enhancer complex,203,229,Gene/Protein	"[{""token"": ""ALY"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""activation domains"", ""start_span"": 87, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""AML - 1"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""CBF alpha2"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""TCR alpha enhancer complex"", ""start_span"": 203, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Functional studies showed a 2. 5 - fold increase in promoter activity when this 19 - bp binding site was deleted in the reporter constructs IL - 1beta / CAT and IL - 1beta / SV40 promoter / CAT.	19 - bp binding site,80,100,Gene/Protein	reporter constructs,120,139,Gene/Protein	IL - 1beta,140,150,Gene/Protein	/ CAT,151,156,Gene/Protein	IL - 1beta,161,171,Gene/Protein	/ SV40 promoter,172,187,Gene/Protein	/ CAT,188,193,Gene/Protein	"[{""token"": ""19 - bp binding site"", ""start_span"": 80, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""reporter constructs"", ""start_span"": 120, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""/ CAT"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""/ SV40 promoter"", ""start_span"": 172, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""/ CAT"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
This identification, initially made by microsequence analysis, was verified by showing that ( i) LR1 - DNA binding activity increased in B cells transfected with a nucleolin cDNA expression construct; ( ii) LR1 - DNA binding activity was recognized by antibodies raised against recombinant human nucleolin; and ( iii) in B cells transfected with epitope - tagged nucleolin expression constructs, the LR1 - DNA complex was recognized by the anti - tag antibody.	LR1,97,100,Gene/Protein	nucleolin cDNA expression construct,164,199,Gene/Protein	LR1,207,210,Gene/Protein	recombinant human nucleolin,278,305,Gene/Protein	epitope - tagged nucleolin expression constructs,346,394,Gene/Protein	LR1 - DNA complex,400,417,Gene/Protein	anti - tag antibody,440,459,Gene/Protein	"[{""token"": ""LR1"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin cDNA expression construct"", ""start_span"": 164, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""LR1"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""recombinant human nucleolin"", ""start_span"": 278, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""epitope - tagged nucleolin expression constructs"", ""start_span"": 346, ""end_span"": 394, ""type"": ""Gene/Protein""}, {""token"": ""LR1 - DNA complex"", ""start_span"": 400, ""end_span"": 417, ""type"": ""Gene/Protein""}, {""token"": ""anti - tag antibody"", ""start_span"": 440, ""end_span"": 459, ""type"": ""Gene/Protein""}]"	train
Phosphoinositide 3 - kinase ( PI 3 - kinase) is activated by a diverse set of receptors that determine T - cell function, including the T - cell antigen receptor ( TCR), the costimulatory receptor CD28, and negative regulators of T - cell activation such as CTLA - 4.	Phosphoinositide 3 - kinase,0,27,Gene/Protein	PI 3 - kinase,30,43,Gene/Protein	T - cell antigen receptor,136,161,Gene/Protein	TCR,164,167,Gene/Protein	costimulatory receptor CD28,174,201,Gene/Protein	negative regulators,207,226,Gene/Protein	CTLA - 4,258,266,Gene/Protein	"[{""token"": ""Phosphoinositide 3 - kinase"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""T - cell antigen receptor"", ""start_span"": 136, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""costimulatory receptor CD28"", ""start_span"": 174, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""negative regulators"", ""start_span"": 207, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 258, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
These effects of PI 3 - kinase were not mediated by previously identified PI 3 - kinase effectors, such as protein kinase B, a positive regulator of PI 3 - kinase, or the GTPase Rac, and are therefore likely to involve a novel, as yet unknown, effector molecule.	PI 3 - kinase,17,30,Gene/Protein	PI 3 - kinase effectors,74,97,Gene/Protein	protein kinase B,107,123,Gene/Protein	positive regulator,127,145,Gene/Protein	PI 3 - kinase,149,162,Gene/Protein	GTPase Rac,171,181,Gene/Protein	effector molecule,244,261,Gene/Protein	"[{""token"": ""PI 3 - kinase"", ""start_span"": 17, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase effectors"", ""start_span"": 74, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase B"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""positive regulator"", ""start_span"": 127, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""GTPase Rac"", ""start_span"": 171, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""effector molecule"", ""start_span"": 244, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
Following intracranial inoculation in mice, both VZV gE - HSV ( TK) and VZV IE62 - HSV ( gC) induced an IgG response against VZV gE or VZV IE62.	VZV gE - HSV,49,61,Gene/Protein	TK,64,66,Gene/Protein	VZV IE62 - HSV,72,86,Gene/Protein	gC,89,91,Gene/Protein	IgG,104,107,Gene/Protein	VZV gE,125,131,Gene/Protein	VZV IE62,135,143,Gene/Protein	"[{""token"": ""VZV gE - HSV"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""TK"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""VZV IE62 - HSV"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""gC"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""VZV gE"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""VZV IE62"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
We have developed a novel assay to monitor the active, GTP - bound form of Rap1 based on the differential affinity of Rap1GTP and Rap1GDP for the Rap binding domain of RalGDS ( RBD).	GTP - bound form,55,71,Gene/Protein	Rap1,75,79,Gene/Protein	Rap1GTP,118,125,Gene/Protein	Rap1GDP,130,137,Gene/Protein	Rap binding domain,146,164,Gene/Protein	RalGDS,168,174,Gene/Protein	RBD,177,180,Gene/Protein	"[{""token"": ""GTP - bound form"", ""start_span"": 55, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Rap1"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Rap1GTP"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Rap1GDP"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Rap binding domain"", ""start_span"": 146, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""RalGDS"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""RBD"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
In addition, the Ets - NF - kappaB / NFAT interaction requires the presence of DNA binding sites for both proteins, as it is abolished by the DNA intercalating agents propidium iodide and ethidium bromide and enhanced by the presence of synthetic oligonucleotides containing binding sites for Ets and NF - kappaB proteins.	Ets,17,20,Gene/Protein	NF - kappaB,23,34,Gene/Protein	NFAT,37,41,Gene/Protein	DNA binding sites,79,96,Gene/Protein	binding sites,275,288,Gene/Protein	Ets,293,296,Gene/Protein	NF - kappaB proteins,301,321,Gene/Protein	"[{""token"": ""Ets"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding sites"", ""start_span"": 79, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 275, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 293, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB proteins"", ""start_span"": 301, ""end_span"": 321, ""type"": ""Gene/Protein""}]"	train
We considered four bZIP transcription factors as candidates for this putative IL - 3 - regulated factor, each of which binds avidly to the DNA consensus sequence recognized by E2A - HLF and is related to the Caenorhabditis elegans CES - 2 ( cell death specification protein) neuron - specific mediator of cell death.	bZIP transcription factors,19,45,Gene/Protein	IL - 3 - regulated factor,78,103,Gene/Protein	DNA consensus sequence,139,161,Gene/Protein	E2A - HLF,176,185,Gene/Protein	Caenorhabditis elegans CES - 2,208,238,Gene/Protein	cell death specification protein,241,273,Gene/Protein	neuron - specific mediator of cell death,275,315,Gene/Protein	"[{""token"": ""bZIP transcription factors"", ""start_span"": 19, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 - regulated factor"", ""start_span"": 78, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""DNA consensus sequence"", ""start_span"": 139, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""Caenorhabditis elegans CES - 2"", ""start_span"": 208, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""cell death specification protein"", ""start_span"": 241, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""neuron - specific mediator of cell death"", ""start_span"": 275, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
By using a reverse transcription - PCR - based approach and a set of primers specific for the DNA - binding domains of highly homologous members of the C / EBP family of transcriptional regulators, we have cloned a novel human gene encoding a member of the C / EBP gene family, identified as the human homolog of CRP1, C / EBP - epsilon.	DNA - binding domains,94,115,Gene/Protein	C / EBP family,152,166,Gene/Protein	transcriptional regulators,170,196,Gene/Protein	novel human gene,215,231,Gene/Protein	C / EBP gene family,257,276,Gene/Protein	CRP1,313,317,Gene/Protein	C / EBP - epsilon,319,336,Gene/Protein	"[{""token"": ""DNA - binding domains"", ""start_span"": 94, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP family"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 170, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""novel human gene"", ""start_span"": 215, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP gene family"", ""start_span"": 257, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""CRP1"", ""start_span"": 313, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 319, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	train
CD4 + T cells costimulated with the A6H mAb upregulated CD80, CD86, CD71, interleukin - 2 ( IL - 2) R alpha, IL - 2R beta and IL - 2R gamma, while no corresponding up - regulation of these cell surface molecules was seen in CD8 + T cells.	A6H mAb,36,43,Gene/Protein	CD80,56,60,Gene/Protein	CD86,62,66,Gene/Protein	CD71,68,72,Gene/Protein	IL - 2R beta,109,121,Gene/Protein	IL - 2R gamma,126,139,Gene/Protein	cell surface molecules,189,211,Gene/Protein	"[{""token"": ""A6H mAb"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""CD71"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 109, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""cell surface molecules"", ""start_span"": 189, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Using electrophoretic mobility shift analysis we demonstrated that the promoter region spanning base pairs - 1 to - 275, which contains several putative binding sites for transcription factors, is bound by nuclear factors Sp1 and IRBP but not by C / EBPs.	promoter region,71,86,Gene/Protein	base pairs - 1 to - 275,96,119,Gene/Protein	transcription factors,171,192,Gene/Protein	nuclear factors,206,221,Gene/Protein	Sp1,222,225,Gene/Protein	IRBP,230,234,Gene/Protein	C / EBPs,246,254,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""base pairs - 1 to - 275"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 171, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""IRBP"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPs"", ""start_span"": 246, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Activation of T lymphocytes by Ags or cytokines results in translocation of the transcription factors NF - kappa B, AP - 1, NFAT, and STAT from the cytoplasm into the nucleus.	Ags,31,34,Gene/Protein	cytokines,38,47,Gene/Protein	transcription factors,80,101,Gene/Protein	NF - kappa B,102,114,Gene/Protein	AP - 1,116,122,Gene/Protein	NFAT,124,128,Gene/Protein	STAT,134,138,Gene/Protein	"[{""token"": ""Ags"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Besides ligand - induced receptor heterodimerization and contacts of the two IL - 4 receptor subunits alpha and gamma with Janus kinases JAK1 and JAK3 a prominent constitutive binding between JAK1 and signal transducer and activator of transcription STAT5 was detected.	IL - 4 receptor subunits alpha and gamma,77,117,Gene/Protein	Janus kinases,123,136,Gene/Protein	JAK1,137,141,Gene/Protein	JAK3,146,150,Gene/Protein	JAK1,192,196,Gene/Protein	signal transducer and activator of transcription,201,249,Gene/Protein	STAT5,250,255,Gene/Protein	"[{""token"": ""IL - 4 receptor subunits alpha and gamma"", ""start_span"": 77, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription"", ""start_span"": 201, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 250, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
The effect of both cytokines on the monocyte maturation / differentiation ( CD11b, CD13, and CD26) and other macrophage markers ( CD14 and CD68) was examined.	cytokines,19,28,Gene/Protein	CD11b,76,81,Gene/Protein	CD13,83,87,Gene/Protein	CD26,93,97,Gene/Protein	macrophage markers,109,127,Gene/Protein	CD14,130,134,Gene/Protein	CD68,139,143,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CD13"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CD26"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""macrophage markers"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
The 5 ' - UTR contains binding sites for the transcription factors AP - 1, NF - kappaB, NF - AT, IRF, and Sp1.	5 ' - UTR,4,13,Gene/Protein	binding sites,23,36,Gene/Protein	transcription factors,45,66,Gene/Protein	NF - kappaB,75,86,Gene/Protein	NF - AT,88,95,Gene/Protein	IRF,97,100,Gene/Protein	Sp1,106,109,Gene/Protein	"[{""token"": ""5 ' - UTR"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IRF"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
Expression of an active form of Ras, Ras ( G12V), suppressed the IL - 2 - induced beta - casein and OSM gene expression, and the negative effect of Ras is mediated by the region between - 105 and - 193 in the beta - casein promoter.	Ras,32,35,Gene/Protein	IL - 2,65,71,Gene/Protein	beta - casein,82,95,Gene/Protein	OSM,100,103,Gene/Protein	Ras,148,151,Gene/Protein	- 105 and - 193,186,201,Gene/Protein	beta - casein promoter,209,231,Gene/Protein	"[{""token"": ""Ras"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""OSM"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""- 105 and - 193"", ""start_span"": 186, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein promoter"", ""start_span"": 209, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Engagement of any of these receptors induces the rapid tyrosine phosphorylation of a shared group of intracellular signaling proteins, including Vav, Cbl, p85 phosphoinositide 3 - kinase, and the Src family kinases Lck and Fyn.	intracellular signaling proteins,101,133,Gene/Protein	Vav,145,148,Gene/Protein	Cbl,150,153,Gene/Protein	p85 phosphoinositide 3 - kinase,155,186,Gene/Protein	Src family kinases,196,214,Gene/Protein	Lck,215,218,Gene/Protein	Fyn,223,226,Gene/Protein	"[{""token"": ""intracellular signaling proteins"", ""start_span"": 101, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""p85 phosphoinositide 3 - kinase"", ""start_span"": 155, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""Src family kinases"", ""start_span"": 196, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""Fyn"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
In contrast, expression of dominant negative mutants of Ras and Raf - 1, in these cells, did not have any effect on FcR - mediated nuclear factor activation, suggesting that the mitogen - activated protein kinase ( MAPK) signaling pathway was not used by these receptors.	dominant negative mutants,27,52,Gene/Protein	Ras,56,59,Gene/Protein	Raf - 1,64,71,Gene/Protein	FcR,116,119,Gene/Protein	nuclear factor,131,145,Gene/Protein	mitogen - activated protein kinase,178,212,Gene/Protein	MAPK,215,219,Gene/Protein	"[{""token"": ""dominant negative mutants"", ""start_span"": 27, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""FcR"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 178, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Hepatocytes achieve an efficient hormonal control of this promoter through a functional interaction between the estrogen responsive elements and a promoter proximal region upstream of the TATA box, which is characterized by a high density of binding sites for the transcription factors CTF / NF - 1, C / EBP and HNF3.	estrogen responsive elements,112,140,Gene/Protein	promoter proximal region,147,171,Gene/Protein	TATA box,188,196,Gene/Protein	transcription factors,264,285,Gene/Protein	CTF / NF - 1,286,298,Gene/Protein	C / EBP,300,307,Gene/Protein	HNF3,312,316,Gene/Protein	"[{""token"": ""estrogen responsive elements"", ""start_span"": 112, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""promoter proximal region"", ""start_span"": 147, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 264, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""CTF / NF - 1"", ""start_span"": 286, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""HNF3"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Gene/Protein""}]"	train
Cytokines, IL - 2, IL - 4, IL - 6, IL - 7, IL - 12, and IL - 15 are key regulators of human peripheral blood T and NK cell activation and differentiation but the precise mechanisms that give rise to their differential activities within these cells are not clear.	Cytokines,0,9,Gene/Protein	IL - 2,11,17,Gene/Protein	IL - 4,19,25,Gene/Protein	IL - 6,27,33,Gene/Protein	IL - 7,35,41,Gene/Protein	IL - 12,43,50,Gene/Protein	IL - 15,56,63,Gene/Protein	"[{""token"": ""Cytokines"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}]"	train
Interestingly, tg epsilon26 thymocytes expressed GATA - 3 and TCF - 1, but not LEF - 1 and PEBP - 2alpha, among T cell - specific transcription factors that are involved in early T cell development, indicating that GATA - 3 and TCF - 1 expressed during thymocyte development do not necessarily determine the cell fate into T cell lineage.	GATA - 3,49,57,Gene/Protein	TCF - 1,62,69,Gene/Protein	LEF - 1,79,86,Gene/Protein	PEBP - 2alpha,91,104,Gene/Protein	T cell - specific transcription factors,112,151,Gene/Protein	GATA - 3,215,223,Gene/Protein	TCF - 1,228,235,Gene/Protein	"[{""token"": ""GATA - 3"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PEBP - 2alpha"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific transcription factors"", ""start_span"": 112, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 215, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
However, transactivation of the CD4 promoter by ORFs U86 and U89 is independent of the CRE element, suggesting that additional HHV - 6 ORFs are likely to contribute to CD4 gene activation.	CD4 promoter,32,44,Gene/Protein	ORFs,48,52,Gene/Protein	U86,53,56,Gene/Protein	U89,61,64,Gene/Protein	CRE element,87,98,Gene/Protein	HHV - 6 ORFs,127,139,Gene/Protein	CD4 gene,168,176,Gene/Protein	"[{""token"": ""CD4 promoter"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""U86"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""U89"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CRE element"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""HHV - 6 ORFs"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CD4 gene"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
To circumvent this problem, we developed an alternative procedure which allowed us to show that in neutrophils, LPS and TNFalpha induce a NF - kappaB DNA - binding activity which essentially consists of p50 / RelA dimers, and that IFNgamma promotes the binding of STAT1 homodimers to the IFNgamma response region of the FcgammaRI promoter.	TNFalpha,120,128,Gene/Protein	NF - kappaB,138,149,Gene/Protein	p50 / RelA dimers,203,220,Gene/Protein	IFNgamma,231,239,Gene/Protein	STAT1 homodimers,264,280,Gene/Protein	IFNgamma response region,288,312,Gene/Protein	FcgammaRI promoter,320,338,Gene/Protein	"[{""token"": ""TNFalpha"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""p50 / RelA dimers"", ""start_span"": 203, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 homodimers"", ""start_span"": 264, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma response region"", ""start_span"": 288, ""end_span"": 312, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI promoter"", ""start_span"": 320, ""end_span"": 338, ""type"": ""Gene/Protein""}]"	train
The results suggest that the IL - 4RE of the IL - 4 - inducible gene can accommodate both IL - 4 - and IFN - gamma - activated factors, such as STAT 6 and STAT 1, either in homodimeric or heterodimeric forms and the binding of these different proteins to the respective promoter may play a potential regulatory role in the IL - 4 - inducible gene expression.	IL - 4RE,29,37,Gene/Protein	IL - 4 - inducible gene,45,68,Gene/Protein	IL - 4 - and IFN - gamma - activated factors,90,134,Gene/Protein	STAT 6,144,150,Gene/Protein	STAT 1,155,161,Gene/Protein	homodimeric or heterodimeric forms,173,207,Gene/Protein	IL - 4,323,329,Gene/Protein	"[{""token"": ""IL - 4RE"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - inducible gene"", ""start_span"": 45, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - and IFN - gamma - activated factors"", ""start_span"": 90, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""STAT 6"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""STAT 1"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""homodimeric or heterodimeric forms"", ""start_span"": 173, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 323, ""end_span"": 329, ""type"": ""Gene/Protein""}]"	train
We have previously shown that NFAT is targeted to inactive calcineurin at a region distinct from the calcineurin active site ( Aramburu, J., Garcia - Cozar, F. J., Raghavan, A., Okamura, H., Rao, A., and Hogan, P. G. ( 1998) Mol. Cell 1, 627 - 637); this region is also involved in NFAT binding to activated calcineurin, since binding is inhibited by an NFAT peptide spanning the calcineurin docking site on NFAT.	NFAT,30,34,Gene/Protein	calcineurin,59,70,Gene/Protein	calcineurin active site,101,124,Gene/Protein	NFAT,282,286,Gene/Protein	calcineurin,308,319,Gene/Protein	calcineurin,380,391,Gene/Protein	NFAT,408,412,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin active site"", ""start_span"": 101, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 282, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 308, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 380, ""end_span"": 391, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 408, ""end_span"": 412, ""type"": ""Gene/Protein""}]"	train
NFAT binding to the calcineurin catalytic domain was inhibited by the calcineurin autoinhibitory domain and the RII substrate peptide, which bind in the calcineurin active site, as well as by the NFAT docking site peptide, which binds to a region of calcineurin distinct from the active site.	NFAT,0,4,Gene/Protein	calcineurin catalytic domain,20,48,Gene/Protein	calcineurin autoinhibitory domain,70,103,Gene/Protein	calcineurin active site,153,176,Gene/Protein	NFAT,196,200,Gene/Protein	calcineurin,250,261,Gene/Protein	active site,280,291,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin catalytic domain"", ""start_span"": 20, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin autoinhibitory domain"", ""start_span"": 70, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin active site"", ""start_span"": 153, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 250, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""active site"", ""start_span"": 280, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Similarly, a kinase - deficient mutant of NIK ( NF - kappaB - inducing kinase), which represents an upstream kinase in the TNF - alpha and IL - 1 signaling pathways leading to IKKalpha and IKKbeta activation, blocks Tax induction of NF - kappaB.	kinase - deficient mutant,13,38,Gene/Protein	NIK,42,45,Gene/Protein	NF - kappaB - inducing kinase,48,77,Gene/Protein	IKKalpha,176,184,Gene/Protein	IKKbeta,189,196,Gene/Protein	Tax,216,219,Gene/Protein	NF - kappaB,233,244,Gene/Protein	"[{""token"": ""kinase - deficient mutant"", ""start_span"": 13, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - inducing kinase"", ""start_span"": 48, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 233, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
Additionally, to determine the impact of RXR for erythroid cell development, dominant interfering mutant RXRs, lacking the transcriptional activator functions AF - 1 and AF - 2, or AF - 2 only, or the entire DNA - binding domain, were introduced into erythroid progenitor cells via recombinant retrovirus vectors and analyzed for RXR - specific effects.	RXR,41,44,Gene/Protein	mutant RXRs,98,109,Gene/Protein	AF - 1,159,165,Gene/Protein	AF - 2,170,176,Gene/Protein	AF - 2,181,187,Gene/Protein	entire DNA - binding domain,201,228,Gene/Protein	RXR,330,333,Gene/Protein	"[{""token"": ""RXR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""mutant RXRs"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""AF - 1"", ""start_span"": 159, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""AF - 2"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""AF - 2"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""entire DNA - binding domain"", ""start_span"": 201, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 330, ""end_span"": 333, ""type"": ""Gene/Protein""}]"	train
Impairments in the translocation of Rel - B and c - Rel further suggest that the NFKB family members Rel - A, Rel - B and c - Rel are not required for the transcription of IL - 2 in the peripheral T lymphocytes of patients with breast cancer.	Rel - B,36,43,Gene/Protein	c - Rel,48,55,Gene/Protein	NFKB family members,81,100,Gene/Protein	Rel - A,101,108,Gene/Protein	Rel - B,110,117,Gene/Protein	c - Rel,122,129,Gene/Protein	IL - 2,172,178,Gene/Protein	"[{""token"": ""Rel - B"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NFKB family members"", ""start_span"": 81, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Rel - A"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Rel - B"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
We demonstrate in this report that overexpression of an activated form of Rho enhances AP - 1 activity in Jurkat T cells in the presence of phorbol myristate acetate ( PMA), but activated Rho ( V14Rho) has little or no effect on NFAT, Oct - 1, and NF - kappaB enhancer element activities under similar conditions.	Rho,74,77,Gene/Protein	AP - 1,87,93,Gene/Protein	Rho,188,191,Gene/Protein	V14Rho,194,200,Gene/Protein	NFAT,229,233,Gene/Protein	Oct - 1,235,242,Gene/Protein	NF - kappaB enhancer element,248,276,Gene/Protein	"[{""token"": ""Rho"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""V14Rho"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 235, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB enhancer element"", ""start_span"": 248, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
To investigate further, we then purified a number of different kinases, including PKC, PhK, ZAP - 70, ERK, and MEK 1 ( a MKK), and showed that Ro 09 - 2210 was a selective inhibitor of MEK1 in vitro ( IC50 = 59 nM).	PKC,82,85,Gene/Protein	PhK,87,90,Gene/Protein	ZAP - 70,92,100,Gene/Protein	ERK,102,105,Gene/Protein	MEK 1,111,116,Gene/Protein	MKK,121,124,Gene/Protein	MEK1,185,189,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PhK"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""MEK 1"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""MKK"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Epstein - Barr virus - transforming protein latent infection membrane protein 1 activates transcription factor NF - kappaB through a pathway that includes the NF - kappaB - inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.	Epstein - Barr virus - transforming protein,0,43,Gene/Protein	latent infection membrane protein 1,44,79,Gene/Protein	transcription factor NF - kappaB,90,122,Gene/Protein	NF - kappaB - inducing kinase,159,188,Gene/Protein	IkappaB kinases,197,212,Gene/Protein	IKKalpha,213,221,Gene/Protein	IKKbeta,226,233,Gene/Protein	"[{""token"": ""Epstein - Barr virus - transforming protein"", ""start_span"": 0, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""latent infection membrane protein 1"", ""start_span"": 44, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappaB"", ""start_span"": 90, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - inducing kinase"", ""start_span"": 159, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB kinases"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus oncoprotein latent infection membrane protein 1 ( LMP1) is a constitutively aggregated pseudo - tumor necrosis factor receptor ( TNFR) that activates transcription factor NF - kappaB through two sites in its C - terminal cytoplasmic domain.	Epstein - Barr virus oncoprotein,4,36,Gene/Protein	latent infection membrane protein 1,37,72,Gene/Protein	LMP1,75,79,Gene/Protein	pseudo - tumor necrosis factor receptor,112,151,Gene/Protein	TNFR,154,158,Gene/Protein	transcription factor NF - kappaB,175,207,Gene/Protein	C - terminal cytoplasmic domain,233,264,Gene/Protein	"[{""token"": ""Epstein - Barr virus oncoprotein"", ""start_span"": 4, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""latent infection membrane protein 1"", ""start_span"": 37, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""pseudo - tumor necrosis factor receptor"", ""start_span"": 112, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TNFR"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappaB"", ""start_span"": 175, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal cytoplasmic domain"", ""start_span"": 233, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
One site is similar to activated TNFRII in associating with TNFR - associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD.	TNFRII,33,39,Gene/Protein	TNFR - associated factors,60,85,Gene/Protein	TRAF1,86,91,Gene/Protein	TRAF2,96,101,Gene/Protein	TNFRI,137,142,Gene/Protein	TNFRI death domain interacting protein,167,205,Gene/Protein	TRADD,206,211,Gene/Protein	"[{""token"": ""TNFRII"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TNFR - associated factors"", ""start_span"": 60, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TRAF1"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""TNFRI"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""TNFRI death domain interacting protein"", ""start_span"": 167, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Recently, many investigators have been interested in the study on eosinophil biology since genes association with eosinophils such as interleukin - 5 or eosinophil granule proteins ( EPO, ECP, EDN, MBP, and CLC), were isolated.	interleukin - 5,134,149,Gene/Protein	eosinophil granule proteins,153,180,Gene/Protein	EPO,183,186,Gene/Protein	ECP,188,191,Gene/Protein	EDN,193,196,Gene/Protein	MBP,198,201,Gene/Protein	CLC,207,210,Gene/Protein	"[{""token"": ""interleukin - 5"", ""start_span"": 134, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil granule proteins"", ""start_span"": 153, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""ECP"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""EDN"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""CLC"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
The mechanism by which eosinophil - specific genes encoding primary and secondary granule proteins ( e. g. ECP, EDN, EPO, MBP, and CLC) are expressed and regulated during eosinophilopoiesis is also unknown.	eosinophil - specific genes,23,50,Gene/Protein	secondary granule proteins,72,98,Gene/Protein	ECP,107,110,Gene/Protein	EDN,112,115,Gene/Protein	EPO,117,120,Gene/Protein	MBP,122,125,Gene/Protein	CLC,131,134,Gene/Protein	"[{""token"": ""eosinophil - specific genes"", ""start_span"": 23, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""secondary granule proteins"", ""start_span"": 72, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""ECP"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""EDN"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CLC"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
To elucidate the roles of individual GATA factors in erythropoiesis, conditional alleles of GATA - 1, GATA - 2, and GATA - 3 were prepared by fusing each of the factors to the hormone - binding domain of the human estrogen receptor ( ER).	GATA factors,37,49,Gene/Protein	GATA - 1,92,100,Gene/Protein	GATA - 2,102,110,Gene/Protein	GATA - 3,116,124,Gene/Protein	hormone - binding domain,176,200,Gene/Protein	human estrogen receptor,208,231,Gene/Protein	ER,234,236,Gene/Protein	"[{""token"": ""GATA factors"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""hormone - binding domain"", ""start_span"": 176, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""human estrogen receptor"", ""start_span"": 208, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""ER"", ""start_span"": 234, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
The multiple biological activities of tumor necrosis factor ( TNF) are mediated by two distinct cell surface receptors of 55 kd ( TNFRp55) and 75 kd ( TNFRp75).	tumor necrosis factor,38,59,Gene/Protein	TNF,62,65,Gene/Protein	cell surface receptors,96,118,Gene/Protein	55 kd,122,127,Gene/Protein	TNFRp55,130,137,Gene/Protein	75 kd,143,148,Gene/Protein	TNFRp75,151,158,Gene/Protein	"[{""token"": ""tumor necrosis factor"", ""start_span"": 38, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""cell surface receptors"", ""start_span"": 96, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""55 kd"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TNFRp55"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""75 kd"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""TNFRp75"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
We therefore examined the effects of EC on T cell nuclear factors known to regulate IL - 2 transcription, including c - jun and c - fos - two components of the transcription factor AP - 1, NFAT, and others.	T cell nuclear factors,43,65,Gene/Protein	IL - 2,84,90,Gene/Protein	c - jun,116,123,Gene/Protein	c - fos - two components,128,152,Gene/Protein	transcription factor,160,180,Gene/Protein	AP - 1,181,187,Gene/Protein	NFAT,189,193,Gene/Protein	"[{""token"": ""T cell nuclear factors"", ""start_span"": 43, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""c - fos - two components"", ""start_span"": 128, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 160, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
The levels of GATA - 1, Epo - R and globin mRNA expressed were not affected by a 24 - hour incubation of either cell line with Epo, GM - CSF or interleukin - 3 ( IL - 3).	GATA - 1,14,22,Gene/Protein	Epo - R,24,31,Gene/Protein	globin mRNA,36,47,Gene/Protein	Epo,127,130,Gene/Protein	GM - CSF,132,140,Gene/Protein	interleukin - 3,144,159,Gene/Protein	IL - 3,162,168,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Epo - R"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""globin mRNA"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
For further mapping purposes, a fusion promoter was constructed with the granulocyte / macrophage colony - stimulating factor basic promoter containing 60 base pairs of sequence upstream from the cap site of the mouse granulocyte / macrophage colony - stimulating factor gene and various lengths of the 5 ' upstream sequence of the IL - 4 gene.	fusion promoter,32,47,Gene/Protein	granulocyte / macrophage colony - stimulating factor basic promoter,73,140,Gene/Protein	60 base pairs of sequence,152,177,Gene/Protein	cap site,196,204,Gene/Protein	mouse granulocyte / macrophage colony - stimulating factor gene,212,275,Gene/Protein	5 ' upstream sequence,303,324,Gene/Protein	IL - 4 gene,332,343,Gene/Protein	"[{""token"": ""fusion promoter"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte / macrophage colony - stimulating factor basic promoter"", ""start_span"": 73, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""60 base pairs of sequence"", ""start_span"": 152, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""cap site"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""mouse granulocyte / macrophage colony - stimulating factor gene"", ""start_span"": 212, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream sequence"", ""start_span"": 303, ""end_span"": 324, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 332, ""end_span"": 343, ""type"": ""Gene/Protein""}]"	train
The viral trans - activators appear to target specific DNA binding protein such as NF - kB and Sp1 to cis - acting DNA site and promote lymphokine gene expression without TCR - mediated stimulation.	viral trans - activators,4,28,Gene/Protein	DNA binding protein,55,74,Gene/Protein	NF - kB,83,90,Gene/Protein	Sp1,95,98,Gene/Protein	cis - acting DNA site,102,123,Gene/Protein	lymphokine gene,136,151,Gene/Protein	TCR,171,174,Gene/Protein	"[{""token"": ""viral trans - activators"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding protein"", ""start_span"": 55, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting DNA site"", ""start_span"": 102, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine gene"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
In three unrelated Japanese children with combined pituitary hormone deficiency, we identified three point mutations in the Pit - 1 gene, Pro24Leu, Arg143Gln, and Arg271Trp, located on the major transactivation region, POU - specific domain, and POU - homeodomain, respectively.	Pit - 1 gene,124,136,Gene/Protein	Pro24Leu,138,146,Gene/Protein	Arg143Gln,148,157,Gene/Protein	Arg271Trp,163,172,Gene/Protein	major transactivation region,189,217,Gene/Protein	POU - specific domain,219,240,Gene/Protein	POU - homeodomain,246,263,Gene/Protein	"[{""token"": ""Pit - 1 gene"", ""start_span"": 124, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Pro24Leu"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Arg143Gln"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Arg271Trp"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""major transactivation region"", ""start_span"": 189, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""POU - specific domain"", ""start_span"": 219, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""POU - homeodomain"", ""start_span"": 246, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
Here we have therefore examined the effect of the phorbol ester PMA ( phorbol 12 - myristate 13 - acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA ( 5 ' - ( N - ethyl) - carboxamido adenosine) and forskolin to raise cAMP, on the levels of c - Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein - 1 ( AP - 1).	PKC,124,127,Gene/Protein	adenosine receptor,153,171,Gene/Protein	c - Fos,277,284,Gene/Protein	Jun,289,292,Gene/Protein	transcription factor,348,368,Gene/Protein	activator protein - 1,370,391,Gene/Protein	AP - 1,394,400,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""adenosine receptor"", ""start_span"": 153, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 277, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 289, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 348, ""end_span"": 368, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 370, ""end_span"": 391, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 394, ""end_span"": 400, ""type"": ""Gene/Protein""}]"	train
In spite of its association with p50 in vitro, however, we found a lymphoid cell - specific nuclear factor in vivo that contains c - Rel but not p50 epitopes; this factor, termed IL - 6 kappa B binding factor II, appears to contain the c - Rel homodimer and preferentially recognizes several IL - 6 kappa B - related kappa B motifs.	p50,33,36,Gene/Protein	lymphoid cell - specific nuclear factor,67,106,Gene/Protein	c - Rel,129,136,Gene/Protein	p50 epitopes,145,157,Gene/Protein	IL - 6 kappa B binding factor II,179,211,Gene/Protein	c - Rel homodimer,236,253,Gene/Protein	IL - 6 kappa B - related kappa B motifs,292,331,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""lymphoid cell - specific nuclear factor"", ""start_span"": 67, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""p50 epitopes"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 kappa B binding factor II"", ""start_span"": 179, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel homodimer"", ""start_span"": 236, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 kappa B - related kappa B motifs"", ""start_span"": 292, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	train
The recent definition of a consensus DNA binding sequence for the Ets family of transcription factors has allowed the identification of potential Ets binding sites in the promoters and enhancers of many inducible T - cell genes.	DNA binding sequence,37,57,Gene/Protein	Ets family,66,76,Gene/Protein	transcription factors,80,101,Gene/Protein	Ets binding sites,146,163,Gene/Protein	promoters,171,180,Gene/Protein	enhancers,185,194,Gene/Protein	inducible T - cell genes,203,227,Gene/Protein	"[{""token"": ""DNA binding sequence"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Ets family"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Ets binding sites"", ""start_span"": 146, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 185, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""inducible T - cell genes"", ""start_span"": 203, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
In directing the synthesis of RNA through the intervening DNA and the gene by a tracking and transcription mechanism, the HS2 enhancer may ( i) open up the chromatin structure of a gene domain and ( ii) deliver enhancer binding proteins to the promoter sequence where they may stimulate the transcription of the gene at the cap site.	RNA,30,33,Gene/Protein	DNA,58,61,Gene/Protein	HS2 enhancer,122,134,Gene/Protein	chromatin structure,156,175,Gene/Protein	gene domain,181,192,Gene/Protein	enhancer binding proteins,211,236,Gene/Protein	cap site,324,332,Gene/Protein	"[{""token"": ""RNA"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""DNA"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""HS2 enhancer"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""chromatin structure"", ""start_span"": 156, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""gene domain"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""enhancer binding proteins"", ""start_span"": 211, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""cap site"", ""start_span"": 324, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	train
The KBF1 factor, which binds to the enhancer A located in the promoter of the mouse MHC class I gene H - 2Kb, is indistinguishable from the p50 DNA binding subunit of the transcription factor NF - kappa B, which regulates a series of genes involved in immune and inflammatory responses.	KBF1 factor,4,15,Gene/Protein	enhancer A,36,46,Gene/Protein	promoter,62,70,Gene/Protein	mouse MHC class I gene,78,100,Gene/Protein	H - 2Kb,101,108,Gene/Protein	p50 DNA binding subunit,140,163,Gene/Protein	transcription factor NF - kappa B,171,204,Gene/Protein	"[{""token"": ""KBF1 factor"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""enhancer A"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""mouse MHC class I gene"", ""start_span"": 78, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""H - 2Kb"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""p50 DNA binding subunit"", ""start_span"": 140, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappa B"", ""start_span"": 171, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
Consistent with this result, these cell lines expressed increased levels of mRNAs encoding the AP - 1 proteins, c - Fos, Fra - 1, c - Jun, JunB, and JunD.	mRNAs,76,81,Gene/Protein	AP - 1 proteins,95,110,Gene/Protein	c - Fos,112,119,Gene/Protein	Fra - 1,121,128,Gene/Protein	c - Jun,130,137,Gene/Protein	JunB,139,143,Gene/Protein	JunD,149,153,Gene/Protein	"[{""token"": ""mRNAs"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 proteins"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
These are prominent enzymes in the endocytic pathway through which soluble protein Ag enter APC, and resistant segments in Ag may, therefore, be expected to contain more T - cell determinants than susceptible segments.	enzymes,20,27,Gene/Protein	soluble protein Ag,67,85,Gene/Protein	APC,92,95,Gene/Protein	resistant segments,101,119,Gene/Protein	Ag,123,125,Gene/Protein	T - cell determinants,170,191,Gene/Protein	susceptible segments,197,217,Gene/Protein	"[{""token"": ""enzymes"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""soluble protein Ag"", ""start_span"": 67, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""resistant segments"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Ag"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""T - cell determinants"", ""start_span"": 170, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""susceptible segments"", ""start_span"": 197, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
We have analyzed the functional domains of the minimal Thy - 1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1, an inverted CCAAT box, and sequences proximal to the transcription start site.	minimal Thy - 1 promoter,47,71,Gene/Protein	dominant promoter elements,90,116,Gene/Protein	multiple binding sites,128,150,Gene/Protein	transcription factor,159,179,Gene/Protein	Sp1,180,183,Gene/Protein	CCAAT box,197,206,Gene/Protein	transcription start site,238,262,Gene/Protein	"[{""token"": ""minimal Thy - 1 promoter"", ""start_span"": 47, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""dominant promoter elements"", ""start_span"": 90, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""multiple binding sites"", ""start_span"": 128, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 159, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT box"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 238, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus DR promoter is located upstream of the PstI repeats, and in addition to the TATA box, it contains an upstream region ( positions - 69 to - 220) responsive to EB1 ( Z) ( the BZLF1 - encoded transcription factor) and an enhancer with two functionally distinct domains, A and B.	Epstein - Barr virus DR promoter,4,36,Gene/Protein	PstI repeats,64,76,Gene/Protein	TATA box,101,109,Gene/Protein	upstream region,126,141,Gene/Protein	BZLF1 - encoded transcription factor,198,234,Gene/Protein	enhancer,243,251,Gene/Protein	B,298,299,Gene/Protein	"[{""token"": ""Epstein - Barr virus DR promoter"", ""start_span"": 4, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""PstI repeats"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""upstream region"", ""start_span"": 126, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1 - encoded transcription factor"", ""start_span"": 198, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 243, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 298, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
The expression of transiently transfected expression vectors under the control of the long terminal repeat ( LTR) of the human immunodeficiency virus ( HIV) or its enhancer sequence and the translocation of the HIV enhancer - binding protein NF - kappa B were analyzed in two human T - cell clones stimulated through their T - cell receptor complex or by tumor necrosis factor or phorbol 12 - myristate 13 - acetate.	long terminal repeat,86,106,Gene/Protein	LTR,109,112,Gene/Protein	enhancer sequence,164,181,Gene/Protein	HIV enhancer - binding protein,211,241,Gene/Protein	NF - kappa B,242,254,Gene/Protein	T - cell receptor complex,323,348,Gene/Protein	tumor necrosis factor,355,376,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 86, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""enhancer sequence"", ""start_span"": 164, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer - binding protein"", ""start_span"": 211, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 242, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor complex"", ""start_span"": 323, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 355, ""end_span"": 376, ""type"": ""Gene/Protein""}]"	train
A novel B - cell - specific transcription factor, BSAP, was identified as a mammalian homolog of the sea urchin protein TSAP, which interacts with the promoters of four tissue - specific late histone H2A - 2 and H2B - 2 genes.	B - cell - specific transcription factor,8,48,Gene/Protein	BSAP,50,54,Gene/Protein	mammalian homolog,76,93,Gene/Protein	sea urchin protein,101,119,Gene/Protein	TSAP,120,124,Gene/Protein	promoters,151,160,Gene/Protein	tissue - specific late histone H2A - 2 and H2B - 2 genes,169,225,Gene/Protein	"[{""token"": ""B - cell - specific transcription factor"", ""start_span"": 8, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""mammalian homolog"", ""start_span"": 76, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""sea urchin protein"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""TSAP"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""tissue - specific late histone H2A - 2 and H2B - 2 genes"", ""start_span"": 169, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
From this and other findings the picture emerges that there are at least three categories of factors which mediate cell - type - specific transcription in B lymphocytes: ( a) cell - specific factors such as Oct - 2A and Oct - 2B that are not expressed in most other cell types: ( b) ubiquitous factors such as NF - kappa B that are constitutively active in B cells but are sequestered in an inactive form in other cells; ( c) ubiquitously active factors, exemplified by the one binding to the E3 sequence motif.	cell - specific factors,175,198,Gene/Protein	Oct - 2A,207,215,Gene/Protein	Oct - 2B,220,228,Gene/Protein	ubiquitous factors,283,301,Gene/Protein	NF - kappa B,310,322,Gene/Protein	ubiquitously active factors,426,453,Gene/Protein	E3 sequence motif,493,510,Gene/Protein	"[{""token"": ""cell - specific factors"", ""start_span"": 175, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2B"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous factors"", ""start_span"": 283, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 310, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitously active factors"", ""start_span"": 426, ""end_span"": 453, ""type"": ""Gene/Protein""}, {""token"": ""E3 sequence motif"", ""start_span"": 493, ""end_span"": 510, ""type"": ""Gene/Protein""}]"	train
Previous transfection studies of HIV LTR constructs linked to the chloramphenicol acetyltransferase gene indicated that multiple regulatory regions including the enhancer, SP1, TATA and TAR regions were important for HIV gene expression.	HIV LTR constructs,33,51,Gene/Protein	chloramphenicol acetyltransferase gene,66,104,Gene/Protein	regulatory regions,129,147,Gene/Protein	enhancer,162,170,Gene/Protein	SP1,172,175,Gene/Protein	TATA,177,181,Gene/Protein	TAR regions,186,197,Gene/Protein	"[{""token"": ""HIV LTR constructs"", ""start_span"": 33, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase gene"", ""start_span"": 66, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 129, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""SP1"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""TATA"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""TAR regions"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
We investigated the regulation of the promoter ( BMRF1) for this early gene by studying its responsiveness in vitro to two immediate - early viral transactivators, BZLF1 ( Z) and BRLF1 ( R), focusing on the differences in response in lymphoid cells and epithelial cells.	promoter,38,46,Gene/Protein	BMRF1,49,54,Gene/Protein	immediate - early viral transactivators,123,162,Gene/Protein	BZLF1,164,169,Gene/Protein	Z,172,173,Gene/Protein	BRLF1,179,184,Gene/Protein	R,187,188,Gene/Protein	"[{""token"": ""promoter"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early viral transactivators"", ""start_span"": 123, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 172, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""BRLF1"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""R"", ""start_span"": 187, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
The changes in the composition of IL - 2Rs were accompanied by inhibition of IL - 2 - induced tyrosine phosphorylation of the Janus protein - tyrosine kinase 3 ( Jak3) and signal transducers and activators of transcription called Stat3 and Stat5.	IL - 2Rs,34,42,Gene/Protein	IL - 2,77,83,Gene/Protein	Janus protein - tyrosine kinase 3,126,159,Gene/Protein	Jak3,162,166,Gene/Protein	signal transducers and activators of transcription,172,222,Gene/Protein	Stat3,230,235,Gene/Protein	Stat5,240,245,Gene/Protein	"[{""token"": ""IL - 2Rs"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Janus protein - tyrosine kinase 3"", ""start_span"": 126, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 172, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Synergistic induction of the IL - 6 gene by IFN - gamma and TNF - alpha, in monocytic cells, involved cooperation between the IRF - 1 and NF kappa B p65 homodimers with concomitant removal of the negative effect of the retinoblastoma control element present in the IL - 6 promoter.	IL - 6 gene,29,40,Gene/Protein	IFN - gamma,44,55,Gene/Protein	TNF - alpha,60,71,Gene/Protein	IRF - 1,126,133,Gene/Protein	NF kappa B p65 homodimers,138,163,Gene/Protein	retinoblastoma control element,219,249,Gene/Protein	IL - 6 promoter,265,280,Gene/Protein	"[{""token"": ""IL - 6 gene"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B p65 homodimers"", ""start_span"": 138, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""retinoblastoma control element"", ""start_span"": 219, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 promoter"", ""start_span"": 265, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	train
NMR analysis demonstrated the presence of three alpha - helices ( Val10 - Gln22, Glu30 - Leu41 and Phe50 - Tyr65) connected by loop regions ( Ser23 - Ala49 and Leu42 - Pro49).	alpha - helices,48,63,Gene/Protein	Val10 - Gln22,66,79,Gene/Protein	Glu30 - Leu41,81,94,Gene/Protein	Phe50 - Tyr65,99,112,Gene/Protein	loop regions,127,139,Gene/Protein	Ser23 - Ala49,142,155,Gene/Protein	Leu42 - Pro49,160,173,Gene/Protein	"[{""token"": ""alpha - helices"", ""start_span"": 48, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Val10 - Gln22"", ""start_span"": 66, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Glu30 - Leu41"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Phe50 - Tyr65"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""loop regions"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Ser23 - Ala49"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Leu42 - Pro49"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Whereas TPCK inhibits phosphorylation of I kappa B and, consequently, activation of NF - kappa B, it markedly enhances the activity of JNK, the MAP kinase - related kinase that phosphorylates the transactivation domain of c - Jun.	TPCK,8,12,Gene/Protein	I kappa B,41,50,Gene/Protein	NF - kappa B,84,96,Gene/Protein	JNK,135,138,Gene/Protein	MAP kinase - related kinase,144,171,Gene/Protein	transactivation domain,196,218,Gene/Protein	c - Jun,222,229,Gene/Protein	"[{""token"": ""TPCK"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase - related kinase"", ""start_span"": 144, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domain"", ""start_span"": 196, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 222, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Triggering of complement receptors CR1 ( CD35) and CR3 ( CD11b / CD18) induces nuclear translocation of NF - kappa B ( p50 / p65) in human monocytes and enhances viral replication in HIV - infected monocytic cells.	complement receptors,14,34,Gene/Protein	CR1,35,38,Gene/Protein	CD35,41,45,Gene/Protein	CR3,51,54,Gene/Protein	CD11b / CD18,57,69,Gene/Protein	NF - kappa B,104,116,Gene/Protein	p50 / p65,119,128,Gene/Protein	"[{""token"": ""complement receptors"", ""start_span"": 14, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""CR1"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""CD35"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""CR3"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 57, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 104, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
This region ( termed the zinc finger protein binding region ( ZIP)) serves as binding site for two differently regulated zinc finger proteins: the constitutively expressed transcription factor Sp1 and the inducible early growth response protein EGR - 1.	zinc finger protein binding region,25,59,Gene/Protein	ZIP,62,65,Gene/Protein	zinc finger proteins,121,141,Gene/Protein	constitutively expressed transcription factor,147,192,Gene/Protein	Sp1,193,196,Gene/Protein	inducible early growth response protein,205,244,Gene/Protein	EGR - 1,245,252,Gene/Protein	"[{""token"": ""zinc finger protein binding region"", ""start_span"": 25, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""ZIP"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger proteins"", ""start_span"": 121, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""constitutively expressed transcription factor"", ""start_span"": 147, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""inducible early growth response protein"", ""start_span"": 205, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 245, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
By using a nucleosome - assembly system derived from Drosophila embryos, we find that the packaging of DNA into chromatin in vitro strongly represses HIV - 1 transcription and that repression can be counteracted efficiently by preincubation of the DNA with LEF - 1 ( or LEF - 1 and Ets - 1) supplemented with fractions containing the promoter - binding protein, Sp1.	nucleosome,11,21,Gene/Protein	chromatin,112,121,Gene/Protein	LEF - 1,257,264,Gene/Protein	LEF - 1,270,277,Gene/Protein	Ets - 1,282,289,Gene/Protein	promoter - binding protein,334,360,Gene/Protein	Sp1,362,365,Gene/Protein	"[{""token"": ""nucleosome"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""chromatin"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 257, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 270, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 282, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""promoter - binding protein"", ""start_span"": 334, ""end_span"": 360, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 362, ""end_span"": 365, ""type"": ""Gene/Protein""}]"	train
A truncation mutant of LEF - 1 ( HMG - 88), which contains the HMG box but lacks the trans - activation domain, did not activate transcription from nucleosomal DNA, indicating that bending of DNA by the HMG domain is not sufficient to activate transcription in vitro.	truncation mutant,2,19,Gene/Protein	LEF - 1,23,30,Gene/Protein	HMG - 88,33,41,Gene/Protein	HMG box,63,70,Gene/Protein	trans - activation domain,85,110,Gene/Protein	nucleosomal DNA,148,163,Gene/Protein	HMG domain,203,213,Gene/Protein	"[{""token"": ""truncation mutant"", ""start_span"": 2, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""HMG - 88"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""HMG box"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""trans - activation domain"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""nucleosomal DNA"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""HMG domain"", ""start_span"": 203, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
In addition, the Ah receptor complex recognized a DNA binding site for B cell lineage - specific activator protein ( BSAP) in the promoter region of the human CD19 gene which is similar to the consensus Ah receptor DNA binding site.	Ah receptor complex,17,36,Gene/Protein	DNA binding site,50,66,Gene/Protein	B cell lineage - specific activator protein,71,114,Gene/Protein	BSAP,117,121,Gene/Protein	promoter region,130,145,Gene/Protein	CD19 gene,159,168,Gene/Protein	consensus Ah receptor DNA binding site,193,231,Gene/Protein	"[{""token"": ""Ah receptor complex"", ""start_span"": 17, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding site"", ""start_span"": 50, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""B cell lineage - specific activator protein"", ""start_span"": 71, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 130, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CD19 gene"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""consensus Ah receptor DNA binding site"", ""start_span"": 193, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	valid
Here we show that the lymphoid - specific transcription factor Oct - 2A plays a critical role in HLA - DRA gene expression in class II - positive B cell lines, and that the high mobility group protein ( HMG) I / Y binds to multiple sites within the DRA promoter, including the Oct - 2A binding site.	lymphoid - specific transcription factor Oct - 2A,22,71,Gene/Protein	HLA - DRA gene,97,111,Gene/Protein	high mobility group protein,173,200,Gene/Protein	HMG,203,206,Gene/Protein	I / Y,208,213,Gene/Protein	DRA promoter,249,261,Gene/Protein	Oct - 2A binding site,277,298,Gene/Protein	"[{""token"": ""lymphoid - specific transcription factor Oct - 2A"", ""start_span"": 22, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA gene"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""high mobility group protein"", ""start_span"": 173, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""HMG"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""I / Y"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 249, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A binding site"", ""start_span"": 277, ""end_span"": 298, ""type"": ""Gene/Protein""}]"	valid
In lymphoblastoid cell lines, six EBV - encoded nuclear antigens ( EBNA1, 2, 3A, 3B, 3C, - LP), three latent membrane proteins ( LMP1, 2A, 2B), and two nuclear RNAs ( EBERs) are expressed.	EBV - encoded nuclear antigens,34,64,Gene/Protein	latent membrane proteins,102,126,Gene/Protein	LMP1,129,133,Gene/Protein	2A,135,137,Gene/Protein	2B,139,141,Gene/Protein	nuclear RNAs,152,164,Gene/Protein	EBERs,167,172,Gene/Protein	"[{""token"": ""EBV - encoded nuclear antigens"", ""start_span"": 34, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane proteins"", ""start_span"": 102, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""2A"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""2B"", ""start_span"": 139, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""nuclear RNAs"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""EBERs"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	valid
Computer analysis of the SM protein sequence showed a C terminal section of SM to be related to genome positional homologues of four other herpesviruses and revealed consensus CKII sites near the N termini of the EBV SM protein, the herpes simplex virus ( HSV) ICP27 protein and the herpesvirus saimiri ( HVS) open reading frame 57 protein.	SM protein,25,35,Gene/Protein	C terminal section,54,72,Gene/Protein	SM,76,78,Gene/Protein	genome positional homologues,96,124,Gene/Protein	consensus CKII sites,166,186,Gene/Protein	N termini,196,205,Gene/Protein	EBV SM protein,213,227,Gene/Protein	"[{""token"": ""SM protein"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""C terminal section"", ""start_span"": 54, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""SM"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""genome positional homologues"", ""start_span"": 96, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""consensus CKII sites"", ""start_span"": 166, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""N termini"", ""start_span"": 196, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""EBV SM protein"", ""start_span"": 213, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	valid
OBJECTIVE: To determine whether activation of Epstein - Barr virus ( EBV) replication in tumour cells of AIDS - related non - Hodgkin ' s lymphoma ( ARNHL) is correlated with CD4 + cell counts and influences antibody response to EBV [ anti - Z Epstein - Barr replicative activator ( ZEBRA), anti - early antigen ( EA), anti - viral capsid antigen ( VCA)].	CD4 +,175,180,Gene/Protein	anti - Z Epstein - Barr replicative activator,235,280,Gene/Protein	ZEBRA,283,288,Gene/Protein	anti - early antigen,291,311,Gene/Protein	EA,314,316,Gene/Protein	anti - viral capsid antigen,319,346,Gene/Protein	VCA,349,352,Gene/Protein	"[{""token"": ""CD4 +"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""anti - Z Epstein - Barr replicative activator"", ""start_span"": 235, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""ZEBRA"", ""start_span"": 283, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""anti - early antigen"", ""start_span"": 291, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""EA"", ""start_span"": 314, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""anti - viral capsid antigen"", ""start_span"": 319, ""end_span"": 346, ""type"": ""Gene/Protein""}, {""token"": ""VCA"", ""start_span"": 349, ""end_span"": 352, ""type"": ""Gene/Protein""}]"	valid
In order to elucidate the role of c - myb gene in erythroid differentiation of K562 cell induced by hemin ( Hm) and erythropoietin ( Epo), we constructed recombinant plasmid that could produce antisense myb RNA after induction with dexamethasone.	c - myb gene,34,46,Gene/Protein	hemin,100,105,Gene/Protein	Hm,108,110,Gene/Protein	erythropoietin,116,130,Gene/Protein	Epo,133,136,Gene/Protein	recombinant plasmid,154,173,Gene/Protein	antisense myb RNA,193,210,Gene/Protein	"[{""token"": ""c - myb gene"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""hemin"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Hm"", ""start_span"": 108, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 116, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""recombinant plasmid"", ""start_span"": 154, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""antisense myb RNA"", ""start_span"": 193, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	valid
Expression and genomic configuration of GM - CSF, IL - 3, M - CSF receptor ( C - FMS), early growth response gene - 1 ( EGR - 1) and M - CSF genes in primary myelodysplastic syndromes.	GM - CSF,40,48,Gene/Protein	IL - 3,50,56,Gene/Protein	M - CSF receptor,58,74,Gene/Protein	C - FMS,77,84,Gene/Protein	early growth response gene - 1,87,117,Gene/Protein	EGR - 1,120,127,Gene/Protein	M - CSF genes,133,146,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF receptor"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""C - FMS"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""early growth response gene - 1"", ""start_span"": 87, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF genes"", ""start_span"": 133, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	valid
Both stimuli induced the appearance of the NF - kappa B components ( c - Rel, p65 ( RelA), and p50 ( NF - kappa B1)) and NF - kappa B DNA binding activity in the nucleus.	NF - kappa B components,43,66,Gene/Protein	c - Rel,69,76,Gene/Protein	p65,78,81,Gene/Protein	RelA,84,88,Gene/Protein	p50,95,98,Gene/Protein	NF - kappa B1,101,114,Gene/Protein	NF - kappa B,121,133,Gene/Protein	"[{""token"": ""NF - kappa B components"", ""start_span"": 43, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	valid
Sequence analyses of pCD41 indicate that there are two potential open reading frames ( ORFs), A and B, which are homologous to the ORFs found in the genomic clone pGD41.	pCD41,21,26,Gene/Protein	open reading frames,65,84,Gene/Protein	ORFs,87,91,Gene/Protein	A,94,95,Gene/Protein	B,100,101,Gene/Protein	ORFs,131,135,Gene/Protein	pGD41,163,168,Gene/Protein	"[{""token"": ""pCD41"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""open reading frames"", ""start_span"": 65, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""A"", ""start_span"": 94, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 100, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""pGD41"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	valid
To further elucidate the role of this variant octamer motif in the regulation of germline transcription from the unrearranged kappa locus, we have quantitated the relative binding affinity of Oct - 1 and Oct - 2 for the variant octamer motif and determined the functional role of this octamer motif in transcriptional activation.	octamer motif,46,59,Gene/Protein	germline,81,89,Gene/Protein	kappa locus,126,137,Gene/Protein	Oct - 1,192,199,Gene/Protein	Oct - 2,204,211,Gene/Protein	octamer motif,228,241,Gene/Protein	octamer motif,285,298,Gene/Protein	"[{""token"": ""octamer motif"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""kappa locus"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 228, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 285, ""end_span"": 298, ""type"": ""Gene/Protein""}]"	valid
Flow cytometry analyses on cultured cells that were treated with tepoxalin or antisense oligonucleotides to the P65 / p50 subunit of NF - kappa B, and then stimulated with PMA, revealed a reduced expression of CD11b / CD18 on monocytic HL60 cells, and endothelial adhesion molecule - 1 ( CD62E) and vascular adhesion molecule - 1 ( CD106) on human umbilical vein endothelial cells.	P65 / p50 subunit,112,129,Gene/Protein	NF - kappa B,133,145,Gene/Protein	CD11b / CD18,210,222,Gene/Protein	endothelial adhesion molecule - 1,252,285,Gene/Protein	CD62E,288,293,Gene/Protein	vascular adhesion molecule - 1,299,329,Gene/Protein	CD106,332,337,Gene/Protein	"[{""token"": ""P65 / p50 subunit"", ""start_span"": 112, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 133, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 210, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""endothelial adhesion molecule - 1"", ""start_span"": 252, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""CD62E"", ""start_span"": 288, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""vascular adhesion molecule - 1"", ""start_span"": 299, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 332, ""end_span"": 337, ""type"": ""Gene/Protein""}]"	valid
Therefore, to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF / ETS element) motif found in the HCMV and chimpanzee CMV MIE enhancers, we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937, K - 562, HL - 60, THP - 1, and Jurkat cell lines.	SNE motifs,66,76,Gene/Protein	SEE,102,105,Gene/Protein	SRF / ETS element,108,125,Gene/Protein	HCMV and chimpanzee CMV MIE enhancers,146,183,Gene/Protein	multimerized wild - type and mutant elements,261,305,Gene/Protein	SCMV MIE,328,336,Gene/Protein	simian virus 40 minimal promoter regions,340,380,Gene/Protein	"[{""token"": ""SNE motifs"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""SEE"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""SRF / ETS element"", ""start_span"": 108, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""HCMV and chimpanzee CMV MIE enhancers"", ""start_span"": 146, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""multimerized wild - type and mutant elements"", ""start_span"": 261, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""SCMV MIE"", ""start_span"": 328, ""end_span"": 336, ""type"": ""Gene/Protein""}, {""token"": ""simian virus 40 minimal promoter regions"", ""start_span"": 340, ""end_span"": 380, ""type"": ""Gene/Protein""}]"	valid
The identification of oriP and the EBNA2 - dependent enhancer as the major positive cis elements involved in regulating Cp activity in LCL suggests that EBNA gene transcription is largely autoregulated by EBNA 1 and EBNA 2.	oriP,22,26,Gene/Protein	EBNA2 - dependent enhancer,35,61,Gene/Protein	cis elements,84,96,Gene/Protein	Cp,120,122,Gene/Protein	EBNA gene,153,162,Gene/Protein	EBNA 1,205,211,Gene/Protein	EBNA 2,216,222,Gene/Protein	"[{""token"": ""oriP"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""EBNA2 - dependent enhancer"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""cis elements"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""EBNA gene"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""EBNA 1"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""EBNA 2"", ""start_span"": 216, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	valid
DNase I hypersensitive site ( DHS) mapping revealed that the perforin locus contained six DHS within 7. 0 kb of the 5 ' upstream sequence ( - 7. 0 kb) and two DHS in intron 2.	DNase I hypersensitive site,0,27,Gene/Protein	DHS,30,33,Gene/Protein	perforin locus,61,75,Gene/Protein	DHS,90,93,Gene/Protein	5 ' upstream sequence,116,137,Gene/Protein	DHS,159,162,Gene/Protein	intron 2,166,174,Gene/Protein	"[{""token"": ""DNase I hypersensitive site"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""DHS"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""perforin locus"", ""start_span"": 61, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""DHS"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream sequence"", ""start_span"": 116, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""DHS"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""intron 2"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	valid
Instead, ATF - 2 and Jun proteins bind to the composite kappa 3 / CRE site and NFATp binds to a newly identified second NFAT site centered at - 76 nucleotides relative to the TNF - alpha transcription start site.	ATF - 2,9,16,Gene/Protein	Jun proteins,21,33,Gene/Protein	composite kappa 3 / CRE site,46,74,Gene/Protein	NFATp,79,84,Gene/Protein	NFAT site,120,129,Gene/Protein	- 76 nucleotides,142,158,Gene/Protein	TNF - alpha transcription start site,175,211,Gene/Protein	"[{""token"": ""ATF - 2"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""Jun proteins"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""composite kappa 3 / CRE site"", ""start_span"": 46, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NFAT site"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""- 76 nucleotides"", ""start_span"": 142, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha transcription start site"", ""start_span"": 175, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	valid
Gel mobility shift and immunoprecipitation analyses revealed that in addition to activating STAT3 ( signal transducer and activator of transcription - 3) and STAT5, IL - 2 induced tyrosine and serine phosphorylation of STAT1 alpha, which formed IFN - gamma - activated sequence - binding complexes by itself and with STAT3.	STAT3,92,97,Gene/Protein	signal transducer and activator of transcription - 3,100,152,Gene/Protein	STAT5,158,163,Gene/Protein	IL - 2,165,171,Gene/Protein	STAT1 alpha,219,230,Gene/Protein	IFN - gamma - activated sequence - binding complexes,245,297,Gene/Protein	STAT3,317,322,Gene/Protein	"[{""token"": ""STAT3"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription - 3"", ""start_span"": 100, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - activated sequence - binding complexes"", ""start_span"": 245, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 317, ""end_span"": 322, ""type"": ""Gene/Protein""}]"	valid
Therefore, we analyzed the expression, DNA binding, and transcriptional activity of the endogenous RA and VitD3 receptors [ retinoic acid receptors ( RARs), retinoid X receptors ( RXRs), and VitD3 receptor ( VDR)] in the U - 937 cell line, in which RA and VitD3 induce distinct monocytic differentiation pathways.	endogenous RA and VitD3 receptors,88,121,Gene/Protein	retinoic acid receptors,124,147,Gene/Protein	RARs,150,154,Gene/Protein	retinoid X receptors,157,177,Gene/Protein	RXRs,180,184,Gene/Protein	VitD3 receptor,191,205,Gene/Protein	VDR,208,211,Gene/Protein	"[{""token"": ""endogenous RA and VitD3 receptors"", ""start_span"": 88, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptors"", ""start_span"": 124, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""VitD3 receptor"", ""start_span"": 191, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	valid
Two explanations for hyporesponsiveness of the human iNOS promoter to LPS + / - IFN - gamma were found: ( 1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS / IFN - gamma induced expression of the mouse iNOS gene; and ( 2) and absence of one or more nuclear factors in human macrophages ( e. g., an LPS - inducible nuclear factor - kappa B / Rel complex), that is ( are) required for maximal expression of the gene.	human iNOS promoter,47,66,Gene/Protein	IFN - gamma,80,91,Gene/Protein	enhancer element,188,204,Gene/Protein	IFN - gamma,243,254,Gene/Protein	mouse iNOS gene,281,296,Gene/Protein	nuclear factors,334,349,Gene/Protein	LPS - inducible nuclear factor - kappa B / Rel complex,383,437,Gene/Protein	"[{""token"": ""human iNOS promoter"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""enhancer element"", ""start_span"": 188, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 243, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""mouse iNOS gene"", ""start_span"": 281, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 334, ""end_span"": 349, ""type"": ""Gene/Protein""}, {""token"": ""LPS - inducible nuclear factor - kappa B / Rel complex"", ""start_span"": 383, ""end_span"": 437, ""type"": ""Gene/Protein""}]"	valid
CD40 signaling activates downstream effectors, including the tyrosine protein kinase, Lyn, the phosphatidylinositol - 3 - kinase ( PI - 3 kinase), and the transcription factor, NF - kappa B.	CD40,0,4,Gene/Protein	downstream effectors,25,45,Gene/Protein	tyrosine protein kinase,61,84,Gene/Protein	Lyn,86,89,Gene/Protein	phosphatidylinositol - 3 - kinase,95,128,Gene/Protein	PI - 3 kinase,131,144,Gene/Protein	NF - kappa B,177,189,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""downstream effectors"", ""start_span"": 25, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine protein kinase"", ""start_span"": 61, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Lyn"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol - 3 - kinase"", ""start_span"": 95, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""PI - 3 kinase"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	valid
STAT1 activity was evident on the STAT binding sequences ( SBE) present in the promoters of genes which are up - regulated during monocyte to macrophage maturation such as FcgammaRI and ICAM - 1, and in the promoter of the transcription factor IFN regulatory factor - 1.	STAT1,0,5,Gene/Protein	STAT binding sequences,34,56,Gene/Protein	SBE,59,62,Gene/Protein	promoters,79,88,Gene/Protein	FcgammaRI,172,181,Gene/Protein	ICAM - 1,186,194,Gene/Protein	transcription factor IFN regulatory factor - 1,223,269,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""STAT binding sequences"", ""start_span"": 34, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""SBE"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI"", ""start_span"": 172, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor IFN regulatory factor - 1"", ""start_span"": 223, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	valid
As2O3 induced PML ( promyelocytic leukemia) protein degradation but did not modulate expression of cell cycle - related proteins, including c - myc, retinoblastoma protein, cyclin - dependent kinase 4, cyclin D1, and p53, or expression of differentiation - related antigens.	cell cycle - related proteins,99,128,Gene/Protein	c - myc,140,147,Gene/Protein	retinoblastoma protein,149,171,Gene/Protein	cyclin - dependent kinase 4,173,200,Gene/Protein	cyclin D1,202,211,Gene/Protein	p53,217,220,Gene/Protein	differentiation - related antigens,239,273,Gene/Protein	"[{""token"": ""cell cycle - related proteins"", ""start_span"": 99, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""retinoblastoma protein"", ""start_span"": 149, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinase 4"", ""start_span"": 173, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D1"", ""start_span"": 202, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""differentiation - related antigens"", ""start_span"": 239, ""end_span"": 273, ""type"": ""Gene/Protein""}]"	valid
However, binding of SHP2 to SIT is not required for inhibition of NF - AT induction, suggesting that SIT not only regulates NF - AT activity but also controls NF - AT unrelated pathways of T cell activation involving SHP2.	SHP2,20,24,Gene/Protein	SIT,28,31,Gene/Protein	NF - AT,66,73,Gene/Protein	SIT,101,104,Gene/Protein	NF - AT,124,131,Gene/Protein	NF - AT,159,166,Gene/Protein	SHP2,217,221,Gene/Protein	"[{""token"": ""SHP2"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""SIT"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""SIT"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""SHP2"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	valid
However, CD80 and CD86 also induce distinct signal transduction pathways including the tyrosine phosphorylation of CD28 and phospholipase Cgamma1 and the SH2 - dependent association of phosphoinositide 3 - kinase with CD28.	CD80,9,13,Gene/Protein	CD86,18,22,Gene/Protein	CD28,115,119,Gene/Protein	phospholipase Cgamma1,124,145,Gene/Protein	SH2,154,157,Gene/Protein	phosphoinositide 3 - kinase,185,212,Gene/Protein	CD28,218,222,Gene/Protein	"[{""token"": ""CD80"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase Cgamma1"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""SH2"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""phosphoinositide 3 - kinase"", ""start_span"": 185, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	valid
The functional contribution of the kappaB - Sp1 composite site in P / I - inducible fas promoter activation was verified by using kappaB - Sp1 concatamers ( - 295 to - 286) in a thymidine kinase promoter - driven reporter construct and native promoter constructs in Jurkat cells overexpressing IkappaB - alpha.	kappaB - Sp1 composite site,35,62,Gene/Protein	P / I - inducible fas promoter,66,96,Gene/Protein	Sp1,139,142,Gene/Protein	- 295 to - 286,157,171,Gene/Protein	thymidine kinase promoter - driven reporter construct,178,231,Gene/Protein	native promoter constructs,236,262,Gene/Protein	IkappaB - alpha,294,309,Gene/Protein	"[{""token"": ""kappaB - Sp1 composite site"", ""start_span"": 35, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""P / I - inducible fas promoter"", ""start_span"": 66, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""- 295 to - 286"", ""start_span"": 157, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase promoter - driven reporter construct"", ""start_span"": 178, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""native promoter constructs"", ""start_span"": 236, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 294, ""end_span"": 309, ""type"": ""Gene/Protein""}]"	valid
RESULTS: We identified peptides derived from EWS / FLI - 1 fusion protein and from mutated K - RAS protein ( encompassing respectively the fusion point and the mutation at position 12) that showed binding motif for HLA - Cw * 0702 and HLA - A3 respectively.	EWS / FLI - 1 fusion protein,45,73,Gene/Protein	mutated K - RAS protein,83,106,Gene/Protein	fusion point,139,151,Gene/Protein	position 12,172,183,Gene/Protein	binding motif,197,210,Gene/Protein	HLA - Cw * 0702,215,230,Gene/Protein	HLA - A3,235,243,Gene/Protein	"[{""token"": ""EWS / FLI - 1 fusion protein"", ""start_span"": 45, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""mutated K - RAS protein"", ""start_span"": 83, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""fusion point"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""position 12"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""binding motif"", ""start_span"": 197, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""HLA - Cw * 0702"", ""start_span"": 215, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""HLA - A3"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	valid
A threonine residue at position 234, previously shown to be important for CD40 association with TNF receptor - associated factor 2 ( TRAF2), TRAF3, and TRAF5, was not required for NF - kappa B activation.	position 234,23,35,Gene/Protein	CD40,74,78,Gene/Protein	TNF receptor - associated factor 2,96,130,Gene/Protein	TRAF2,133,138,Gene/Protein	TRAF3,141,146,Gene/Protein	TRAF5,152,157,Gene/Protein	NF - kappa B,180,192,Gene/Protein	"[{""token"": ""position 234"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""TNF receptor - associated factor 2"", ""start_span"": 96, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""TRAF5"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	valid
Treatment of cells expressing the chimeric receptor kit / IL - 4R alpha with SCF induces activation of the IL - 4R alpha - associated kinase JAK - 1 and the transcription factor STAT6.	chimeric receptor,34,51,Gene/Protein	kit / IL - 4R alpha,52,71,Gene/Protein	SCF,77,80,Gene/Protein	IL - 4R alpha - associated kinase,107,140,Gene/Protein	JAK - 1,141,148,Gene/Protein	transcription factor,157,177,Gene/Protein	STAT6,178,183,Gene/Protein	"[{""token"": ""chimeric receptor"", ""start_span"": 34, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""kit / IL - 4R alpha"", ""start_span"": 52, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha - associated kinase"", ""start_span"": 107, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""JAK - 1"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	valid
Clonal analysis revealed individual responses to the two immediate early proteins BZLF1 and BRLF1, and to three ( BMLF1, BMRF1, and BALF2) of the six early proteins tested.	immediate early proteins,57,81,Gene/Protein	BZLF1,82,87,Gene/Protein	BRLF1,92,97,Gene/Protein	BMLF1,114,119,Gene/Protein	BMRF1,121,126,Gene/Protein	BALF2,132,137,Gene/Protein	early proteins,150,164,Gene/Protein	"[{""token"": ""immediate early proteins"", ""start_span"": 57, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""BRLF1"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""BMLF1"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""BALF2"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""early proteins"", ""start_span"": 150, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	valid
c - Fos protein was shown essential for an optimal transactivation of the HIV - 1 long terminal repeat ( LTR) by Tat: incubation of Jurkat cells with antisense, but not sense, c - fos oligonucleotides significantly reduced either the Tat - enhanced expression of an LTR - CAT reporter construct or the levels of gag p24 in the culture supernatants of Jurkat cells and PBMC acutely infected with HIV - 1.	c - Fos,0,7,Gene/Protein	long terminal repeat,82,102,Gene/Protein	LTR,105,108,Gene/Protein	Tat,113,116,Gene/Protein	Tat,234,237,Gene/Protein	LTR - CAT reporter construct,266,294,Gene/Protein	gag p24,312,319,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""LTR - CAT reporter construct"", ""start_span"": 266, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""gag p24"", ""start_span"": 312, ""end_span"": 319, ""type"": ""Gene/Protein""}]"	valid
The interaction of Tax1 with NF - YB was specific in that NF - YB did not interact with a variety of other transcription factors, including human immunodeficiency virus Tat, human papillomavirus E6, and Bicoid, or with the M7 ( amino acids 29CP - AS) Tax1 mutant.	Tax1,19,23,Gene/Protein	NF - YB,29,36,Gene/Protein	NF - YB,58,65,Gene/Protein	transcription factors,107,128,Gene/Protein	human immunodeficiency virus Tat,140,172,Gene/Protein	human papillomavirus E6,174,197,Gene/Protein	Bicoid,203,209,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""NF - YB"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""NF - YB"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 107, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""human immunodeficiency virus Tat"", ""start_span"": 140, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""human papillomavirus E6"", ""start_span"": 174, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Bicoid"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	valid
In order to evaluate the conditions for optimal expression and immunogenicity of varicella - zoster virus ( VZV) proteins in a herpes simplex virus - 1 ( HSV - 1) vector, we selected the VZV glycoprotein E ( gE), encoded by ORF 68 and the VZV product of ORF 62, an immediate - early major tegument protein ( IE62).	VZV glycoprotein E,187,205,Gene/Protein	gE,208,210,Gene/Protein	ORF 68,224,230,Gene/Protein	VZV product,239,250,Gene/Protein	ORF 62,254,260,Gene/Protein	immediate - early major tegument protein,265,305,Gene/Protein	IE62,308,312,Gene/Protein	"[{""token"": ""VZV glycoprotein E"", ""start_span"": 187, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""gE"", ""start_span"": 208, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""ORF 68"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""VZV product"", ""start_span"": 239, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""ORF 62"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early major tegument protein"", ""start_span"": 265, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""IE62"", ""start_span"": 308, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	valid
When introduced into interleukin 3 ( IL - 3) - dependent mouse pro - B lymphocytes, E2A - HLF prevents apoptosis induced by growth factor deprivation, suggesting that IL - 3 mediates cell survival through activation of a transcription factor whose activity can be constitutively replaced by the chimeric oncoprotein.	interleukin 3,21,34,Gene/Protein	IL - 3,37,43,Gene/Protein	E2A - HLF,84,93,Gene/Protein	growth factor,124,137,Gene/Protein	IL - 3,167,173,Gene/Protein	transcription factor,221,241,Gene/Protein	chimeric oncoprotein,295,315,Gene/Protein	"[{""token"": ""interleukin 3"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""growth factor"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 221, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""chimeric oncoprotein"", ""start_span"": 295, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	valid
The gene encodes an 85 - kDa protein, designated BASH ( B cell adaptor containing SH2 domain), that contains N - terminal acidic domains with SH2 domain - binding phosphotyrosine - based motifs, a proline - rich domain, and a C - terminal SH2 domain.	85 - kDa protein,20,36,Gene/Protein	BASH,49,53,Gene/Protein	B cell adaptor containing SH2 domain,56,92,Gene/Protein	N - terminal acidic domains,109,136,Gene/Protein	SH2 domain - binding phosphotyrosine - based motifs,142,193,Gene/Protein	proline - rich domain,197,218,Gene/Protein	C - terminal SH2 domain,226,249,Gene/Protein	"[{""token"": ""85 - kDa protein"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""BASH"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""B cell adaptor containing SH2 domain"", ""start_span"": 56, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal acidic domains"", ""start_span"": 109, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain - binding phosphotyrosine - based motifs"", ""start_span"": 142, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""proline - rich domain"", ""start_span"": 197, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal SH2 domain"", ""start_span"": 226, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	valid
These studies revealed that the major protein in extracts of PMN activated by G - CSF to bind the high - affinity serum - inducible element ( hSIE) is a 72 - kDa protein that cross - reacts with Stat3 monoclonal antibody, which we have designated Stat3gamma.	major protein,32,45,Gene/Protein	G - CSF,78,85,Gene/Protein	high - affinity serum - inducible element,98,139,Gene/Protein	hSIE,142,146,Gene/Protein	72 - kDa protein,153,169,Gene/Protein	Stat3 monoclonal antibody,195,220,Gene/Protein	Stat3gamma,247,257,Gene/Protein	"[{""token"": ""major protein"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity serum - inducible element"", ""start_span"": 98, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""hSIE"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""72 - kDa protein"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Stat3 monoclonal antibody"", ""start_span"": 195, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""Stat3gamma"", ""start_span"": 247, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	valid
These motifs are regulatory sequences within the so - called AU - rich elements ( AREs) often found in 3 ' untranslated regions of genes such as cytokines, proto - oncogenes, and transcription factors.	regulatory sequences,17,37,Gene/Protein	AU - rich elements,61,79,Gene/Protein	AREs,82,86,Gene/Protein	3 ' untranslated regions,103,127,Gene/Protein	cytokines,145,154,Gene/Protein	proto - oncogenes,156,173,Gene/Protein	transcription factors,179,200,Gene/Protein	"[{""token"": ""regulatory sequences"", ""start_span"": 17, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""AU - rich elements"", ""start_span"": 61, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""AREs"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""3 ' untranslated regions"", ""start_span"": 103, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogenes"", ""start_span"": 156, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 179, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	valid
p130, predominantly in Form 1, and hypophosphorylated pRb bind an E2F DNA binding site; p130 complexes E2F - 4, whereas pRb binds both E2F - 4 and E2F - 1.	p130,0,4,Gene/Protein	hypophosphorylated pRb,35,57,Gene/Protein	E2F DNA binding site,66,86,Gene/Protein	p130,88,92,Gene/Protein	E2F - 4,103,110,Gene/Protein	pRb,120,123,Gene/Protein	E2F - 1,147,154,Gene/Protein	"[{""token"": ""p130"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""hypophosphorylated pRb"", ""start_span"": 35, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""E2F DNA binding site"", ""start_span"": 66, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 4"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	valid
The effect of Rho on AP - 1 is independent of the mitogen - activated protein kinase pathway, as a dominant - negative MEK and a MEK inhibitor ( PD98059) did not affect Rho - induced AP - 1 activity.	Rho,14,17,Gene/Protein	AP - 1,21,27,Gene/Protein	mitogen - activated protein kinase,50,84,Gene/Protein	dominant - negative MEK,99,122,Gene/Protein	MEK,129,132,Gene/Protein	Rho,169,172,Gene/Protein	AP - 1,183,189,Gene/Protein	"[{""token"": ""Rho"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 50, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""dominant - negative MEK"", ""start_span"": 99, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	valid
Dominant negative mutants of NIK, IKKalpha, or IKKbeta substantially inhibited NF - kappaB activation by LMP1 or by each of its effector sites.	Dominant negative mutants,0,25,Gene/Protein	NIK,29,32,Gene/Protein	IKKalpha,34,42,Gene/Protein	IKKbeta,47,54,Gene/Protein	NF - kappaB,79,90,Gene/Protein	LMP1,105,109,Gene/Protein	effector sites,128,142,Gene/Protein	"[{""token"": ""Dominant negative mutants"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""effector sites"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	valid
MyD88, originally isolated as a myeloid differentiation primary response gene, is shown to act as an adaptor in interleukin - 1 ( IL - 1) signaling by interacting with both the IL - 1 receptor complex and IL - 1 receptor - associated kinase ( IRAK).	MyD88,0,5,Gene/Protein	primary response gene,56,77,Gene/Protein	interleukin - 1,112,127,Gene/Protein	IL - 1,130,136,Gene/Protein	IL - 1 receptor complex,177,200,Gene/Protein	IL - 1 receptor - associated kinase,205,240,Gene/Protein	IRAK,243,247,Gene/Protein	"[{""token"": ""MyD88"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""primary response gene"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor complex"", ""start_span"": 177, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor - associated kinase"", ""start_span"": 205, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""IRAK"", ""start_span"": 243, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	valid
Somewhat unexpectedly, the constitutive p21ras activity did not cause an increased DNA binding of transcription factors PEA1 ( AP1), PEA3, Oct - 2 or NF - kB	p21ras,40,46,Gene/Protein	transcription factors,98,119,Gene/Protein	PEA1,120,124,Gene/Protein	AP1,127,130,Gene/Protein	PEA3,133,137,Gene/Protein	Oct - 2,139,146,Gene/Protein	NF - kB,150,157,Gene/Protein	"[{""token"": ""p21ras"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 98, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""PEA1"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""PEA3"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	valid
Little effect was observed with 50 - kDa forms of p105 NF - kappa B or rel, in combination with p65 or full - length c - rel, which do not stimulate the HIV enhancer in these cells.	50 - kDa forms,32,46,Gene/Protein	p105,50,54,Gene/Protein	NF - kappa B,55,67,Gene/Protein	rel,71,74,Gene/Protein	p65,96,99,Gene/Protein	full - length c - rel,103,124,Gene/Protein	HIV enhancer,153,165,Gene/Protein	"[{""token"": ""50 - kDa forms"", ""start_span"": 32, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""rel"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""full - length c - rel"", ""start_span"": 103, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	valid
Furthermore, an antiserum against KBF1 ( identical to 50 kDa NF - kappa B protein) reacted with the p50 of NF - GM2, indicating that the NF - GM2 polypeptide can not be immunologically differentiated from the 50 kDa subunit of NF - kappa B.	KBF1,34,38,Gene/Protein	50 kDa NF - kappa B protein,54,81,Gene/Protein	p50,100,103,Gene/Protein	NF - GM2,107,115,Gene/Protein	NF - GM2 polypeptide,137,157,Gene/Protein	50 kDa subunit,209,223,Gene/Protein	NF - kappa B,227,239,Gene/Protein	"[{""token"": ""KBF1"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""50 kDa NF - kappa B protein"", ""start_span"": 54, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2 polypeptide"", ""start_span"": 137, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""50 kDa subunit"", ""start_span"": 209, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 227, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	valid
When the human epsilon - or beta - globin genes driven by the dominant control region ( DCR) are introduced into this system, the human epsilon - globin gene, in contrast to the beta - globin gene, is not deregulated by the presence of the DCR and is expressed strictly as an embryonic gene.	human epsilon - or beta - globin genes,9,47,Gene/Protein	dominant control region,62,85,Gene/Protein	DCR,88,91,Gene/Protein	human epsilon - globin gene,130,157,Gene/Protein	beta - globin gene,178,196,Gene/Protein	DCR,240,243,Gene/Protein	embryonic gene,276,290,Gene/Protein	"[{""token"": ""human epsilon - or beta - globin genes"", ""start_span"": 9, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""dominant control region"", ""start_span"": 62, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""DCR"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""human epsilon - globin gene"", ""start_span"": 130, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin gene"", ""start_span"": 178, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""DCR"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""embryonic gene"", ""start_span"": 276, ""end_span"": 290, ""type"": ""Gene/Protein""}]"	valid
IBR is a 503 - amino - acid - long acidic protein which is 99. 0% identical to the recently reported human NRF - 1 / alpha - Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG).	IBR,0,3,Gene/Protein	503 - amino - acid - long acidic protein,9,49,Gene/Protein	human NRF - 1 / alpha - Pal factor,101,135,Gene/Protein	transcription factors,175,196,Gene/Protein	P3A2,197,201,Gene/Protein	erected wing gene product,206,231,Gene/Protein	EWG,234,237,Gene/Protein	"[{""token"": ""IBR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""503 - amino - acid - long acidic protein"", ""start_span"": 9, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""human NRF - 1 / alpha - Pal factor"", ""start_span"": 101, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 175, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""P3A2"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""erected wing gene product"", ""start_span"": 206, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""EWG"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	valid
This death - promoting activity of Bik can be suppressed by coexpression of Bcl - 2, Bcl - XL, EBV - BHRF1 and E1B - 19 kDa proteins suggesting that Bik may be a common target for both cellular and viral anti - apoptotic proteins.	Bik,35,38,Gene/Protein	Bcl - 2,76,83,Gene/Protein	Bcl - XL,85,93,Gene/Protein	EBV - BHRF1,95,106,Gene/Protein	E1B - 19 kDa,111,123,Gene/Protein	Bik,149,152,Gene/Protein	cellular and viral anti - apoptotic proteins,185,229,Gene/Protein	"[{""token"": ""Bik"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - XL"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""EBV - BHRF1"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""E1B - 19 kDa"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Bik"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""cellular and viral anti - apoptotic proteins"", ""start_span"": 185, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	valid
In particular, naturally occurring sequence variation impacted transcription factor binding to an activating transcription factor / cAMP response element binding ( ATF / CREB) binding site ( located between the LEF - 1 and distal NF - kappaB transcription factor binding sites) that we identified in previous studies of the HIV - 1 LTR.	transcription factor,63,83,Gene/Protein	activating transcription factor,98,129,Gene/Protein	cAMP response element binding,132,161,Gene/Protein	ATF,164,167,Gene/Protein	CREB,170,174,Gene/Protein	LEF - 1 and distal NF - kappaB transcription factor binding sites,211,276,Gene/Protein	HIV - 1 LTR,324,335,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 63, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""activating transcription factor"", ""start_span"": 98, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""cAMP response element binding"", ""start_span"": 132, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""ATF"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1 and distal NF - kappaB transcription factor binding sites"", ""start_span"": 211, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 324, ""end_span"": 335, ""type"": ""Gene/Protein""}]"	test
METHODOLOGY: A polymerase chain reaction - based method was used to amplify a polymorphic CAG repeat in the first exon of the androgen receptor gene after selective digestion of the active X chromosome with a methylation - sensitive enzyme, HpaII to distinguish between the paternal and maternal alleles and to identify their methylation status.	CAG repeat,90,100,Gene/Protein	first exon,108,118,Gene/Protein	androgen receptor gene,126,148,Gene/Protein	active X chromosome,182,201,Gene/Protein	methylation - sensitive enzyme,209,239,Gene/Protein	HpaII,241,246,Gene/Protein	paternal and maternal alleles,274,303,Gene/Protein	"[{""token"": ""CAG repeat"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""first exon"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""androgen receptor gene"", ""start_span"": 126, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""active X chromosome"", ""start_span"": 182, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""methylation - sensitive enzyme"", ""start_span"": 209, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""HpaII"", ""start_span"": 241, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""paternal and maternal alleles"", ""start_span"": 274, ""end_span"": 303, ""type"": ""Gene/Protein""}]"	test
Moreover, we show that ectopic expression of the E2A protein E12 in this macrophage line results in the induction of many B lineage genes, including EBF, IL7Ralpha, lambda5, and Rag - 1, and the ability to induce kappa light chain in response to mitogen.	E2A,49,52,Gene/Protein	E12,61,64,Gene/Protein	many B lineage genes,117,137,Gene/Protein	EBF,149,152,Gene/Protein	IL7Ralpha,154,163,Gene/Protein	lambda5,165,172,Gene/Protein	kappa light chain,213,230,Gene/Protein	"[{""token"": ""E2A"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""E12"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""many B lineage genes"", ""start_span"": 117, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""EBF"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""IL7Ralpha"", ""start_span"": 154, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""lambda5"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""kappa light chain"", ""start_span"": 213, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	test
A central role for Egr - 1 in hypoxia - mediated tissue factor expression was confirmed by experiments with homozygous Egr - 1 null mice; wild - type mice subjected to oxygen deprivation expressed tissue factor and showed fibrin deposition, but hypoxic homozygous Egr - 1 null mice displayed neither tissue factor nor fibrin.	Egr - 1,19,26,Gene/Protein	Egr - 1,119,126,Gene/Protein	oxygen deprivation expressed tissue factor,168,210,Gene/Protein	fibrin,222,228,Gene/Protein	Egr - 1,264,271,Gene/Protein	tissue factor,300,313,Gene/Protein	fibrin,318,324,Gene/Protein	"[{""token"": ""Egr - 1"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""oxygen deprivation expressed tissue factor"", ""start_span"": 168, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""fibrin"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 264, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""tissue factor"", ""start_span"": 300, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""fibrin"", ""start_span"": 318, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	test
Scavenger receptor and receptor for advanced glycated end products ( RAGE) ligands failed to activate ERK and p38 MAPK in the absence of significant increases in protein tyrosine phosphorylation, demonstrating that scavenger receptors and RAGE are not linked to these pathways.	Scavenger receptor,0,18,Gene/Protein	receptor for advanced glycated end products,23,66,Gene/Protein	RAGE,69,73,Gene/Protein	ERK,102,105,Gene/Protein	p38 MAPK,110,118,Gene/Protein	scavenger receptors,215,234,Gene/Protein	RAGE,239,243,Gene/Protein	"[{""token"": ""Scavenger receptor"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""receptor for advanced glycated end products"", ""start_span"": 23, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""RAGE"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPK"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""scavenger receptors"", ""start_span"": 215, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""RAGE"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	test
We have used the hydrophobic repeats of the HSF1 trimerization domain in the yeast two - hybrid protein interaction assay to identify heat shock factor binding protein 1 ( HSBP1), a novel, conserved, 76 - amino - acid protein that contains two extended arrays of hydrophobic repeats that interact with the HSF1 heptad repeats.	hydrophobic repeats,17,36,Gene/Protein	HSF1,44,48,Gene/Protein	heat shock factor binding protein 1,134,169,Gene/Protein	HSBP1,172,177,Gene/Protein	76 - amino - acid protein,200,225,Gene/Protein	hydrophobic repeats,263,282,Gene/Protein	HSF1 heptad repeats,306,325,Gene/Protein	"[{""token"": ""hydrophobic repeats"", ""start_span"": 17, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""HSF1"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""heat shock factor binding protein 1"", ""start_span"": 134, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""HSBP1"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""76 - amino - acid protein"", ""start_span"": 200, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""hydrophobic repeats"", ""start_span"": 263, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""HSF1 heptad repeats"", ""start_span"": 306, ""end_span"": 325, ""type"": ""Gene/Protein""}]"	test
To understand the molecular basis of the functional specificity between E2A and HEB / E2 - 2 in mammalian development, we generated and tested a panel of E2A knockin mutations including subtle mutations in the E12 and E47 exons and substitution of both E12 and E47 exons with a human HEB cDNA.	E2A,72,75,Gene/Protein	HEB,80,83,Gene/Protein	E2 - 2,86,92,Gene/Protein	E2A,154,157,Gene/Protein	E12 and E47 exons,210,227,Gene/Protein	E12 and E47 exons,253,270,Gene/Protein	human HEB cDNA,278,292,Gene/Protein	"[{""token"": ""E2A"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""HEB"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""E2 - 2"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""E12 and E47 exons"", ""start_span"": 210, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""E12 and E47 exons"", ""start_span"": 253, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""human HEB cDNA"", ""start_span"": 278, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	test
Furthermore, the activity of transcription factors regulating the IL - 2 promoter - enhancer region including activation protein - 1, CD28 response element and nuclear factor kappaB were 4 - 8 times higher after CD80 compared to CD86 ligation.	transcription factors,29,50,Gene/Protein	IL - 2 promoter - enhancer region,66,99,Gene/Protein	activation protein - 1,110,132,Gene/Protein	CD28 response element,134,155,Gene/Protein	nuclear factor kappaB,160,181,Gene/Protein	CD80,212,216,Gene/Protein	CD86,229,233,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 29, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter - enhancer region"", ""start_span"": 66, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""activation protein - 1"", ""start_span"": 110, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response element"", ""start_span"": 134, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 160, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	test
Nevertheless, there was a substantial difference in IL - 12 responsiveness between these two groups of T cells: compared to anti - CD28 - costimulated T cells, T cells that were not costimulated with anti - CD28 exhibited decreased levels of Janus kinases ( JAK) JAK2 / TYK2 and STAT4 phosphorylation and IFN - y production following IL - 12 stimulation.	IL - 12,52,59,Gene/Protein	anti - CD28,124,135,Gene/Protein	Janus kinases,242,255,Gene/Protein	JAK,258,261,Gene/Protein	JAK2 / TYK2,263,274,Gene/Protein	STAT4,279,284,Gene/Protein	IL - 12,334,341,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 242, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""JAK2 / TYK2"", ""start_span"": 263, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 279, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 334, ""end_span"": 341, ""type"": ""Gene/Protein""}]"	test
Subsequently, it appears that IL - 12 / STAT4 serves two essential functions in the development of TH1 cells: as growth signal, inducing survival and cell division; and as trans - activator, prolonging IFN - gamma synthesis through a genetic interaction with the coactivator, CREB - binding protein.	IL - 12,30,37,Gene/Protein	STAT4,40,45,Gene/Protein	growth signal,113,126,Gene/Protein	trans - activator,172,189,Gene/Protein	IFN - gamma,202,213,Gene/Protein	coactivator,263,274,Gene/Protein	CREB - binding protein,276,298,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""growth signal"", ""start_span"": 113, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""trans - activator"", ""start_span"": 172, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 202, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""coactivator"", ""start_span"": 263, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""CREB - binding protein"", ""start_span"": 276, ""end_span"": 298, ""type"": ""Gene/Protein""}]"	test
In response to IL - 4, the IL - 4R activates a set of phosphotyrosine binding domain - containing proteins, including insulin receptor substrate 1 / 2, Shc, and IL - 4R interacting protein, as well as Stat6.	IL - 4,15,21,Gene/Protein	IL - 4R,27,34,Gene/Protein	phosphotyrosine binding domain - containing proteins,54,106,Gene/Protein	insulin receptor substrate 1 / 2,118,150,Gene/Protein	Shc,152,155,Gene/Protein	IL - 4R interacting protein,161,188,Gene/Protein	Stat6,201,206,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""phosphotyrosine binding domain - containing proteins"", ""start_span"": 54, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""insulin receptor substrate 1 / 2"", ""start_span"": 118, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""Shc"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R interacting protein"", ""start_span"": 161, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	test
This could be accounted for by GILZ - mediated inhibition of Egr - 2 and Egr - 3, NFAT / AP - 1 - inducible transcription factors that bind a regulatory element in the FasL promoter and up - regulate FasL expression.	GILZ,31,35,Gene/Protein	Egr - 2,61,68,Gene/Protein	Egr - 3,73,80,Gene/Protein	NFAT / AP - 1,82,95,Gene/Protein	transcription factors,108,129,Gene/Protein	regulatory element,142,160,Gene/Protein	FasL promoter,168,181,Gene/Protein	"[{""token"": ""GILZ"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 2"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 3"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NFAT / AP - 1"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 108, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""regulatory element"", ""start_span"": 142, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""FasL promoter"", ""start_span"": 168, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	test
Whereas homodimerization of GILZ required the presence of its leucine zipper, the interaction with c - Fos and c - Jun occurred through the N - terminal 60 - amino acid region of GILZ.	GILZ,28,32,Gene/Protein	leucine zipper,62,76,Gene/Protein	c - Fos,99,106,Gene/Protein	c - Jun,111,118,Gene/Protein	N - terminal,140,152,Gene/Protein	60 - amino acid region,153,175,Gene/Protein	GILZ,179,183,Gene/Protein	"[{""token"": ""GILZ"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""leucine zipper"", ""start_span"": 62, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal"", ""start_span"": 140, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""60 - amino acid region"", ""start_span"": 153, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""GILZ"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	test
Activation of NF - kappaB by CML - modified albumin increased secretion of proinflammatory cytokines ( tumor necrosis factor - alpha, interleukin - 1beta, and monocyte chemoattractant protein - 1) severalfold, and inhibition of p38 MAPK blocked these increases.	NF - kappaB,14,25,Gene/Protein	CML - modified albumin,29,51,Gene/Protein	proinflammatory cytokines,75,100,Gene/Protein	tumor necrosis factor - alpha,103,132,Gene/Protein	interleukin - 1beta,134,153,Gene/Protein	monocyte chemoattractant protein - 1,159,195,Gene/Protein	p38 MAPK,228,236,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""CML - modified albumin"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""proinflammatory cytokines"", ""start_span"": 75, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 103, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1beta"", ""start_span"": 134, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemoattractant protein - 1"", ""start_span"": 159, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPK"", ""start_span"": 228, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	test
NF - kappaB and activator protein - 1 ( AP - 1) activation were assessed by gel shift assay, and mRNA expression of interleukin - 6, tumor necrosis factor - alpha, KC, monocyte chemoattractant protein - 1, and inducible nitric oxide synthase was assessed by semiquantitative RT - PCR.	NF - kappaB,0,11,Gene/Protein	activator protein - 1,16,37,Gene/Protein	AP - 1,40,46,Gene/Protein	interleukin - 6,116,131,Gene/Protein	tumor necrosis factor - alpha,133,162,Gene/Protein	monocyte chemoattractant protein - 1,168,204,Gene/Protein	inducible nitric oxide synthase,210,241,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 16, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 133, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemoattractant protein - 1"", ""start_span"": 168, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""inducible nitric oxide synthase"", ""start_span"": 210, ""end_span"": 241, ""type"": ""Gene/Protein""}]"	test
The binding of Sp1 and Sp3 to Rp correlated with the reporter activities in the mutagenesis study, establishing a direct link between transcriptional activation of Rp by Rta and DNA binding by Sp1 and / or Sp3.	Sp1,15,18,Gene/Protein	Sp3,23,26,Gene/Protein	Rp,30,32,Gene/Protein	Rp,164,166,Gene/Protein	Rta,170,173,Gene/Protein	Sp1,193,196,Gene/Protein	Sp3,206,209,Gene/Protein	"[{""token"": ""Sp1"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Sp3"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""Rp"", ""start_span"": 30, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""Rp"", ""start_span"": 164, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Rta"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Sp3"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	test
Here we show that the IL - 2 - induced expression of Gadd45gamma is dependent on a signaling pathway mediated by the tyrosine kinase Jak3 and the transcription factors Stat5a and Stat5b ( signal transducer and activator of transcription).	IL - 2,22,28,Gene/Protein	Gadd45gamma,53,64,Gene/Protein	tyrosine kinase Jak3,117,137,Gene/Protein	transcription factors,146,167,Gene/Protein	Stat5a,168,174,Gene/Protein	Stat5b,179,185,Gene/Protein	signal transducer and activator of transcription,188,236,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Gadd45gamma"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinase Jak3"", ""start_span"": 117, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 146, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""Stat5a"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""Stat5b"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription"", ""start_span"": 188, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	test
Terminal effectors of B cell Fas - resistance include the known anti - apoptotic gene products, Bcl - xL and FLIP, and a novel anti - apoptotic gene that encodes FAIM ( Fas Apoptosis Inhibitory Molecule).	Fas,29,32,Gene/Protein	anti - apoptotic gene products,64,94,Gene/Protein	Bcl - xL,96,104,Gene/Protein	FLIP,109,113,Gene/Protein	anti - apoptotic gene,127,148,Gene/Protein	FAIM,162,166,Gene/Protein	Fas Apoptosis Inhibitory Molecule,169,202,Gene/Protein	"[{""token"": ""Fas"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""anti - apoptotic gene products"", ""start_span"": 64, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""FLIP"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""anti - apoptotic gene"", ""start_span"": 127, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""FAIM"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Fas Apoptosis Inhibitory Molecule"", ""start_span"": 169, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	test
IL - 6 upregulates suppressor of cytokine signaling 1 ( SOCS1) expression in activated CD4 + T cells, thereby interfering with signal transducer and activator of transcription 1 ( STAT1) phosphorylation induced by interferon gamma ( IFNgamma).	IL - 6,0,6,Gene/Protein	suppressor of cytokine signaling 1,19,53,Gene/Protein	SOCS1,56,61,Gene/Protein	signal transducer and activator of transcription 1,127,177,Gene/Protein	STAT1,180,185,Gene/Protein	interferon gamma,214,230,Gene/Protein	IFNgamma,233,241,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""suppressor of cytokine signaling 1"", ""start_span"": 19, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription 1"", ""start_span"": 127, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""interferon gamma"", ""start_span"": 214, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 233, ""end_span"": 241, ""type"": ""Gene/Protein""}]"	test
Using a reporter system to detect interaction of CREB and CREB - binding protein ( CBP), in this study we found that CREB binds to CBP only by engagement of both CD3 and CD28.	CREB,49,53,Gene/Protein	CREB - binding protein,58,80,Gene/Protein	CBP,83,86,Gene/Protein	CREB,117,121,Gene/Protein	CBP,131,134,Gene/Protein	CD3,162,165,Gene/Protein	CD28,170,174,Gene/Protein	"[{""token"": ""CREB"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CREB - binding protein"", ""start_span"": 58, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	test
The induction of this complex by SF was not affected by neutralization of TNF - alpha or IL - 6 in SF, and the complex was not inducible by TNF - alpha, IL - 1beta, TNF - alpha / IL - 1beta, IL - 6, platelet derived growth factor, lipopolysaccharide, or tetradecanoyl phorbol acetate.	TNF - alpha,74,85,Gene/Protein	IL - 6,89,95,Gene/Protein	TNF - alpha,140,151,Gene/Protein	TNF - alpha,165,176,Gene/Protein	IL - 1beta,179,189,Gene/Protein	IL - 6,191,197,Gene/Protein	platelet derived growth factor,199,229,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 140, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 179, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""platelet derived growth factor"", ""start_span"": 199, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	test
Investigating the intracellular signaling pathways induced by SDF - 1 and TPO revealed some overlapping patterns of protein phosphorylation / activation ( mitogen - activated protein kinase [ MAPK] p42 / 44, MAPK p38, and AKT [ protein kinase B]) and some that were distinct for TPO ( eg, JAK - STAT) and for SDF - 1 ( eg, NF - kappa B).	SDF - 1,62,69,Gene/Protein	TPO,74,77,Gene/Protein	MAPK p38,208,216,Gene/Protein	TPO,279,282,Gene/Protein	JAK - STAT,289,299,Gene/Protein	SDF - 1,309,316,Gene/Protein	NF - kappa B,323,335,Gene/Protein	"[{""token"": ""SDF - 1"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""TPO"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""MAPK p38"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""TPO"", ""start_span"": 279, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""JAK - STAT"", ""start_span"": 289, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""SDF - 1"", ""start_span"": 309, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 323, ""end_span"": 335, ""type"": ""Gene/Protein""}]"	test
A transient transfection study showed that Tax can activate transcription through the AP - 1 - binding site in a human T cell line, whereas any combination of AP - 1 proteins did so much less than Tax, indicating that the activation of the AP - 1 site by Tax may require a mechanism other than the induction of AP - 1 mRNA.	Tax,43,46,Gene/Protein	AP - 1 - binding site,86,107,Gene/Protein	AP - 1 proteins,159,174,Gene/Protein	Tax,197,200,Gene/Protein	AP - 1 site,240,251,Gene/Protein	Tax,255,258,Gene/Protein	AP - 1 mRNA,311,322,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 - binding site"", ""start_span"": 86, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 proteins"", ""start_span"": 159, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 site"", ""start_span"": 240, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 mRNA"", ""start_span"": 311, ""end_span"": 322, ""type"": ""Gene/Protein""}]"	test
Here we show that site C binds members of the ubiquitously expressed RFX family of proteins, notably RFX1, RFX3, and the associated factor MIBP1, whereas sites B and D both bind the B - cell - specific activator protein BSAP / Pax5.	site C,18,24,Gene/Protein	RFX family of proteins,69,91,Gene/Protein	RFX1,101,105,Gene/Protein	RFX3,107,111,Gene/Protein	MIBP1,139,144,Gene/Protein	sites B and D,154,167,Gene/Protein	B - cell - specific activator protein BSAP / Pax5,182,231,Gene/Protein	"[{""token"": ""site C"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""RFX family of proteins"", ""start_span"": 69, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""RFX1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""RFX3"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""MIBP1"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""sites B and D"", ""start_span"": 154, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific activator protein BSAP / Pax5"", ""start_span"": 182, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	test
Deletion analysis revealed that T cell specificity was conferred by a 49 - bp fragment ( bp - 319 to - 270) that included a potential binding site for AP - 1 transcription factors 6 bp upstream of a binding site for Elf - 1, a member of the Ets family of transcription factors.	49 - bp fragment,70,86,Gene/Protein	bp - 319 to - 270,89,106,Gene/Protein	potential binding site,124,146,Gene/Protein	AP - 1 transcription factors,151,179,Gene/Protein	binding site for Elf - 1,199,223,Gene/Protein	Ets family,241,251,Gene/Protein	transcription factors,255,276,Gene/Protein	"[{""token"": ""49 - bp fragment"", ""start_span"": 70, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""bp - 319 to - 270"", ""start_span"": 89, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""potential binding site"", ""start_span"": 124, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factors"", ""start_span"": 151, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""binding site for Elf - 1"", ""start_span"": 199, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""Ets family"", ""start_span"": 241, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 255, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	test
The DNA motif WGATAR has been identified within transcriptional regulatory domains of globin and other erythroid - specific genes and the activator proteins that bind to this regulatory element, the GATA factors, belong to a multi - gene family that is expressed in chicken erythroid cells.	transcriptional regulatory domains,48,82,Gene/Protein	globin,86,92,Gene/Protein	erythroid - specific genes,103,129,Gene/Protein	activator proteins,138,156,Gene/Protein	regulatory element,175,193,Gene/Protein	GATA factors,199,211,Gene/Protein	multi - gene family,225,244,Gene/Protein	"[{""token"": ""transcriptional regulatory domains"", ""start_span"": 48, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""globin"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific genes"", ""start_span"": 103, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""activator proteins"", ""start_span"": 138, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""regulatory element"", ""start_span"": 175, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""GATA factors"", ""start_span"": 199, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""multi - gene family"", ""start_span"": 225, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	test
In contrast to the purely enhancer - dependent effect of cytokines such as TNF on the activity of the HIV regulatory region ( LTR), we observed that okadaic acid ( OKA) activates HIV transcription through both the enhancer, responding to the factor NF - kappa B, and the promoter domain of the LTR.	cytokines,57,66,Gene/Protein	TNF,75,78,Gene/Protein	HIV regulatory region,102,123,Gene/Protein	LTR,126,129,Gene/Protein	NF - kappa B,249,261,Gene/Protein	promoter domain,271,286,Gene/Protein	LTR,294,297,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""HIV regulatory region"", ""start_span"": 102, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 249, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""promoter domain"", ""start_span"": 271, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 294, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	train
Our results suggest that SP1 phosphorylation induced by OKA, a selective inhibitor of the serine - threonine phosphatase PP2A, facilitates the formation of a transcription complex involving general transcription factors, HIV Tat, and Sp1 proteins.	SP1,25,28,Gene/Protein	serine - threonine phosphatase,90,120,Gene/Protein	PP2A,121,125,Gene/Protein	transcription complex,158,179,Gene/Protein	transcription factors,198,219,Gene/Protein	HIV Tat,221,228,Gene/Protein	Sp1 proteins,234,246,Gene/Protein	"[{""token"": ""SP1"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""serine - threonine phosphatase"", ""start_span"": 90, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""transcription complex"", ""start_span"": 158, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 198, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""HIV Tat"", ""start_span"": 221, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 proteins"", ""start_span"": 234, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
Whereas the Jak kinases Jak1 and Jak3 and the signal transducer and activator of transcription proteins Stat3 and Stat5 are activated in normal T cells in response to IL - 2, this signaling pathway was constitutively activated in HTLV - I - transformed cells.	Jak kinases,12,23,Gene/Protein	Jak1,24,28,Gene/Protein	Jak3,33,37,Gene/Protein	transcription proteins,81,103,Gene/Protein	Stat3,104,109,Gene/Protein	Stat5,114,119,Gene/Protein	IL - 2,167,173,Gene/Protein	"[{""token"": ""Jak kinases"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""transcription proteins"", ""start_span"": 81, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
The proximal promoter contains a region termed CLEO ( - 54 to - 31) that consists of a purine - rich element abutting an activator protein - 1 ( AP - 1) - like site, as well as an upstream nuclear factor - kappa B ( NF - kappa B) site ( - 85 to - 76) and a CK - 1 element ( - 101 to - 92).	proximal promoter,4,21,Gene/Protein	CLEO,47,51,Gene/Protein	- 54 to - 31,54,66,Gene/Protein	purine - rich element,87,108,Gene/Protein	- 85 to - 76,237,249,Gene/Protein	CK - 1 element,257,271,Gene/Protein	- 101 to - 92,274,287,Gene/Protein	"[{""token"": ""proximal promoter"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CLEO"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""- 54 to - 31"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""purine - rich element"", ""start_span"": 87, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""- 85 to - 76"", ""start_span"": 237, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""CK - 1 element"", ""start_span"": 257, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""- 101 to - 92"", ""start_span"": 274, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
The specificity of CIITA for three major MHC class II genes, DR, DQ and DP, is mediated by its remaining C - terminal residues ( amino acids 317 - 1130).	CIITA,19,24,Gene/Protein	MHC class II genes,41,59,Gene/Protein	DR,61,63,Gene/Protein	DQ,65,67,Gene/Protein	DP,72,74,Gene/Protein	C - terminal residues,105,126,Gene/Protein	amino acids 317 - 1130,129,151,Gene/Protein	"[{""token"": ""CIITA"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II genes"", ""start_span"": 41, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""DR"", ""start_span"": 61, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""DQ"", ""start_span"": 65, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""DP"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal residues"", ""start_span"": 105, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 317 - 1130"", ""start_span"": 129, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
Adhesion of human monocytes to P - selectin, the most rapidly expressed endothelial tethering factor, increased the secretion of monocyte chemotactic protein - 1 ( MCP - 1) and tumor necrosis factor - alpha ( TNF - alpha) by the leukocytes when they were stimulated with platelet - activating factor.	P - selectin,31,43,Gene/Protein	endothelial tethering factor,72,100,Gene/Protein	monocyte chemotactic protein - 1,129,161,Gene/Protein	MCP - 1,164,171,Gene/Protein	tumor necrosis factor - alpha,177,206,Gene/Protein	TNF - alpha,209,220,Gene/Protein	platelet - activating factor,271,299,Gene/Protein	"[{""token"": ""P - selectin"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""endothelial tethering factor"", ""start_span"": 72, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemotactic protein - 1"", ""start_span"": 129, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 177, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""platelet - activating factor"", ""start_span"": 271, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
Moreover, tethering by P - selectin specifically enhanced nuclear translocation of nuclear factor - kappa B ( NF - kappa B), a transcription factor required for expression of MCP - 1, TNF - alpha, and other immediate - early genes.	P - selectin,23,35,Gene/Protein	nuclear factor - kappa B,83,107,Gene/Protein	NF - kappa B,110,122,Gene/Protein	transcription factor,127,147,Gene/Protein	MCP - 1,175,182,Gene/Protein	TNF - alpha,184,195,Gene/Protein	immediate - early genes,207,230,Gene/Protein	"[{""token"": ""P - selectin"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 83, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 127, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early genes"", ""start_span"": 207, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
The data indicate that PKC - epsilon and, to a lesser extent PKC - alpha but not - zeta, can regulate the transcription factors AP - 1 and nuclear factor of activated T cells ( NF - AT - 1).	PKC - epsilon,23,36,Gene/Protein	PKC - alpha,61,72,Gene/Protein	- zeta,81,87,Gene/Protein	transcription factors,106,127,Gene/Protein	AP - 1,128,134,Gene/Protein	factor of activated T cells,147,174,Gene/Protein	NF - AT - 1,177,188,Gene/Protein	"[{""token"": ""PKC - epsilon"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""PKC - alpha"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""- zeta"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 106, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""factor of activated T cells"", ""start_span"": 147, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - 1"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Coexpression of HMG I / Y and Oct - 2 in cell lines lacking Oct - 2 results in high levels of HLA - DRA gene expression, and in vitro DNA - binding studies reveal that HMG I / Y stimulates Oct - 2A binding to the HLA - DRA promoter.	HMG I / Y,16,25,Gene/Protein	Oct - 2,30,37,Gene/Protein	Oct - 2,60,67,Gene/Protein	HLA - DRA gene,94,108,Gene/Protein	I / Y,172,177,Gene/Protein	Oct - 2A,189,197,Gene/Protein	HLA - DRA promoter,213,231,Gene/Protein	"[{""token"": ""HMG I / Y"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA gene"", ""start_span"": 94, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""I / Y"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA promoter"", ""start_span"": 213, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
We further demonstrate that Tax induction of nuclear c - Rel expression is activated by the RelA ( p65) subunit of NF - kappa B, which activates transcription of the c - rel gene through an intrinsic kappa B enhancer element.	Tax,28,31,Gene/Protein	c - Rel,53,60,Gene/Protein	RelA,92,96,Gene/Protein	p65,99,102,Gene/Protein	NF - kappa B,115,127,Gene/Protein	c - rel gene,166,178,Gene/Protein	kappa B enhancer element,200,224,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""c - rel gene"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""kappa B enhancer element"", ""start_span"": 200, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
TNF - alpha, therefore, emerges as the main factor responsible for a second phase of NF - kappa B regulation, controlling both translocation of p65 and c - rel, and new mRNA synthesis for c - rel and p105 / p50.	TNF - alpha,0,11,Gene/Protein	NF - kappa B,85,97,Gene/Protein	p65,144,147,Gene/Protein	c - rel,152,159,Gene/Protein	mRNA,169,173,Gene/Protein	c - rel,188,195,Gene/Protein	p105 / p50,200,210,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 188, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""p105 / p50"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
GM - kappa B defines a binding site for NF - kappa B, and GC - box defines a binding site for three ( A1, A2, B) constitutive proteins.	GM - kappa B,0,12,Gene/Protein	NF - kappa B,40,52,Gene/Protein	GC - box,58,66,Gene/Protein	A1,102,104,Gene/Protein	A2,106,108,Gene/Protein	B,110,111,Gene/Protein	constitutive proteins,113,134,Gene/Protein	"[{""token"": ""GM - kappa B"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""GC - box"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""A1"", ""start_span"": 102, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""A2"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 110, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""constitutive proteins"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The NR2 hybrid allowed us to exclude three candidate genes for AGS: hepatic nuclear factor 3 beta ( HNF3 beta), paired box 1 ( PAX1), and cystatin C ( CST3) as shown by their localization outside of the deletion.	candidate genes,43,58,Gene/Protein	hepatic nuclear factor 3 beta,68,97,Gene/Protein	HNF3 beta,100,109,Gene/Protein	paired box 1,112,124,Gene/Protein	PAX1,127,131,Gene/Protein	cystatin C,138,148,Gene/Protein	CST3,151,155,Gene/Protein	"[{""token"": ""candidate genes"", ""start_span"": 43, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""hepatic nuclear factor 3 beta"", ""start_span"": 68, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""HNF3 beta"", ""start_span"": 100, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""paired box 1"", ""start_span"": 112, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""PAX1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""cystatin C"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""CST3"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
The NS - Meg cells were positive for alpha - naphthyl acetate esterase and periodic acid - Schiff ( PAS) staining and for surface CD4, CD7, CD13, CD34, CD41a, and glycophorin A antigens.	alpha - naphthyl acetate esterase,37,70,Gene/Protein	CD4,130,133,Gene/Protein	CD7,135,138,Gene/Protein	CD13,140,144,Gene/Protein	CD34,146,150,Gene/Protein	CD41a,152,157,Gene/Protein	glycophorin A antigens,163,185,Gene/Protein	"[{""token"": ""alpha - naphthyl acetate esterase"", ""start_span"": 37, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CD7"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""CD13"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""CD41a"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""glycophorin A antigens"", ""start_span"": 163, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
In this paper, we report that cross - linking of CD28 ( but not CD2, CD5, LFA - 1, or CD7) leads to an elevation of c - jun mRNA, with only minimal activation of c - fos expression.	CD28,49,53,Gene/Protein	CD2,64,67,Gene/Protein	CD5,69,72,Gene/Protein	LFA - 1,74,81,Gene/Protein	CD7,86,89,Gene/Protein	c - jun mRNA,116,128,Gene/Protein	c - fos,162,169,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""LFA - 1"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CD7"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""c - jun mRNA"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Constitutive NF - kappa B was not maintained by autocrine action of cytokines TNF, interleukin 6, interleukin 10, granulocyte - macrophage colony - stimulating factor or macrophage colony - stimulating factor, since neutralizing antibodies did not reduce constitutive DNA - binding activity.	NF - kappa B,13,25,Gene/Protein	cytokines,68,77,Gene/Protein	TNF,78,81,Gene/Protein	interleukin 6,83,96,Gene/Protein	interleukin,98,109,Gene/Protein	granulocyte - macrophage colony - stimulating factor,114,166,Gene/Protein	macrophage colony - stimulating factor,170,208,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 6"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""interleukin"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 114, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""macrophage colony - stimulating factor"", ""start_span"": 170, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
Removal of the carboxy terminus enables ERP to interact with a variety of ets - binding sites including the E74 site, the IgH enhancer pi site, and the lck promoter ets site, suggesting a carboxy - terminal negative regulatory domain.	carboxy terminus,15,31,Gene/Protein	ERP,40,43,Gene/Protein	ets - binding sites,74,93,Gene/Protein	E74 site,108,116,Gene/Protein	IgH enhancer pi site,122,142,Gene/Protein	lck promoter ets site,152,173,Gene/Protein	carboxy - terminal negative regulatory domain,188,233,Gene/Protein	"[{""token"": ""carboxy terminus"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ERP"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ets - binding sites"", ""start_span"": 74, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""E74 site"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer pi site"", ""start_span"": 122, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""lck promoter ets site"", ""start_span"": 152, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""carboxy - terminal negative regulatory domain"", ""start_span"": 188, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
We focused our studies on the role of Pit - 1 and of PR as potential transcriptional regulators, since the POU domain protein Pit - 1 is essential in the control of pituitary PRL expression, and progesterone induces decidual transformation of the endometrial stroma, a differentiation process during which the decidual PRL gene is activated.	Pit - 1,38,45,Gene/Protein	PR,53,55,Gene/Protein	transcriptional regulators,69,95,Gene/Protein	POU domain protein,107,125,Gene/Protein	Pit - 1,126,133,Gene/Protein	PRL,175,178,Gene/Protein	PRL gene,319,327,Gene/Protein	"[{""token"": ""Pit - 1"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PR"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 69, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""POU domain protein"", ""start_span"": 107, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Pit - 1"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""PRL"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""PRL gene"", ""start_span"": 319, ""end_span"": 327, ""type"": ""Gene/Protein""}]"	train
NF - kappa B ( P65 or P65 / P50 heterodimer) bound to the P sequence in electrophoretic mobility shift assays ( EMSA) and activated transcription through the P sequence when expression plasmids were cotransfected with P sequence - driven reporter plasmids in Jurkat T cells.	NF - kappa B,0,12,Gene/Protein	P65,15,18,Gene/Protein	P65 / P50 heterodimer,22,43,Gene/Protein	P sequence,58,68,Gene/Protein	P sequence,158,168,Gene/Protein	expression plasmids,174,193,Gene/Protein	P sequence - driven reporter plasmids,218,255,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""P65"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""P65 / P50 heterodimer"", ""start_span"": 22, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""P sequence"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""expression plasmids"", ""start_span"": 174, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""P sequence - driven reporter plasmids"", ""start_span"": 218, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Wild - type and chimeric HLF proteins also bound closely related sites identified previously for bZIP proteins of both the proline - and acidic amino acid - rich ( PAR) and C / EBP subfamilies; however, E2A - HLF proteins were significantly less tolerant of certain deviations from the HLF consensus binding site.	chimeric HLF proteins,16,37,Gene/Protein	bZIP proteins,97,110,Gene/Protein	proline,123,130,Gene/Protein	PAR,164,167,Gene/Protein	C / EBP subfamilies,173,192,Gene/Protein	E2A - HLF,203,212,Gene/Protein	HLF consensus binding site,286,312,Gene/Protein	"[{""token"": ""chimeric HLF proteins"", ""start_span"": 16, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""bZIP proteins"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""proline"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""PAR"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP subfamilies"", ""start_span"": 173, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 203, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""HLF consensus binding site"", ""start_span"": 286, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
Although no qualitative difference was observed between specific granules and gelatinase granules with respect to cytochrome b558 and Mac - 1, stimulation of the neutrophil with FMLP resulted in a selective mobilization of the least dense peroxidase - negative granules, ie, gelatinase granules, which, in concert with secretory vesicles, furnish the plasma membrane with Mac - 1 and cytochrome b558.	gelatinase,78,88,Gene/Protein	cytochrome b558,114,129,Gene/Protein	Mac - 1,134,141,Gene/Protein	FMLP,178,182,Gene/Protein	gelatinase,275,285,Gene/Protein	Mac - 1,372,379,Gene/Protein	cytochrome b558,384,399,Gene/Protein	"[{""token"": ""gelatinase"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""cytochrome b558"", ""start_span"": 114, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 1"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""FMLP"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""gelatinase"", ""start_span"": 275, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 1"", ""start_span"": 372, ""end_span"": 379, ""type"": ""Gene/Protein""}, {""token"": ""cytochrome b558"", ""start_span"": 384, ""end_span"": 399, ""type"": ""Gene/Protein""}]"	train
We demonstrate that the staphylococcal superantigens toxic shock syndrome toxin - 1 ( TSST - 1) and staphylococcal enterotoxin A ( SEA) activate HIV - 1 - LTR - driven transcription of chloramphenicol acetyl transferase in the human monocytic cell line THP - 1.	staphylococcal superantigens,24,52,Gene/Protein	toxic shock syndrome toxin - 1,53,83,Gene/Protein	TSST - 1,86,94,Gene/Protein	staphylococcal enterotoxin A,100,128,Gene/Protein	SEA,131,134,Gene/Protein	HIV - 1 - LTR,145,158,Gene/Protein	chloramphenicol acetyl transferase,185,219,Gene/Protein	"[{""token"": ""staphylococcal superantigens"", ""start_span"": 24, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""toxic shock syndrome toxin - 1"", ""start_span"": 53, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""TSST - 1"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""staphylococcal enterotoxin A"", ""start_span"": 100, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""SEA"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 - LTR"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyl transferase"", ""start_span"": 185, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
In contrast, FK506 or EGTA ( Ca2 + chelator) similarly affected the formation of kappa B - like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins ( c - Rel, p65, p50, and p49).	kappa B - like site binding complexes,81,118,Gene/Protein	antibodies,153,163,Gene/Protein	human Rel family proteins,176,201,Gene/Protein	c - Rel,204,211,Gene/Protein	p65,213,216,Gene/Protein	p50,218,221,Gene/Protein	p49,227,230,Gene/Protein	"[{""token"": ""kappa B - like site binding complexes"", ""start_span"": 81, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""human Rel family proteins"", ""start_span"": 176, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""p49"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Site B ( nt 4519 to 4545) specifically bound four distinct nuclear protein complexes: a ubiquitous factor, a T - cell - specific factor, a B - cell - specific factor, and the monocyte / macrophage - and B - cell - specific transcription factor PU. 1 / Spi - 1.	Site B,0,6,Gene/Protein	nt 4519 to 4545,9,24,Gene/Protein	nuclear protein complexes,59,84,Gene/Protein	ubiquitous factor,88,105,Gene/Protein	T - cell - specific factor,109,135,Gene/Protein	B - cell - specific factor,139,165,Gene/Protein	monocyte / macrophage - and B - cell - specific transcription factor,175,243,Gene/Protein	"[{""token"": ""Site B"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""nt 4519 to 4545"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""nuclear protein complexes"", ""start_span"": 59, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous factor"", ""start_span"": 88, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific factor"", ""start_span"": 109, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific factor"", ""start_span"": 139, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""monocyte / macrophage - and B - cell - specific transcription factor"", ""start_span"": 175, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Pretreatment of cells with protein tyrosine kinase inhibitors and the dominant negative allele of c - Raf - 1 ( Raf 301) inhibited I kappa B alpha degradation, NF - kappa B binding, and transactivation of kappa B reporter constructs by hypoxia.	tyrosine kinase,35,50,Gene/Protein	dominant negative allele,70,94,Gene/Protein	c - Raf - 1,98,109,Gene/Protein	Raf 301,112,119,Gene/Protein	I kappa B alpha,131,146,Gene/Protein	NF - kappa B,160,172,Gene/Protein	kappa B reporter constructs,205,232,Gene/Protein	"[{""token"": ""tyrosine kinase"", ""start_span"": 35, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative allele"", ""start_span"": 70, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""c - Raf - 1"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""Raf 301"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 160, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""kappa B reporter constructs"", ""start_span"": 205, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
Most importantly, we show a Tax - dependent correlation between expression of NFKB2 ( p100) and processing to the DNA binding NFKB2 ( p52) form, induction of c - Rel, and trans - activation of NF - kappa B - mediated gene expression.	Tax,28,31,Gene/Protein	NFKB2,78,83,Gene/Protein	p100,86,90,Gene/Protein	NFKB2,126,131,Gene/Protein	p52,134,137,Gene/Protein	c - Rel,158,165,Gene/Protein	NF - kappa B,193,205,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
In clonogenetic fetal calf serum - supplemented ( FCS +) or - nonsupplemented ( FCS -) culture treated with saturating levels of interleukin - 3 ( IL - 3) granulocyte - macrophage colony - stimulating factor ( GM - CSF) and erythropoietin ( Ep) ( combined with c - kit ligand in FCS ( -) - culture conditions), RA induces a dramatic dose - dependent shift from erythroid to granulomonocytic colony formation, the latter colonies being essentially represented by granulocytic clones.	interleukin - 3,129,144,Gene/Protein	IL - 3,147,153,Gene/Protein	granulocyte - macrophage colony - stimulating factor,155,207,Gene/Protein	GM - CSF,210,218,Gene/Protein	erythropoietin,224,238,Gene/Protein	Ep,241,243,Gene/Protein	c - kit,261,268,Gene/Protein	"[{""token"": ""interleukin - 3"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 155, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 224, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""Ep"", ""start_span"": 241, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""c - kit"", ""start_span"": 261, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
Furthermore, R24 treatment resulted in translocation of c - rel, but little or no NF kappa B p50 or p65, from the cytoplasm to the nucleus and an increase of NF kappa B binding complexes containing c - rel and p50.	R24,13,16,Gene/Protein	c - rel,56,63,Gene/Protein	NF kappa B p50,82,96,Gene/Protein	p65,100,103,Gene/Protein	NF kappa B binding complexes,158,186,Gene/Protein	c - rel,198,205,Gene/Protein	p50,210,213,Gene/Protein	"[{""token"": ""R24"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B p50"", ""start_span"": 82, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B binding complexes"", ""start_span"": 158, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 210, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
By assaying CAT enzyme activity across a 24 - h PRL induction time course, we were able to assign G1 vs. S phase PRL responses of the IRF - 1 gene to different regions of the IRF - 1 5 ' - flanking and promoter DNA.	CAT enzyme,12,22,Gene/Protein	PRL,48,51,Gene/Protein	PRL,113,116,Gene/Protein	IRF - 1 gene,134,146,Gene/Protein	IRF - 1,175,182,Gene/Protein	5 ' - flanking,183,197,Gene/Protein	promoter DNA,202,214,Gene/Protein	"[{""token"": ""CAT enzyme"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""PRL"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""PRL"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 gene"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""promoter DNA"", ""start_span"": 202, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
Two multicopy basal enhancer motifs within the SCMV MIE enhancer, namely, 11 copies of the 16 - bp cyclic AMP response element ( CRE) and 3 copies of novel 17 - bp serum response factor ( SRF) binding sites referred to as the SNE ( SRF / NFkappaB - like element), as well as four classical NFkappaB sites within the HCMV version, contribute to TPA responsiveness in transient assays in monocyte and T - cell types.	multicopy basal enhancer motifs,4,35,Gene/Protein	MIE enhancer,52,64,Gene/Protein	cyclic AMP response element,99,126,Gene/Protein	CRE,129,132,Gene/Protein	SNE,226,229,Gene/Protein	SRF / NFkappaB - like element,232,261,Gene/Protein	NFkappaB sites,290,304,Gene/Protein	"[{""token"": ""multicopy basal enhancer motifs"", ""start_span"": 4, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""MIE enhancer"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP response element"", ""start_span"": 99, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""SNE"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""SRF / NFkappaB - like element"", ""start_span"": 232, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB sites"", ""start_span"": 290, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	train
In particular, Tax is capable of modulating the expression or activity of various host transcription factors, including members of the NF - kappa B / Rel and CREB / ATF families, as well as the cellular factors HEB - 1 and p67SRF.	Tax,15,18,Gene/Protein	transcription factors,87,108,Gene/Protein	NF - kappa B / Rel,135,153,Gene/Protein	CREB / ATF families,158,177,Gene/Protein	cellular factors,194,210,Gene/Protein	HEB - 1,211,218,Gene/Protein	p67SRF,223,229,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 87, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF families"", ""start_span"": 158, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""cellular factors"", ""start_span"": 194, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""HEB - 1"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""p67SRF"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
This contrasts with induction of c - fos by both CD40 and sIg, which is PKC independent and indicates that CD40 is capable of signaling through PKC or a closely related kinase.	c - fos,33,40,Gene/Protein	CD40,49,53,Gene/Protein	sIg,58,61,Gene/Protein	PKC,72,75,Gene/Protein	CD40,107,111,Gene/Protein	PKC,144,147,Gene/Protein	kinase,169,175,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""sIg"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
We now show that in EBV - transformed B lymphocytes most of TRAF1 or TRAF3 and 5% of TRAF2 are associated with LMP1 and that most of LMP1 is associated with TRAF1 or TRAF3.	TRAF1,60,65,Gene/Protein	TRAF3,69,74,Gene/Protein	TRAF2,85,90,Gene/Protein	LMP1,111,115,Gene/Protein	LMP1,133,137,Gene/Protein	TRAF1,157,162,Gene/Protein	TRAF3,166,171,Gene/Protein	"[{""token"": ""TRAF1"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""TRAF1"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
The Rel / NF - kappa B proteins, p50, p52, p65, c - Rel, and RelB, constitute a family of transcription factors involved in the positive regulation of a variety of genes during the immune response.	Rel / NF - kappa B proteins,4,31,Gene/Protein	p50,33,36,Gene/Protein	p52,38,41,Gene/Protein	p65,43,46,Gene/Protein	c - Rel,48,55,Gene/Protein	RelB,61,65,Gene/Protein	transcription factors,90,111,Gene/Protein	"[{""token"": ""Rel / NF - kappa B proteins"", ""start_span"": 4, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 90, ""end_span"": 111, ""type"": ""Gene/Protein""}]"	train
In this study, we isolated the genomic DNA for human IRF - 2 gene, determined the intron - exon structure of the human IRF - 2 gene, mapped the major transcription initiation site, identified a number of potential regulatory elements in the 5 ' - flanking region, and localized the IRF - 2 gene on human chromosome 4.	genomic DNA,31,42,Gene/Protein	human IRF - 2 gene,47,65,Gene/Protein	human IRF - 2 gene,113,131,Gene/Protein	major transcription initiation site,144,179,Gene/Protein	5 ' - flanking region,241,262,Gene/Protein	IRF - 2 gene,282,294,Gene/Protein	human chromosome 4,298,316,Gene/Protein	"[{""token"": ""genomic DNA"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""human IRF - 2 gene"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""human IRF - 2 gene"", ""start_span"": 113, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""major transcription initiation site"", ""start_span"": 144, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 241, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 2 gene"", ""start_span"": 282, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 4"", ""start_span"": 298, ""end_span"": 316, ""type"": ""Gene/Protein""}]"	train
The promoter region lacked a TATA box but contained potential binding sites for the transcriptional factors including two Sp1, CRE, Myb and NFkB located at positions - 153, - 178, - 286, - 875, and - 1011, respectively.	promoter region,4,19,Gene/Protein	TATA box,29,37,Gene/Protein	transcriptional factors,84,107,Gene/Protein	Sp1,122,125,Gene/Protein	CRE,127,130,Gene/Protein	Myb,132,135,Gene/Protein	NFkB,140,144,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional factors"", ""start_span"": 84, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Myb"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NFkB"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
Constitutive binding of further factor proteins to DNA, such as JunD, c - Fos and FosB, was detected in several patients whereas the localisation and DNA binding of other factors such as c - Jun, RelA / p65 and c - Rel was unaltered.	factor proteins,32,47,Gene/Protein	JunD,64,68,Gene/Protein	c - Fos,70,77,Gene/Protein	FosB,82,86,Gene/Protein	c - Jun,187,194,Gene/Protein	RelA / p65,196,206,Gene/Protein	c - Rel,211,218,Gene/Protein	"[{""token"": ""factor proteins"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""FosB"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""RelA / p65"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
Furthermore both childrens ' T cells were unable to produce the cytokines IL - 2, interferon - gamma ( IFN - gamma), IL - 4 and tumor necrosis factor - alpha ( TNF - alpha).	cytokines,64,73,Gene/Protein	IL - 2,74,80,Gene/Protein	interferon - gamma,82,100,Gene/Protein	IFN - gamma,103,114,Gene/Protein	IL - 4,117,123,Gene/Protein	tumor necrosis factor - alpha,128,157,Gene/Protein	TNF - alpha,160,171,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 82, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 128, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
These results suggest that phosphorylated pRB is constitutively expressed in MM cells and that IL - 6 further shifts pRB from its dephosphorylated to its phosphorylated form, thereby promoting MM cell growth via two mechanisms; by decreasing the amount of E2F bound by dephosphorylated pRB due to reduced dephosphorylated pRB, thereby releasing growth arrest; and by upregulating IL - 6 secretion by MM cells and related IL - 6 - mediated autocrine tumor cell growth.	phosphorylated pRB,27,45,Gene/Protein	IL - 6,95,101,Gene/Protein	pRB,117,120,Gene/Protein	dephosphorylated pRB,269,289,Gene/Protein	dephosphorylated pRB,305,325,Gene/Protein	IL - 6,380,386,Gene/Protein	IL - 6,421,427,Gene/Protein	"[{""token"": ""phosphorylated pRB"", ""start_span"": 27, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""pRB"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""dephosphorylated pRB"", ""start_span"": 269, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""dephosphorylated pRB"", ""start_span"": 305, ""end_span"": 325, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 380, ""end_span"": 386, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 421, ""end_span"": 427, ""type"": ""Gene/Protein""}]"	train
p38 and p63 may provide a docking site for Grb2, thereby linking Grb2 SH3 - binding proteins SOS1, SLP - 76, and p120 to downstream signalling events.	p38,0,3,Gene/Protein	p63,8,11,Gene/Protein	Grb2,43,47,Gene/Protein	Grb2 SH3 - binding proteins,65,92,Gene/Protein	SOS1,93,97,Gene/Protein	SLP - 76,99,107,Gene/Protein	p120,113,117,Gene/Protein	"[{""token"": ""p38"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""p63"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Grb2 SH3 - binding proteins"", ""start_span"": 65, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""SOS1"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""p120"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
In this study, we characterize an essential upstream IL - 2 response element that contains both consensus and non - consensus GAS motifs, two putative Ets binding sites ( EBS), one of which overlaps the consensus GAS motif, and a GATA motif, which overlaps the non - consensus GAS motif.	IL - 2 response element,53,76,Gene/Protein	consensus and non - consensus GAS motifs,96,136,Gene/Protein	Ets binding sites,151,168,Gene/Protein	EBS,171,174,Gene/Protein	consensus GAS motif,203,222,Gene/Protein	GATA motif,230,240,Gene/Protein	non - consensus GAS motif,261,286,Gene/Protein	"[{""token"": ""IL - 2 response element"", ""start_span"": 53, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""consensus and non - consensus GAS motifs"", ""start_span"": 96, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Ets binding sites"", ""start_span"": 151, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""consensus GAS motif"", ""start_span"": 203, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""GATA motif"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""non - consensus GAS motif"", ""start_span"": 261, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
The proximal region in PFP9a20 contained two potential Sp1 binding sites ( GC box and GT box) and one Ets binding site ( EBS).	proximal region,4,19,Gene/Protein	PFP9a20,23,30,Gene/Protein	Sp1 binding sites,55,72,Gene/Protein	GC box,75,81,Gene/Protein	GT box,86,92,Gene/Protein	Ets binding site,102,118,Gene/Protein	EBS,121,124,Gene/Protein	"[{""token"": ""proximal region"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""PFP9a20"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 binding sites"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""GC box"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GT box"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Ets binding site"", ""start_span"": 102, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
In contrast, engagement of the TCR by class II MHC / superantigen, either with or without CD28 ligation, resulted in the induction of NF - AT, AP - 1, and NF - kappaB as well as IL - 2 production.	TCR,31,34,Gene/Protein	class II MHC / superantigen,38,65,Gene/Protein	CD28,90,94,Gene/Protein	NF - AT,134,141,Gene/Protein	AP - 1,143,149,Gene/Protein	NF - kappaB,155,166,Gene/Protein	IL - 2,178,184,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""class II MHC / superantigen"", ""start_span"": 38, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
Similar to expression of IL - 2, we demonstrated that recombinant vascular - cell adhesion molecule - 1, when co - immobilized with anti - CD3 mAb, significantly enhanced the induction of transcription factors NF - AT, AP - 1, and NF - kappa B as determined by electromobility shift assays.	IL - 2,25,31,Gene/Protein	recombinant vascular - cell adhesion molecule - 1,54,103,Gene/Protein	anti - CD3 mAb,132,146,Gene/Protein	transcription factors,188,209,Gene/Protein	NF - AT,210,217,Gene/Protein	AP - 1,219,225,Gene/Protein	NF - kappa B,231,243,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""recombinant vascular - cell adhesion molecule - 1"", ""start_span"": 54, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 mAb"", ""start_span"": 132, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 188, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 219, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 231, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Analysis of the expression of genes reported to regulate cytokine - induced proliferation demonstrated that both IL - 2 and IL - 12 induce c - myc mRNA accumulation in NK and T cells, whereas only IL - 2 induces bcl - 2 expression.	genes,30,35,Gene/Protein	cytokine,57,65,Gene/Protein	IL - 2,113,119,Gene/Protein	IL - 12,124,131,Gene/Protein	c - myc mRNA,139,151,Gene/Protein	IL - 2,197,203,Gene/Protein	bcl - 2,212,219,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""c - myc mRNA"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Our data provide the first demonstration that IL - 12 - mediated activation of T and NK cells does not involve expression of members of the immediate - early activation genes family ( egr - 1, c - fos, and junB), AP - 1 transcriptional activity, or bcl - 2 expression.	IL - 12,46,53,Gene/Protein	immediate - early activation genes family,140,181,Gene/Protein	egr - 1,184,191,Gene/Protein	c - fos,193,200,Gene/Protein	junB,206,210,Gene/Protein	AP - 1,213,219,Gene/Protein	bcl - 2,249,256,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early activation genes family"", ""start_span"": 140, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""egr - 1"", ""start_span"": 184, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 249, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
We show here that the plasma cell - specific repressor function, designated SIR ( suppressor of immune response genes), does not act directly on the transcription of class II genes, but instead on the transcription of the AIR - 1 gene, whose product, the class II transactivator ( CIITA), is fundamental for the regulation of the constitutive and inducible expression of MHC class II genes.	SIR,76,79,Gene/Protein	suppressor of immune response genes,82,117,Gene/Protein	class II genes,166,180,Gene/Protein	AIR - 1 gene,222,234,Gene/Protein	class II transactivator,255,278,Gene/Protein	CIITA,281,286,Gene/Protein	MHC class II genes,371,389,Gene/Protein	"[{""token"": ""SIR"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""suppressor of immune response genes"", ""start_span"": 82, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""class II genes"", ""start_span"": 166, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""AIR - 1 gene"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""class II transactivator"", ""start_span"": 255, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 281, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II genes"", ""start_span"": 371, ""end_span"": 389, ""type"": ""Gene/Protein""}]"	train
Effects of IL - 10 and IL - 4 on LPS - induced transcription factors ( AP - 1, NF - IL6 and NF - kappa B) which are involved in IL - 6 regulation.	IL - 10,11,18,Gene/Protein	IL - 4,23,29,Gene/Protein	transcription factors,47,68,Gene/Protein	AP - 1,71,77,Gene/Protein	NF - IL6,79,87,Gene/Protein	NF - kappa B,92,104,Gene/Protein	IL - 6,128,134,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
The use of the protein tyrosine kinase ( PTK) - specific inhibitor herbimycin A dramatically decreased cellular proliferation without altering the activity of the human immunodeficiency virus - 1 long terminal repeat ( HIV - 1 LTR), a promoter largely dependent on the binding of nuclear factor kappa B ( NF - kappa B).	protein tyrosine kinase,15,38,Gene/Protein	PTK,41,44,Gene/Protein	human immunodeficiency virus - 1 long terminal repeat,163,216,Gene/Protein	HIV - 1 LTR,219,230,Gene/Protein	promoter,235,243,Gene/Protein	nuclear factor kappa B,280,302,Gene/Protein	NF - kappa B,305,317,Gene/Protein	"[{""token"": ""protein tyrosine kinase"", ""start_span"": 15, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""human immunodeficiency virus - 1 long terminal repeat"", ""start_span"": 163, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 280, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 305, ""end_span"": 317, ""type"": ""Gene/Protein""}]"	train
By using 70Z / 3 - derived pre - B - cell lines either lacking or expressing human CD14 ( the LPS receptor), it was observed that expression of human CD14 imparted responsiveness to LPS but not to OspA or spirochetal lipopeptides ( assessed by induction of NF - kappa B and expression of surface immunoglobulin M).	human CD14,77,87,Gene/Protein	LPS receptor,94,106,Gene/Protein	human CD14,144,154,Gene/Protein	OspA,197,201,Gene/Protein	spirochetal lipopeptides,205,229,Gene/Protein	NF - kappa B,257,269,Gene/Protein	surface immunoglobulin M,288,312,Gene/Protein	"[{""token"": ""human CD14"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LPS receptor"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""human CD14"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""OspA"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""spirochetal lipopeptides"", ""start_span"": 205, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 257, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""surface immunoglobulin M"", ""start_span"": 288, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
The transcription factor, Nuclear Factor of Activated T cells ( NFAT) is a major target for p21ras and calcium signalling pathways in the IL - 2 gene and is induced by p21ras signals acting in synergy with calcium / calcineurin signals.	transcription factor,4,24,Gene/Protein	Nuclear Factor of Activated T cells,26,61,Gene/Protein	NFAT,64,68,Gene/Protein	p21ras,92,98,Gene/Protein	IL - 2 gene,138,149,Gene/Protein	p21ras,168,174,Gene/Protein	/ calcineurin,214,227,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Nuclear Factor of Activated T cells"", ""start_span"": 26, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""/ calcineurin"", ""start_span"": 214, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
Constitutively active MAPKK - 1 fully activates ERK - 2 and the transcription factor Elk - 1, but does not substitute for activated p21ras and synergize with calcium / calcineurin signals to induce NFAT.	MAPKK - 1,22,31,Gene/Protein	ERK - 2,48,55,Gene/Protein	transcription factor,64,84,Gene/Protein	Elk - 1,85,92,Gene/Protein	p21ras,132,138,Gene/Protein	/ calcineurin,166,179,Gene/Protein	NFAT,198,202,Gene/Protein	"[{""token"": ""MAPKK - 1"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ERK - 2"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 64, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Elk - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""/ calcineurin"", ""start_span"": 166, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
In NK3. 3 cells, IL - 2 induced comparable formation of c - fos promoter sis - inducible element IFN - gamma - activated sequence - binding complexes containing STAT3 alone with complexes containing STAT3 and STAT1 alpha, while in preactivated primary NK cells, it preferentially induced complexes containing STAT3 and STAT1 alpha.	IL - 2,17,23,Gene/Protein	c - fos promoter sis - inducible element IFN - gamma - activated sequence - binding complexes,56,149,Gene/Protein	STAT3,161,166,Gene/Protein	STAT3,199,204,Gene/Protein	STAT1 alpha,209,220,Gene/Protein	STAT3,309,314,Gene/Protein	STAT1 alpha,319,330,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""c - fos promoter sis - inducible element IFN - gamma - activated sequence - binding complexes"", ""start_span"": 56, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 309, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 319, ""end_span"": 330, ""type"": ""Gene/Protein""}]"	train
Cytokines that bind to the interleukin - 2 ( IL - 2) receptor common gamma chain ( gamma c), including IL - 2, IL - 4, IL - 7, IL - 9, and IL - 15, are important for the growth and differentiation of T and B lymphocytes, natural killer cells, macrophages, and monoctyes.	Cytokines,0,9,Gene/Protein	gamma c,69,76,Gene/Protein	IL - 2,103,109,Gene/Protein	IL - 4,111,117,Gene/Protein	IL - 7,119,125,Gene/Protein	IL - 9,127,133,Gene/Protein	IL - 15,139,146,Gene/Protein	"[{""token"": ""Cytokines"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""gamma c"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
To define the activation of the STAT5 homologues and lower molecular weight variant in human monocytes and monocytes differentiated into macrophages by culture in macrophage - CSF ( M - CSF), we measured the GM - CSF induced tyrosine phosphorylation of STAT5A, STAT5B, and any lower molecular weight STAT5 isoforms.	STAT5 homologues,32,48,Gene/Protein	macrophage - CSF,163,179,Gene/Protein	M - CSF,182,189,Gene/Protein	GM - CSF,208,216,Gene/Protein	STAT5A,253,259,Gene/Protein	STAT5B,261,267,Gene/Protein	STAT5 isoforms,300,314,Gene/Protein	"[{""token"": ""STAT5 homologues"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""macrophage - CSF"", ""start_span"": 163, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""STAT5A"", ""start_span"": 253, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 261, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""STAT5 isoforms"", ""start_span"": 300, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	train
Whereas 94 - kD STAT5A was clearly tyrosine phosphorylated and bound to the enhancer element, the gamma response region ( GRR), of the Fc gamma RI gene, substantially less tyrosine phosphorylated STAT5B bound to the immobilized GRR element.	94 - kD STAT5A,8,22,Gene/Protein	enhancer element,76,92,Gene/Protein	gamma response region,98,119,Gene/Protein	GRR,122,125,Gene/Protein	Fc gamma RI gene,135,151,Gene/Protein	STAT5B,196,202,Gene/Protein	GRR element,228,239,Gene/Protein	"[{""token"": ""94 - kD STAT5A"", ""start_span"": 8, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""enhancer element"", ""start_span"": 76, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""gamma response region"", ""start_span"": 98, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""GRR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RI gene"", ""start_span"": 135, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GRR element"", ""start_span"": 228, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Both IL - 13 and IL - 4 induced phosphorylation of IL - 4 STAT ( STAT6) but not STAT1, STAT3, or STAT5.	IL - 13,5,12,Gene/Protein	IL - 4,17,23,Gene/Protein	IL - 4 STAT,51,62,Gene/Protein	STAT6,65,70,Gene/Protein	STAT1,80,85,Gene/Protein	STAT3,87,92,Gene/Protein	STAT5,97,102,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 STAT"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	train
The involvement of members of the PEBP2 / CBF family in chromosome translocations associated with acute myeloid leukemia, and in the transcriptional regulation of the myeloid - specific genes encoding for myeloperoxidase, elastase, and the colony - stimulating factor receptor, highlights the relevance of the regulation of the CD36 gene promoter in monocytic cells by members of the PEBP2 / CBF family.	PEBP2 / CBF family,34,52,Gene/Protein	myeloid - specific genes,167,191,Gene/Protein	myeloperoxidase,205,220,Gene/Protein	elastase,222,230,Gene/Protein	colony - stimulating factor receptor,240,276,Gene/Protein	CD36 gene promoter,328,346,Gene/Protein	PEBP2 / CBF family,384,402,Gene/Protein	"[{""token"": ""PEBP2 / CBF family"", ""start_span"": 34, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""myeloid - specific genes"", ""start_span"": 167, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""myeloperoxidase"", ""start_span"": 205, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""elastase"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""colony - stimulating factor receptor"", ""start_span"": 240, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""CD36 gene promoter"", ""start_span"": 328, ""end_span"": 346, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 / CBF family"", ""start_span"": 384, ""end_span"": 402, ""type"": ""Gene/Protein""}]"	train
The immediate - early gene egr - 1 encodes a transcription factor ( EGR1) that links B - cell antigen receptor ( BCR) signals to downstream activation events through the regulation of previously unidentified target genes.	immediate - early gene,4,26,Gene/Protein	egr - 1,27,34,Gene/Protein	transcription factor,45,65,Gene/Protein	EGR1,68,72,Gene/Protein	B - cell antigen receptor,85,110,Gene/Protein	BCR,113,116,Gene/Protein	target genes,208,220,Gene/Protein	"[{""token"": ""immediate - early gene"", ""start_span"": 4, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""egr - 1"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""EGR1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""B - cell antigen receptor"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""BCR"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
We have previously shown that a DNA - binding factor specific to adult hematopoietic cells ( polypryrimidine - binding factor, PYBF) binds to a pyrimidine - rich region 1 kb upstream from the human delta - globin - encoding gene ( HBD).	DNA - binding factor,32,52,Gene/Protein	polypryrimidine - binding factor,93,125,Gene/Protein	PYBF,127,131,Gene/Protein	pyrimidine - rich region,144,168,Gene/Protein	1 kb upstream,169,182,Gene/Protein	human delta - globin - encoding gene,192,228,Gene/Protein	HBD,231,234,Gene/Protein	"[{""token"": ""DNA - binding factor"", ""start_span"": 32, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""polypryrimidine - binding factor"", ""start_span"": 93, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""PYBF"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""pyrimidine - rich region"", ""start_span"": 144, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""1 kb upstream"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""human delta - globin - encoding gene"", ""start_span"": 192, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
In the locus control region ( LCR) of the beta - globin locus, in vivo footprints on NF - E2 ( or AP - 1) and GATA - 1 motifs remained the same regardless of whether the fetal or the adult globin genes are expressed.	locus control region,7,27,Gene/Protein	LCR,30,33,Gene/Protein	beta - globin locus,42,61,Gene/Protein	NF - E2,85,92,Gene/Protein	AP - 1,98,104,Gene/Protein	GATA - 1 motifs,110,125,Gene/Protein	adult globin genes,183,201,Gene/Protein	"[{""token"": ""locus control region"", ""start_span"": 7, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin locus"", ""start_span"": 42, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1 motifs"", ""start_span"": 110, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""adult globin genes"", ""start_span"": 183, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
Galectin - 3 is a beta - galactoside - binding lectin previously designated as epsilon BP ( IgE - binding protein), CBP35, Mac - 2, L - 29, and L - 34, and its expression has been associated with various physiological and pathological processes, including cell growth, tumor transformation, and metastasis.	beta - galactoside - binding lectin,18,53,Gene/Protein	epsilon BP,79,89,Gene/Protein	IgE - binding protein,92,113,Gene/Protein	CBP35,116,121,Gene/Protein	Mac - 2,123,130,Gene/Protein	L - 29,132,138,Gene/Protein	L - 34,144,150,Gene/Protein	"[{""token"": ""beta - galactoside - binding lectin"", ""start_span"": 18, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""epsilon BP"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IgE - binding protein"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CBP35"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""L - 29"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""L - 34"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
We previously demonstrated that both synthetic ( Exosurf) and modified natural surfactant ( Survanta) downregulated endotoxin - stimulated inflammatory c ytokine mRNA levels and protein products ( tumor necrosis factor - alpha [ TNF], interleukin - 1 - beta [ IL - 1], interleukin - 6 [ IL - 6]) in human alveolar macrophages.	inflammatory c ytokine mRNA,139,166,Gene/Protein	protein products,178,194,Gene/Protein	tumor necrosis factor - alpha,197,226,Gene/Protein	interleukin - 1 - beta,235,257,Gene/Protein	IL - 1,260,266,Gene/Protein	interleukin - 6,269,284,Gene/Protein	IL - 6,287,293,Gene/Protein	"[{""token"": ""inflammatory c ytokine mRNA"", ""start_span"": 139, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""protein products"", ""start_span"": 178, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 197, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1 - beta"", ""start_span"": 235, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 260, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 269, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
In combination with TNF - alpha, IL - 10 stimulated activating protein - 1 ( AP - 1) and nuclear factor ( NF) - kappa B binding activities and cooperated to increase HIV - 1 steady - state mRNA levels and enhance long terminal repeat - directed transcription through activation of the NF - kappa B binding sites, suggesting the IL - 10 effect occurs at least in part at the transcriptional level.	TNF - alpha,20,31,Gene/Protein	IL - 10,33,40,Gene/Protein	activating protein - 1,52,74,Gene/Protein	AP - 1,77,83,Gene/Protein	long terminal repeat,213,233,Gene/Protein	NF - kappa B binding sites,285,311,Gene/Protein	IL - 10,328,335,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""activating protein - 1"", ""start_span"": 52, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 213, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding sites"", ""start_span"": 285, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 328, ""end_span"": 335, ""type"": ""Gene/Protein""}]"	train
We show that an inhibitor of protein phosphatases ( PPs) PP1 / PP2A, calyculin A, induces ( i) phosphorylation of STAT3 on serine and threonine residues, ( ii) inhibition of STAT3 tyrosine phosphorylation and DNA binding activity, and ( iii) relocation of STAT3 from the nucleus to the cytoplasm.	protein phosphatases,29,49,Gene/Protein	PPs,52,55,Gene/Protein	PP1 / PP2A,57,67,Gene/Protein	calyculin A,69,80,Gene/Protein	STAT3,114,119,Gene/Protein	STAT3,174,179,Gene/Protein	STAT3,256,261,Gene/Protein	"[{""token"": ""protein phosphatases"", ""start_span"": 29, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""PPs"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""PP1 / PP2A"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""calyculin A"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 256, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
IL - 10 - activated STAT1 could bind to the GAS - motif sequence in the promoter region of the Fcgamma receptor, but not to that in the promoter region of the COX - 2 gene, whereas IFN - gamma - activated STAT1 and STAT5 could bind to both sequences.	IL - 10 - activated STAT1,0,25,Gene/Protein	GAS - motif sequence,44,64,Gene/Protein	Fcgamma receptor,95,111,Gene/Protein	promoter region,136,151,Gene/Protein	COX - 2 gene,159,171,Gene/Protein	IFN - gamma - activated STAT1,181,210,Gene/Protein	STAT5,215,220,Gene/Protein	"[{""token"": ""IL - 10 - activated STAT1"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""GAS - motif sequence"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Fcgamma receptor"", ""start_span"": 95, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""COX - 2 gene"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - activated STAT1"", ""start_span"": 181, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	train
After up to 90 min exposure time ELISA, EMSA ( electromobility shift assay) and RT - PCR were used to measure protein tyrosine kinase activity, protein activity of NF - kappaB and cytokine ( IL - 1beta, IL - 6, TNF - alpha) specific mRNA levels in BEAS - 2B cells.	protein tyrosine kinase,110,133,Gene/Protein	NF - kappaB,164,175,Gene/Protein	cytokine,180,188,Gene/Protein	IL - 1beta,191,201,Gene/Protein	IL - 6,203,209,Gene/Protein	TNF - alpha,211,222,Gene/Protein	mRNA,233,237,Gene/Protein	"[{""token"": ""protein tyrosine kinase"", ""start_span"": 110, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 211, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
The consequent decrease in the nuclear levels of c - Jun and JunD leads to diminished binding of c - Jun / c - Fos and JunD / c - Fos heterodimers to the AP - 1 consensus sequence in the TNF promoter and, thus, to decreased transactivation of the TNF gene.	c - Jun,49,56,Gene/Protein	JunD,61,65,Gene/Protein	c - Jun / c - Fos,97,114,Gene/Protein	JunD / c - Fos heterodimers,119,146,Gene/Protein	AP - 1 consensus sequence,154,179,Gene/Protein	TNF promoter,187,199,Gene/Protein	TNF gene,247,255,Gene/Protein	"[{""token"": ""c - Jun"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun / c - Fos"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""JunD / c - Fos heterodimers"", ""start_span"": 119, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 consensus sequence"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""TNF promoter"", ""start_span"": 187, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""TNF gene"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
One of the putative targets of calcineurin is the pre - existing, cytosolic component of the nuclear factor of activated T cells ( NFATp; also referred to as NFAT1), which is one of several transcription factors required for the expression of interleukin 2.	calcineurin,31,42,Gene/Protein	cytosolic component,66,85,Gene/Protein	nuclear factor of activated T cells,93,128,Gene/Protein	NFATp,131,136,Gene/Protein	NFAT1,158,163,Gene/Protein	transcription factors,190,211,Gene/Protein	interleukin 2,243,256,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic component"", ""start_span"": 66, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 93, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 190, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 243, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
Inhibition of the NF - kappaB pathway by overexpression of a dominant - active inhibitor of NF - kappaB abolished CD40 - induced up - regulation of both the Bfl - 1 and Bcl - x genes and also eliminated the ability of CD40 to rescue Fas - induced cell death.	NF - kappaB,18,29,Gene/Protein	NF - kappaB,92,103,Gene/Protein	CD40,114,118,Gene/Protein	Bfl - 1,157,164,Gene/Protein	Bcl - x,169,176,Gene/Protein	CD40,218,222,Gene/Protein	Fas,233,236,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Bfl - 1"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - x"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Instead, we propose that ligation of a distinct inhibitory receptor leads to the recruitment of SHP1 via its SH2 domains, activation of SHP1 and subsequently inhibition of TCR signals if the inhibitory receptor is juxtaposed to the TCR.	inhibitory receptor,48,67,Gene/Protein	SHP1,96,100,Gene/Protein	SH2 domains,109,120,Gene/Protein	SHP1,136,140,Gene/Protein	TCR,172,175,Gene/Protein	inhibitory receptor,191,210,Gene/Protein	TCR,232,235,Gene/Protein	"[{""token"": ""inhibitory receptor"", ""start_span"": 48, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domains"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory receptor"", ""start_span"": 191, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
DN constructs of myeloid differentiation protein, IRAK, TNF receptor - associated factor 6, and NF - kappaB - inducing kinase, when coexpressed with TLR2, abrogate TLR2 - mediated NF - kappaB activation.	myeloid differentiation protein,17,48,Gene/Protein	IRAK,50,54,Gene/Protein	TNF receptor - associated factor 6,56,90,Gene/Protein	NF - kappaB - inducing kinase,96,125,Gene/Protein	TLR2,149,153,Gene/Protein	TLR2,164,168,Gene/Protein	NF - kappaB,180,191,Gene/Protein	"[{""token"": ""myeloid differentiation protein"", ""start_span"": 17, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IRAK"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""TNF receptor - associated factor 6"", ""start_span"": 56, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - inducing kinase"", ""start_span"": 96, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
In the present study, we have identified a cellular context ( the interleukin - 2 [ IL - 2] - dependent HT - 2 line) in which the EPO stimulation of the EPOR fails to support cellular proliferation, STAT - 5 induction, or MAPK activation, despite efficient phosphorylation of the EPOR and JAK2 and inhibition of apoptosis after withdrawal of IL - 2.	EPO,130,133,Gene/Protein	EPOR,153,157,Gene/Protein	STAT - 5,199,207,Gene/Protein	MAPK,222,226,Gene/Protein	EPOR,280,284,Gene/Protein	JAK2,289,293,Gene/Protein	IL - 2,342,348,Gene/Protein	"[{""token"": ""EPO"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""EPOR"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 5"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""EPOR"", ""start_span"": 280, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 289, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 342, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor - associated proteins TRADD and receptor - interacting protein ( RIP) but does not induce apoptosis or require RIP for NF - kappaB activation.	Epstein - Barr virus oncoprotein latent membrane protein 1,4,62,Gene/Protein	tumor necrosis factor receptor - associated proteins,75,127,Gene/Protein	TRADD,128,133,Gene/Protein	receptor - interacting protein,138,168,Gene/Protein	RIP,171,174,Gene/Protein	RIP,217,220,Gene/Protein	NF - kappaB,225,236,Gene/Protein	"[{""token"": ""Epstein - Barr virus oncoprotein latent membrane protein 1"", ""start_span"": 4, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor receptor - associated proteins"", ""start_span"": 75, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""receptor - interacting protein"", ""start_span"": 138, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""RIP"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 225, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Transcription factors USF1 and USF2 up - regulate gene expression ( i. e., HIV - 1 long terminal repeats) via interaction with an E box on their target promoters, which is also a binding site for c - Myc.	Transcription factors,0,21,Gene/Protein	USF1,22,26,Gene/Protein	USF2,31,35,Gene/Protein	HIV - 1 long terminal repeats,75,104,Gene/Protein	E box,130,135,Gene/Protein	binding site,179,191,Gene/Protein	c - Myc,196,203,Gene/Protein	"[{""token"": ""Transcription factors"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""USF1"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""USF2"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeats"", ""start_span"": 75, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""E box"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
The signaling events that link FGF receptor - 1 engagement and NF - kappaB activation in Jurkat are probably distinct from the CD28 costimulation pathway, since FGF - 1 - induced Rel / kappaB binding proteins do not contain significant levels of c - Rel and are not identical with the CD28 response complex.	FGF receptor - 1,31,47,Gene/Protein	NF - kappaB,63,74,Gene/Protein	CD28,127,131,Gene/Protein	FGF - 1,161,168,Gene/Protein	Rel / kappaB binding proteins,179,208,Gene/Protein	c - Rel,246,253,Gene/Protein	CD28 response complex,285,306,Gene/Protein	"[{""token"": ""FGF receptor - 1"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""FGF - 1"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""Rel / kappaB binding proteins"", ""start_span"": 179, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""CD28 response complex"", ""start_span"": 285, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
We conclude that ( 1) HTLV - I infection per se does not result in a constitutive phosphorylation of the Jak3, STAT3, and STAT5 proteins; ( 2) malignant transformation in at least some cases of ATLL does not require the constitutive, but may require IL - 2 - induced, activation of the IL - 2R Jak / STAT pathway; and ( 3) there are major differences in T - cell immortalization mechanism ( s) which appear to involve SHP - 1 and target molecules for rapamycin and RAD.	Jak3,105,109,Gene/Protein	STAT3,111,116,Gene/Protein	STAT5,122,127,Gene/Protein	IL - 2,250,256,Gene/Protein	IL - 2R,286,293,Gene/Protein	Jak / STAT,294,304,Gene/Protein	SHP - 1,418,425,Gene/Protein	"[{""token"": ""Jak3"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 250, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 286, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""Jak / STAT"", ""start_span"": 294, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""SHP - 1"", ""start_span"": 418, ""end_span"": 425, ""type"": ""Gene/Protein""}]"	train
The transcription factor NF - kappaB has been shown to play a role in protecting cells against death mediated by TNF We show here that NF - kappaB also has a role in regulating Fas / APO - 1 / CD95 - mediated death, a major pathway of peripheral T cell death.	transcription factor,4,24,Gene/Protein	NF - kappaB,25,36,Gene/Protein	TNF,113,116,Gene/Protein	NF - kappaB,135,146,Gene/Protein	Fas,177,180,Gene/Protein	APO - 1,183,190,Gene/Protein	CD95,193,197,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 135, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Fas"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""APO - 1"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Whereas IL - 4 appears to repress functional IL - 12 signaling through inhibition of IL - 12R beta 2 expression, IFN - gamma in the mouse, and IFN - alpha in the human appear to induce IL - 12R beta 2 expression and promote IL - 12 responsiveness.	IL - 4,8,14,Gene/Protein	IL - 12,45,52,Gene/Protein	IL - 12R beta 2,85,100,Gene/Protein	IFN - gamma,113,124,Gene/Protein	IFN - alpha,143,154,Gene/Protein	IL - 12R beta 2,185,200,Gene/Protein	IL - 12,224,231,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12R beta 2"", ""start_span"": 85, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12R beta 2"", ""start_span"": 185, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Selective activation of STAT1alpha at the IFN - gamma receptor is achieved by specific interaction between a cytosolic tyrosine motif including Y440 in the IFN - gamma receptor alpha - chain and the SH2 domain of STAT1alpha.	STAT1alpha,24,34,Gene/Protein	IFN - gamma receptor,42,62,Gene/Protein	cytosolic tyrosine motif,109,133,Gene/Protein	Y440,144,148,Gene/Protein	IFN - gamma receptor alpha - chain,156,190,Gene/Protein	SH2 domain,199,209,Gene/Protein	STAT1alpha,213,223,Gene/Protein	"[{""token"": ""STAT1alpha"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma receptor"", ""start_span"": 42, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic tyrosine motif"", ""start_span"": 109, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Y440"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma receptor alpha - chain"", ""start_span"": 156, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""STAT1alpha"", ""start_span"": 213, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Type I interferons ( IFN - alpha and IFN - beta) and type II interferon ( IFN - gamma) inhibit induction of these genes by IL - 4 and IL - 13.	Type I interferons,0,18,Gene/Protein	IFN - alpha,21,32,Gene/Protein	IFN - beta,37,47,Gene/Protein	type II interferon,53,71,Gene/Protein	IFN - gamma,74,85,Gene/Protein	IL - 4,123,129,Gene/Protein	IL - 13,134,141,Gene/Protein	"[{""token"": ""Type I interferons"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""type II interferon"", ""start_span"": 53, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
Th1 cells produce IL - 2 and IFN - gamma, whereas Th2 cells produce IL - 4, IL - 5, IL - 6, IL - 10, and IL - 13.	IL - 2,18,24,Gene/Protein	IFN - gamma,29,40,Gene/Protein	IL - 4,68,74,Gene/Protein	IL - 5,76,82,Gene/Protein	IL - 6,84,90,Gene/Protein	IL - 10,92,99,Gene/Protein	IL - 13,105,112,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
In the present study we investigated the possible involvement of the mitogen - activated protein kinase family members extracellular - regulated kinase 1 / 2 ( ERK1 / 2) and c - Jun N - terminal kinase ( JNK) in mediating IL - 6 gene expression in human monocytes, in particular their role in enhancing NF - kappa B activity.	mitogen - activated protein kinase family,69,110,Gene/Protein	extracellular - regulated kinase 1 / 2,119,157,Gene/Protein	ERK1 / 2,160,168,Gene/Protein	Jun N - terminal kinase,178,201,Gene/Protein	JNK,204,207,Gene/Protein	IL - 6,222,228,Gene/Protein	NF - kappa B,303,315,Gene/Protein	"[{""token"": ""mitogen - activated protein kinase family"", ""start_span"": 69, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""extracellular - regulated kinase 1 / 2"", ""start_span"": 119, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""ERK1 / 2"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""Jun N - terminal kinase"", ""start_span"": 178, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 303, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
The E2A - HLF fusion gene, generated by t ( 17; 19) ( q22; p13) in acute lymphoblastic leukemia ( ALL), encodes a chimeric transcription factor in which the trans - activating domains of E2A are fused to the DNA - binding and dimerization domains of hepatic leukemic factor ( HLF).	E2A - HLF fusion gene,4,25,Gene/Protein	chimeric transcription factor,114,143,Gene/Protein	trans - activating domains,157,183,Gene/Protein	E2A,187,190,Gene/Protein	DNA - binding and dimerization domains,208,246,Gene/Protein	hepatic leukemic factor,250,273,Gene/Protein	HLF,276,279,Gene/Protein	"[{""token"": ""E2A - HLF fusion gene"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""chimeric transcription factor"", ""start_span"": 114, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""trans - activating domains"", ""start_span"": 157, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding and dimerization domains"", ""start_span"": 208, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""hepatic leukemic factor"", ""start_span"": 250, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 276, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
Furthermore, the phosphorylation status of TRAF2 had significant effects on the ability of the protein to bind to CD40, as evidenced by our observations that the CD40 cytoplasmic domain interacted preferentially with underphosphorylated TRAF2 and that phosphatase treatment significantly enhanced the binding of TRAF2 to CD40.	TRAF2,43,48,Gene/Protein	CD40,114,118,Gene/Protein	CD40 cytoplasmic domain,162,185,Gene/Protein	TRAF2,237,242,Gene/Protein	phosphatase,252,263,Gene/Protein	TRAF2,312,317,Gene/Protein	CD40,321,325,Gene/Protein	"[{""token"": ""TRAF2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD40 cytoplasmic domain"", ""start_span"": 162, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 252, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 312, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 321, ""end_span"": 325, ""type"": ""Gene/Protein""}]"	train
Overexpression of wild - type Grf40 in Jurkat cells induced a significant increase of SLP - 76 - dependent interleukin ( IL) - 2 promoter and nuclear factor of activated T cell ( NF - AT) activation upon T cell receptor ( TCR) stimulation, whereas the COOH - terminal SH3 - deleted Grf40 mutant lacked any recognizable increase in IL - 2 promoter activity.	wild - type Grf40,18,35,Gene/Protein	nuclear factor of activated T cell,142,176,Gene/Protein	NF - AT,179,186,Gene/Protein	T cell receptor,204,219,Gene/Protein	TCR,222,225,Gene/Protein	COOH - terminal SH3 - deleted Grf40 mutant,252,294,Gene/Protein	IL - 2 promoter,331,346,Gene/Protein	"[{""token"": ""wild - type Grf40"", ""start_span"": 18, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cell"", ""start_span"": 142, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 204, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal SH3 - deleted Grf40 mutant"", ""start_span"": 252, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 331, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	train
Specific inhibitors of p70 ( S6) - kinase ( rapamycin), and Gi protein ( pertussis toxin), prevented induction of IL - 10 production by gp41 in monocytes, while inhibitors of the phosphatidylinositol 3 - kinase ( PI 3 - kinase) ( wortmannin) and mitogen - activated protein kinase ( MAPK) pathway ( PD 98059) did not.	Gi protein,60,70,Gene/Protein	pertussis toxin,73,88,Gene/Protein	IL - 10,114,121,Gene/Protein	gp41,136,140,Gene/Protein	phosphatidylinositol 3 - kinase,179,210,Gene/Protein	PI 3 - kinase,213,226,Gene/Protein	MAPK,283,287,Gene/Protein	"[{""token"": ""Gi protein"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""pertussis toxin"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""gp41"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 179, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 213, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Thus HIV - 1 gp41 - induced IL - 10 up - regulation in monocytes may not involve NF - kappaB, MAPK, or PI 3 - kinase activation, but rather may operate through activation of adenylate cyclase and pertussis - toxin - sensitive Gi / Go protein to effect p70 ( S6) - kinase activation.	gp41,13,17,Gene/Protein	IL - 10,28,35,Gene/Protein	NF - kappaB,81,92,Gene/Protein	MAPK,94,98,Gene/Protein	PI 3 - kinase,103,116,Gene/Protein	adenylate cyclase,174,191,Gene/Protein	pertussis - toxin - sensitive Gi / Go protein,196,241,Gene/Protein	"[{""token"": ""gp41"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""adenylate cyclase"", ""start_span"": 174, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""pertussis - toxin - sensitive Gi / Go protein"", ""start_span"": 196, ""end_span"": 241, ""type"": ""Gene/Protein""}]"	train
Functional studies using human endothelial cells demonstrated that overexpression of CBP rescued cAMP inhibition of NF - kappaB - mediated transcription and transcription mediated by a chimeric protein, GAL4 - p65 ( 286 - 551), which contained the GAL4 DNA binding domain fused to the carboxyl - terminal region of p65 ( amino acids 286 - 551).	CBP,85,88,Gene/Protein	NF - kappaB,116,127,Gene/Protein	chimeric protein,185,201,Gene/Protein	GAL4 DNA binding domain,248,271,Gene/Protein	carboxyl - terminal region,285,311,Gene/Protein	p65,315,318,Gene/Protein	amino acids 286 - 551,321,342,Gene/Protein	"[{""token"": ""CBP"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""chimeric protein"", ""start_span"": 185, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 DNA binding domain"", ""start_span"": 248, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl - terminal region"", ""start_span"": 285, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 315, ""end_span"": 318, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 286 - 551"", ""start_span"": 321, ""end_span"": 342, ""type"": ""Gene/Protein""}]"	train
To further explore the ramifications of CD19 signaling, the current study examined whether phosphorylation of Elk - 1, activation of activator protein - 1 ( AP - 1), or activation of nuclear factor - kappaB ( NF - kappaB) transcription factors occurred following CD19 cross - linking.	CD19,40,44,Gene/Protein	Elk - 1,110,117,Gene/Protein	activator protein - 1,133,154,Gene/Protein	AP - 1,157,163,Gene/Protein	NF - kappaB,209,220,Gene/Protein	transcription factors,222,243,Gene/Protein	CD19,263,267,Gene/Protein	"[{""token"": ""CD19"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Elk - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 133, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 222, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
Functional analyses of DNA fragments containing the TATA element and the identification of a DNase I - hypersensitive chromatin site ( HS 1) in close proximity to the TATA box suggest that the identified TATA motif is important for elk - 1 transcription in vivo.	DNA fragments,23,36,Gene/Protein	TATA element,52,64,Gene/Protein	DNase I - hypersensitive chromatin site,93,132,Gene/Protein	HS 1,135,139,Gene/Protein	TATA box,167,175,Gene/Protein	TATA motif,204,214,Gene/Protein	elk - 1,232,239,Gene/Protein	"[{""token"": ""DNA fragments"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""TATA element"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""DNase I - hypersensitive chromatin site"", ""start_span"": 93, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""HS 1"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""TATA motif"", ""start_span"": 204, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""elk - 1"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Treatment of T lymphocytes with IFN - alpha, IL - 2, IL - 12, and IL - 15 upregulated IL - 2Ralpha, c - myc, and pim - 1 gene expression.	IFN - alpha,32,43,Gene/Protein	IL - 2,45,51,Gene/Protein	IL - 12,53,60,Gene/Protein	IL - 15,66,73,Gene/Protein	IL - 2Ralpha,86,98,Gene/Protein	c - myc,100,107,Gene/Protein	pim - 1 gene,113,125,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2Ralpha"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""pim - 1 gene"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
Interestingly, Nmi lacks an intrinsic transcriptional activation domain; instead, Nmi enhances the association of CBP / p300 coactivator proteins with Stat1 and Stat5, and together with CBP / p300 can augment IL - 2 - and IFNgamma - dependent transcription.	Nmi,15,18,Gene/Protein	transcriptional activation domain,38,71,Gene/Protein	Nmi,82,85,Gene/Protein	CBP / p300 coactivator proteins,114,145,Gene/Protein	Stat1,151,156,Gene/Protein	Stat5,161,166,Gene/Protein	CBP / p300,186,196,Gene/Protein	"[{""token"": ""Nmi"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activation domain"", ""start_span"": 38, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Nmi"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300 coactivator proteins"", ""start_span"": 114, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""CBP / p300"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
These include Fc epsilonRII ( CD23), 15 - lipoxygenase, IL - 1 receptor antagonist ( IL - 1ra), and type I and type II IL - 1 receptors ( IL - 1R).	Fc epsilonRII,14,27,Gene/Protein	CD23,30,34,Gene/Protein	15 - lipoxygenase,37,54,Gene/Protein	IL - 1 receptor antagonist,56,82,Gene/Protein	IL - 1ra,85,93,Gene/Protein	type I and type II IL - 1 receptors,100,135,Gene/Protein	IL - 1R,138,145,Gene/Protein	"[{""token"": ""Fc epsilonRII"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""CD23"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""15 - lipoxygenase"", ""start_span"": 37, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor antagonist"", ""start_span"": 56, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1ra"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""type I and type II IL - 1 receptors"", ""start_span"": 100, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1R"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
However, suppression of IL - 1R gene expression by IFN - gamma and IL - 10 was associated with decreased tyrosine phosphorylation and nuclear translocation of the IL - 4 / IL - 13 - inducible transcription factor, Stat6, suggesting a potential mechanism by which IFN - gamma and IL - 10 may mediate their suppressive effects.	IL - 1R gene,24,36,Gene/Protein	IFN - gamma,51,62,Gene/Protein	IL - 10,67,74,Gene/Protein	IL - 4 / IL - 13 - inducible transcription factor,163,212,Gene/Protein	Stat6,214,219,Gene/Protein	IFN - gamma,263,274,Gene/Protein	IL - 10,279,286,Gene/Protein	"[{""token"": ""IL - 1R gene"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 / IL - 13 - inducible transcription factor"", ""start_span"": 163, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 214, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 263, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 279, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
In UCSD - AML1, we have also identified fusion transcripts between the ecotropic viral insertion site I ( EVI1) gene in 3q26 and GR6 and between EVI1 and Ribophorin I that maps 30 kb telomeric to GR6 in 3q21.	fusion transcripts,40,58,Gene/Protein	3q26,120,124,Gene/Protein	GR6,129,132,Gene/Protein	EVI1,145,149,Gene/Protein	Ribophorin I,154,166,Gene/Protein	GR6,196,199,Gene/Protein	3q21,203,207,Gene/Protein	"[{""token"": ""fusion transcripts"", ""start_span"": 40, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""3q26"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""GR6"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""EVI1"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""Ribophorin I"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""GR6"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""3q21"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
All fusions splice the 5 ' ends of the 3q21 genes into exon 2 of the EVI1 gene, an event that is similar to the normal intergenic splicing of MDS1 - EVI1 and to those previously documented in leukemias with t ( 3; 21) and t ( 3; 12), in which acute myelogenous leukemia 1 - EVI1 fusions and ETV6 - EVI1 fusions, respectively, occur.	5 ' ends,23,31,Gene/Protein	3q21 genes,39,49,Gene/Protein	exon 2,55,61,Gene/Protein	EVI1,69,73,Gene/Protein	MDS1 - EVI1,142,153,Gene/Protein	myelogenous leukemia 1 - EVI1 fusions,249,286,Gene/Protein	ETV6 - EVI1 fusions,291,310,Gene/Protein	"[{""token"": ""5 ' ends"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""3q21 genes"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""exon 2"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""EVI1"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""MDS1 - EVI1"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""myelogenous leukemia 1 - EVI1 fusions"", ""start_span"": 249, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""ETV6 - EVI1 fusions"", ""start_span"": 291, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
Recently, we demonstrated that the DSE are also cAMP - responsive elements ( CRE), since they mediated activation signals elicited by cholera toxin ( Ctx), a potent activator of the cAMP - dependent protein kinase A ( PKA) signal transduction pathway.	DSE,35,38,Gene/Protein	cAMP - responsive elements,48,74,Gene/Protein	CRE,77,80,Gene/Protein	cholera toxin,134,147,Gene/Protein	Ctx,150,153,Gene/Protein	protein kinase A,199,215,Gene/Protein	PKA,218,221,Gene/Protein	"[{""token"": ""DSE"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - responsive elements"", ""start_span"": 48, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""cholera toxin"", ""start_span"": 134, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Ctx"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 199, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
We describe here a heterodimeric binding complex of NF - kappaB subunits ( c - Rel and p65) which is identical to the one obtained using the HIV - LTR - kappaB site as recognition sequence and different from the one ( c - Rel and p50) observed with nuclear extracts from Mo T - lymphoid HTLV - II infected cells.	heterodimeric binding complex,19,48,Gene/Protein	NF - kappaB subunits,52,72,Gene/Protein	c - Rel,75,82,Gene/Protein	p65,87,90,Gene/Protein	HIV - LTR - kappaB site,141,164,Gene/Protein	c - Rel,218,225,Gene/Protein	p50,230,233,Gene/Protein	"[{""token"": ""heterodimeric binding complex"", ""start_span"": 19, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 52, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""HIV - LTR - kappaB site"", ""start_span"": 141, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 230, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
Further, Vpr suppresses expression of IL - 2, IL - 10, IL - 12, TNF alpha and IL - 4, all of which are NF - kappa B - dependent.	Vpr,9,12,Gene/Protein	IL - 2,38,44,Gene/Protein	IL - 10,46,53,Gene/Protein	IL - 12,55,62,Gene/Protein	TNF alpha,64,73,Gene/Protein	IL - 4,78,84,Gene/Protein	NF - kappa B,103,115,Gene/Protein	"[{""token"": ""Vpr"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	train
AIDS - C patients showed low IL - 2 and high IL - 4, IL - 10, and IgE concentratios; conversely, AIDS - GR patients showed high IL - 2 and low IL - 4 and IgE concentrations.	IL - 2,29,35,Gene/Protein	IL - 4,45,51,Gene/Protein	IL - 10,53,60,Gene/Protein	IgE,66,69,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 4,143,149,Gene/Protein	IgE,154,157,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Anti - intercellular adhesion molecule - 1 ( ICAM - 1) and anti - P - selectin antibodies ( monoclonal antibodies [ mAbs]) attenuated phase - 1 neutrophil adhesion, consistent with roles for constitutively expressed ICAM - 1 and enhanced surface expression of preformed P - selectin.	Anti - intercellular adhesion molecule - 1,0,42,Gene/Protein	ICAM - 1,45,53,Gene/Protein	anti - P - selectin antibodies,59,89,Gene/Protein	monoclonal antibodies,92,113,Gene/Protein	mAbs,116,120,Gene/Protein	ICAM - 1,216,224,Gene/Protein	P - selectin,270,282,Gene/Protein	"[{""token"": ""Anti - intercellular adhesion molecule - 1"", ""start_span"": 0, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""anti - P - selectin antibodies"", ""start_span"": 59, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibodies"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""mAbs"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""P - selectin"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	train
Such genes disclose a common element within their promoters, defined Interferon Stimulated Response Element ( ISRE), which binds a nuclear factor ( s) translocated from the cytoplasm to the nucleus ( ISGF3) after the binding of interferon ( IFN) to the specific receptor.	promoters,50,59,Gene/Protein	Interferon Stimulated Response Element,69,107,Gene/Protein	ISRE,110,114,Gene/Protein	nuclear factor,131,145,Gene/Protein	ISGF3,200,205,Gene/Protein	interferon,228,238,Gene/Protein	IFN,241,244,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Interferon Stimulated Response Element"", ""start_span"": 69, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""ISRE"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""ISGF3"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 228, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
We have previously identified new binding sites for transcription factors downstream of the transcription start site ( nt 465 to 720): three AP - 1 sites ( I, II, and III), an AP3 - like motif ( AP3 - L), a downstream binding factor ( DBF) site, and juxtaposed Sp1 sites.	transcription factors,52,73,Gene/Protein	transcription start site,92,116,Gene/Protein	nt 465 to 720,119,132,Gene/Protein	AP - 1 sites,141,153,Gene/Protein	AP3 - like motif,176,192,Gene/Protein	AP3 - L,195,202,Gene/Protein	juxtaposed Sp1 sites,250,270,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 52, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 92, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""nt 465 to 720"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sites"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - like motif"", ""start_span"": 176, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""juxtaposed Sp1 sites"", ""start_span"": 250, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Virus production occurred with slightly delayed kinetics for viruses containing combined mutations in the AP - 1 ( III), AP3 - L, and DBF sites and in the AP3 - L and DBF - sites, whereas viruses mutated in the AP - 1 ( I, II, III) and AP3 - L sites and in the AP - 1 ( I, II, III), AP3 - L, and DBF sites exhibited a severely defective replicative phenotype.	AP3 - L,121,128,Gene/Protein	DBF sites,134,143,Gene/Protein	AP3 - L,155,162,Gene/Protein	DBF - sites,167,178,Gene/Protein	AP3 - L sites,236,249,Gene/Protein	AP3 - L,283,290,Gene/Protein	DBF sites,296,305,Gene/Protein	"[{""token"": ""AP3 - L"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""DBF sites"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""DBF - sites"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L sites"", ""start_span"": 236, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""AP3 - L"", ""start_span"": 283, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""DBF sites"", ""start_span"": 296, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
Both Sp1 and Sp3 bound to the 5 ' portion of this region, whereas a PMA - inducible factor ( PIF) mainly bound to its 3 ' portion and bound to the Sp binding motifs as well.	Sp1,5,8,Gene/Protein	Sp3,13,16,Gene/Protein	5 ' portion,30,41,Gene/Protein	PMA - inducible factor,68,90,Gene/Protein	PIF,93,96,Gene/Protein	3 ' portion,118,129,Gene/Protein	Sp binding motifs,147,164,Gene/Protein	"[{""token"": ""Sp1"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""Sp3"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""5 ' portion"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""PMA - inducible factor"", ""start_span"": 68, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""PIF"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""3 ' portion"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""Sp binding motifs"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
This pattern of STAT protein phosphorylation is identical to IL - 10 receptor activation on normal cells and similar to IFN - alpha ( STAT1 and STAT3) and IFN - gamma ( STAT1) receptor activation in CLL.	STAT protein,16,28,Gene/Protein	IL - 10 receptor,61,77,Gene/Protein	IFN - alpha,120,131,Gene/Protein	STAT1,134,139,Gene/Protein	STAT3,144,149,Gene/Protein	IFN - gamma,155,166,Gene/Protein	STAT1,169,174,Gene/Protein	"[{""token"": ""STAT protein"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 receptor"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
During myelopoiesis, which includes the development of granulocytic and monocytic lineages, transcription factors from several families are active, including AML1 / CBF beta, C / EBP, Ets, c - Myb, HOX, and MZF - 1.	transcription factors,92,113,Gene/Protein	AML1 / CBF beta,158,173,Gene/Protein	C / EBP,175,182,Gene/Protein	Ets,184,187,Gene/Protein	c - Myb,189,196,Gene/Protein	HOX,198,201,Gene/Protein	MZF - 1,207,214,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""AML1 / CBF beta"", ""start_span"": 158, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""c - Myb"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""HOX"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""MZF - 1"", ""start_span"": 207, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
In DNA - protein binding studies, we detected the binding of transcription factors GABP alpha and - beta to a dyad symmetry element ( DSE) of the distal enhancer, which is formed by palindromic binding sites of Ets - like factors.	transcription factors,61,82,Gene/Protein	GABP alpha and - beta,83,104,Gene/Protein	dyad symmetry element,110,131,Gene/Protein	DSE,134,137,Gene/Protein	distal enhancer,146,161,Gene/Protein	palindromic binding sites,182,207,Gene/Protein	Ets - like factors,211,229,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 61, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""GABP alpha and - beta"", ""start_span"": 83, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""dyad symmetry element"", ""start_span"": 110, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""DSE"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""distal enhancer"", ""start_span"": 146, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""palindromic binding sites"", ""start_span"": 182, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""Ets - like factors"", ""start_span"": 211, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
However, IL - 10 did not affect IFN - gamma - induced tyrosine phosphorylation of STAT - 1alpha or alter STAT - 1alpha binding to the IFN - gamma response element ( IRE) in the ICAM - 1 promoter.	IL - 10,9,16,Gene/Protein	IFN - gamma,32,43,Gene/Protein	STAT - 1alpha,82,95,Gene/Protein	STAT - 1alpha,105,118,Gene/Protein	IFN - gamma response element,134,162,Gene/Protein	IRE,165,168,Gene/Protein	ICAM - 1 promoter,177,194,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 1alpha"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 1alpha"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma response element"", ""start_span"": 134, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""IRE"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 177, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
The core of the promoter ( positions - 42 to + 11) is recognized by the lymphoid cell - specific transcription factors Ets - 1, LEF1, and AML1 as well as by CREB / ATF - 1, as is demonstrated in gel shift and footprinting experiments.	promoter,16,24,Gene/Protein	positions - 42 to + 11,27,49,Gene/Protein	lymphoid cell - specific transcription factors,72,118,Gene/Protein	Ets - 1,119,126,Gene/Protein	LEF1,128,132,Gene/Protein	AML1,138,142,Gene/Protein	CREB / ATF - 1,157,171,Gene/Protein	"[{""token"": ""promoter"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""positions - 42 to + 11"", ""start_span"": 27, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""lymphoid cell - specific transcription factors"", ""start_span"": 72, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""LEF1"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""AML1"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF - 1"", ""start_span"": 157, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
The IL - 4 receptor ( IL - 4R) in B cells is composed of two chains, the IL - 4 - binding IL - 4Ralpha chain, which is shared with the IL - 13R, and the IL - 2Rgamma ( gammac) chain, which is shared with IL - 7R, IL - 9R, and IL - 15R.	IL - 4 receptor,4,19,Gene/Protein	IL - 4R,22,29,Gene/Protein	IL - 4 - binding IL - 4Ralpha chain,73,108,Gene/Protein	IL - 13R,135,143,Gene/Protein	IL - 7R,204,211,Gene/Protein	IL - 9R,213,220,Gene/Protein	IL - 15R,226,234,Gene/Protein	"[{""token"": ""IL - 4 receptor"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - binding IL - 4Ralpha chain"", ""start_span"": 73, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7R"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9R"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15R"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
CsA neither inhibits the processing of the NF - kappa B1 precursor p105 to p50, nor does it ` ` stabilize ' ' the C - terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.	NF - kappa B1 precursor,43,66,Gene/Protein	p105,67,71,Gene/Protein	p50,75,78,Gene/Protein	p105,138,142,Gene/Protein	I kappa B gamma,144,159,Gene/Protein	p105,186,190,Gene/Protein	mature p50,205,215,Gene/Protein	"[{""token"": ""NF - kappa B1 precursor"", ""start_span"": 43, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""mature p50"", ""start_span"": 205, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Whereas T cells from young subjects stimulated with cross - linked anti - CD3epsilon mAb OKT3 plus PMA or with the lectin PHA plus PMA demonstrated considerable increases in c - Fos protein expression, the expression of c - Fos but not c - Jun was markedly reduced in stimulated T cells from certain elderly subjects.	cross - linked anti - CD3epsilon mAb,52,88,Gene/Protein	OKT3,89,93,Gene/Protein	lectin,115,121,Gene/Protein	PHA,122,125,Gene/Protein	c - Fos,174,181,Gene/Protein	c - Fos,220,227,Gene/Protein	c - Jun,236,243,Gene/Protein	"[{""token"": ""cross - linked anti - CD3epsilon mAb"", ""start_span"": 52, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""OKT3"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""lectin"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 220, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
Total mRNA was extracted from T cells, and using RT - PCR, changes in the production of IL - 2 and RA receptors ( RAR) - alpha, beta, gamma mRNA were determined.	mRNA,6,10,Gene/Protein	IL - 2,88,94,Gene/Protein	RA receptors,99,111,Gene/Protein	RAR,114,117,Gene/Protein	alpha,121,126,Gene/Protein	beta,128,132,Gene/Protein	gamma mRNA,134,144,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""RA receptors"", ""start_span"": 99, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""alpha"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""beta"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""gamma mRNA"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
ALY is a ubiquitously expressed, nuclear protein that specifically associates with the activation domains of LEF - 1 and AML - 1 ( CBF alpha2, PEBP2 alpha ( B), which is another protein component of the TCR alpha enhancer complex.	ALY,0,3,Gene/Protein	activation domains,87,105,Gene/Protein	LEF - 1,109,116,Gene/Protein	AML - 1,121,128,Gene/Protein	CBF alpha2,131,141,Gene/Protein	PEBP2 alpha,143,154,Gene/Protein	TCR alpha enhancer complex,203,229,Gene/Protein	"[{""token"": ""ALY"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""activation domains"", ""start_span"": 87, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""AML - 1"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""CBF alpha2"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""TCR alpha enhancer complex"", ""start_span"": 203, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Functional studies showed a 2. 5 - fold increase in promoter activity when this 19 - bp binding site was deleted in the reporter constructs IL - 1beta / CAT and IL - 1beta / SV40 promoter / CAT.	19 - bp binding site,80,100,Gene/Protein	reporter constructs,120,139,Gene/Protein	IL - 1beta,140,150,Gene/Protein	/ CAT,151,156,Gene/Protein	IL - 1beta,161,171,Gene/Protein	/ SV40 promoter,172,187,Gene/Protein	/ CAT,188,193,Gene/Protein	"[{""token"": ""19 - bp binding site"", ""start_span"": 80, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""reporter constructs"", ""start_span"": 120, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""/ CAT"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""/ SV40 promoter"", ""start_span"": 172, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""/ CAT"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
This identification, initially made by microsequence analysis, was verified by showing that ( i) LR1 - DNA binding activity increased in B cells transfected with a nucleolin cDNA expression construct; ( ii) LR1 - DNA binding activity was recognized by antibodies raised against recombinant human nucleolin; and ( iii) in B cells transfected with epitope - tagged nucleolin expression constructs, the LR1 - DNA complex was recognized by the anti - tag antibody.	LR1,97,100,Gene/Protein	nucleolin cDNA expression construct,164,199,Gene/Protein	LR1,207,210,Gene/Protein	recombinant human nucleolin,278,305,Gene/Protein	epitope - tagged nucleolin expression constructs,346,394,Gene/Protein	LR1 - DNA complex,400,417,Gene/Protein	anti - tag antibody,440,459,Gene/Protein	"[{""token"": ""LR1"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin cDNA expression construct"", ""start_span"": 164, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""LR1"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""recombinant human nucleolin"", ""start_span"": 278, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""epitope - tagged nucleolin expression constructs"", ""start_span"": 346, ""end_span"": 394, ""type"": ""Gene/Protein""}, {""token"": ""LR1 - DNA complex"", ""start_span"": 400, ""end_span"": 417, ""type"": ""Gene/Protein""}, {""token"": ""anti - tag antibody"", ""start_span"": 440, ""end_span"": 459, ""type"": ""Gene/Protein""}]"	train
Phosphoinositide 3 - kinase ( PI 3 - kinase) is activated by a diverse set of receptors that determine T - cell function, including the T - cell antigen receptor ( TCR), the costimulatory receptor CD28, and negative regulators of T - cell activation such as CTLA - 4.	Phosphoinositide 3 - kinase,0,27,Gene/Protein	PI 3 - kinase,30,43,Gene/Protein	T - cell antigen receptor,136,161,Gene/Protein	TCR,164,167,Gene/Protein	costimulatory receptor CD28,174,201,Gene/Protein	negative regulators,207,226,Gene/Protein	CTLA - 4,258,266,Gene/Protein	"[{""token"": ""Phosphoinositide 3 - kinase"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""T - cell antigen receptor"", ""start_span"": 136, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""costimulatory receptor CD28"", ""start_span"": 174, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""negative regulators"", ""start_span"": 207, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 258, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
These effects of PI 3 - kinase were not mediated by previously identified PI 3 - kinase effectors, such as protein kinase B, a positive regulator of PI 3 - kinase, or the GTPase Rac, and are therefore likely to involve a novel, as yet unknown, effector molecule.	PI 3 - kinase,17,30,Gene/Protein	PI 3 - kinase effectors,74,97,Gene/Protein	protein kinase B,107,123,Gene/Protein	positive regulator,127,145,Gene/Protein	PI 3 - kinase,149,162,Gene/Protein	GTPase Rac,171,181,Gene/Protein	effector molecule,244,261,Gene/Protein	"[{""token"": ""PI 3 - kinase"", ""start_span"": 17, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase effectors"", ""start_span"": 74, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase B"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""positive regulator"", ""start_span"": 127, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""GTPase Rac"", ""start_span"": 171, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""effector molecule"", ""start_span"": 244, ""end_span"": 261, ""type"": ""Gene/Protein""}]"	train
Following intracranial inoculation in mice, both VZV gE - HSV ( TK) and VZV IE62 - HSV ( gC) induced an IgG response against VZV gE or VZV IE62.	VZV gE - HSV,49,61,Gene/Protein	TK,64,66,Gene/Protein	VZV IE62 - HSV,72,86,Gene/Protein	gC,89,91,Gene/Protein	IgG,104,107,Gene/Protein	VZV gE,125,131,Gene/Protein	VZV IE62,135,143,Gene/Protein	"[{""token"": ""VZV gE - HSV"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""TK"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""VZV IE62 - HSV"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""gC"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""VZV gE"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""VZV IE62"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
We have developed a novel assay to monitor the active, GTP - bound form of Rap1 based on the differential affinity of Rap1GTP and Rap1GDP for the Rap binding domain of RalGDS ( RBD).	GTP - bound form,55,71,Gene/Protein	Rap1,75,79,Gene/Protein	Rap1GTP,118,125,Gene/Protein	Rap1GDP,130,137,Gene/Protein	Rap binding domain,146,164,Gene/Protein	RalGDS,168,174,Gene/Protein	RBD,177,180,Gene/Protein	"[{""token"": ""GTP - bound form"", ""start_span"": 55, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Rap1"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Rap1GTP"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Rap1GDP"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Rap binding domain"", ""start_span"": 146, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""RalGDS"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""RBD"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
In addition, the Ets - NF - kappaB / NFAT interaction requires the presence of DNA binding sites for both proteins, as it is abolished by the DNA intercalating agents propidium iodide and ethidium bromide and enhanced by the presence of synthetic oligonucleotides containing binding sites for Ets and NF - kappaB proteins.	Ets,17,20,Gene/Protein	NF - kappaB,23,34,Gene/Protein	NFAT,37,41,Gene/Protein	DNA binding sites,79,96,Gene/Protein	binding sites,275,288,Gene/Protein	Ets,293,296,Gene/Protein	NF - kappaB proteins,301,321,Gene/Protein	"[{""token"": ""Ets"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding sites"", ""start_span"": 79, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 275, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 293, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB proteins"", ""start_span"": 301, ""end_span"": 321, ""type"": ""Gene/Protein""}]"	train
We considered four bZIP transcription factors as candidates for this putative IL - 3 - regulated factor, each of which binds avidly to the DNA consensus sequence recognized by E2A - HLF and is related to the Caenorhabditis elegans CES - 2 ( cell death specification protein) neuron - specific mediator of cell death.	bZIP transcription factors,19,45,Gene/Protein	IL - 3 - regulated factor,78,103,Gene/Protein	DNA consensus sequence,139,161,Gene/Protein	E2A - HLF,176,185,Gene/Protein	Caenorhabditis elegans CES - 2,208,238,Gene/Protein	cell death specification protein,241,273,Gene/Protein	neuron - specific mediator of cell death,275,315,Gene/Protein	"[{""token"": ""bZIP transcription factors"", ""start_span"": 19, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 - regulated factor"", ""start_span"": 78, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""DNA consensus sequence"", ""start_span"": 139, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""Caenorhabditis elegans CES - 2"", ""start_span"": 208, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""cell death specification protein"", ""start_span"": 241, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""neuron - specific mediator of cell death"", ""start_span"": 275, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
By using a reverse transcription - PCR - based approach and a set of primers specific for the DNA - binding domains of highly homologous members of the C / EBP family of transcriptional regulators, we have cloned a novel human gene encoding a member of the C / EBP gene family, identified as the human homolog of CRP1, C / EBP - epsilon.	DNA - binding domains,94,115,Gene/Protein	C / EBP family,152,166,Gene/Protein	transcriptional regulators,170,196,Gene/Protein	novel human gene,215,231,Gene/Protein	C / EBP gene family,257,276,Gene/Protein	CRP1,313,317,Gene/Protein	C / EBP - epsilon,319,336,Gene/Protein	"[{""token"": ""DNA - binding domains"", ""start_span"": 94, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP family"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 170, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""novel human gene"", ""start_span"": 215, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP gene family"", ""start_span"": 257, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""CRP1"", ""start_span"": 313, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 319, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	train
CD4 + T cells costimulated with the A6H mAb upregulated CD80, CD86, CD71, interleukin - 2 ( IL - 2) R alpha, IL - 2R beta and IL - 2R gamma, while no corresponding up - regulation of these cell surface molecules was seen in CD8 + T cells.	A6H mAb,36,43,Gene/Protein	CD80,56,60,Gene/Protein	CD86,62,66,Gene/Protein	CD71,68,72,Gene/Protein	IL - 2R beta,109,121,Gene/Protein	IL - 2R gamma,126,139,Gene/Protein	cell surface molecules,189,211,Gene/Protein	"[{""token"": ""A6H mAb"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""CD71"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 109, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""cell surface molecules"", ""start_span"": 189, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Using electrophoretic mobility shift analysis we demonstrated that the promoter region spanning base pairs - 1 to - 275, which contains several putative binding sites for transcription factors, is bound by nuclear factors Sp1 and IRBP but not by C / EBPs.	promoter region,71,86,Gene/Protein	base pairs - 1 to - 275,96,119,Gene/Protein	transcription factors,171,192,Gene/Protein	nuclear factors,206,221,Gene/Protein	Sp1,222,225,Gene/Protein	IRBP,230,234,Gene/Protein	C / EBPs,246,254,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""base pairs - 1 to - 275"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 171, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""IRBP"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""C / EBPs"", ""start_span"": 246, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Activation of T lymphocytes by Ags or cytokines results in translocation of the transcription factors NF - kappa B, AP - 1, NFAT, and STAT from the cytoplasm into the nucleus.	Ags,31,34,Gene/Protein	cytokines,38,47,Gene/Protein	transcription factors,80,101,Gene/Protein	NF - kappa B,102,114,Gene/Protein	AP - 1,116,122,Gene/Protein	NFAT,124,128,Gene/Protein	STAT,134,138,Gene/Protein	"[{""token"": ""Ags"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Besides ligand - induced receptor heterodimerization and contacts of the two IL - 4 receptor subunits alpha and gamma with Janus kinases JAK1 and JAK3 a prominent constitutive binding between JAK1 and signal transducer and activator of transcription STAT5 was detected.	IL - 4 receptor subunits alpha and gamma,77,117,Gene/Protein	Janus kinases,123,136,Gene/Protein	JAK1,137,141,Gene/Protein	JAK3,146,150,Gene/Protein	JAK1,192,196,Gene/Protein	signal transducer and activator of transcription,201,249,Gene/Protein	STAT5,250,255,Gene/Protein	"[{""token"": ""IL - 4 receptor subunits alpha and gamma"", ""start_span"": 77, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription"", ""start_span"": 201, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 250, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
The effect of both cytokines on the monocyte maturation / differentiation ( CD11b, CD13, and CD26) and other macrophage markers ( CD14 and CD68) was examined.	cytokines,19,28,Gene/Protein	CD11b,76,81,Gene/Protein	CD13,83,87,Gene/Protein	CD26,93,97,Gene/Protein	macrophage markers,109,127,Gene/Protein	CD14,130,134,Gene/Protein	CD68,139,143,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CD13"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CD26"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""macrophage markers"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
The 5 ' - UTR contains binding sites for the transcription factors AP - 1, NF - kappaB, NF - AT, IRF, and Sp1.	5 ' - UTR,4,13,Gene/Protein	binding sites,23,36,Gene/Protein	transcription factors,45,66,Gene/Protein	NF - kappaB,75,86,Gene/Protein	NF - AT,88,95,Gene/Protein	IRF,97,100,Gene/Protein	Sp1,106,109,Gene/Protein	"[{""token"": ""5 ' - UTR"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IRF"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
Expression of an active form of Ras, Ras ( G12V), suppressed the IL - 2 - induced beta - casein and OSM gene expression, and the negative effect of Ras is mediated by the region between - 105 and - 193 in the beta - casein promoter.	Ras,32,35,Gene/Protein	IL - 2,65,71,Gene/Protein	beta - casein,82,95,Gene/Protein	OSM,100,103,Gene/Protein	Ras,148,151,Gene/Protein	- 105 and - 193,186,201,Gene/Protein	beta - casein promoter,209,231,Gene/Protein	"[{""token"": ""Ras"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""OSM"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""- 105 and - 193"", ""start_span"": 186, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein promoter"", ""start_span"": 209, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Engagement of any of these receptors induces the rapid tyrosine phosphorylation of a shared group of intracellular signaling proteins, including Vav, Cbl, p85 phosphoinositide 3 - kinase, and the Src family kinases Lck and Fyn.	intracellular signaling proteins,101,133,Gene/Protein	Vav,145,148,Gene/Protein	Cbl,150,153,Gene/Protein	p85 phosphoinositide 3 - kinase,155,186,Gene/Protein	Src family kinases,196,214,Gene/Protein	Lck,215,218,Gene/Protein	Fyn,223,226,Gene/Protein	"[{""token"": ""intracellular signaling proteins"", ""start_span"": 101, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""p85 phosphoinositide 3 - kinase"", ""start_span"": 155, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""Src family kinases"", ""start_span"": 196, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""Lck"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""Fyn"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
In contrast, expression of dominant negative mutants of Ras and Raf - 1, in these cells, did not have any effect on FcR - mediated nuclear factor activation, suggesting that the mitogen - activated protein kinase ( MAPK) signaling pathway was not used by these receptors.	dominant negative mutants,27,52,Gene/Protein	Ras,56,59,Gene/Protein	Raf - 1,64,71,Gene/Protein	FcR,116,119,Gene/Protein	nuclear factor,131,145,Gene/Protein	mitogen - activated protein kinase,178,212,Gene/Protein	MAPK,215,219,Gene/Protein	"[{""token"": ""dominant negative mutants"", ""start_span"": 27, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""FcR"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 178, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Hepatocytes achieve an efficient hormonal control of this promoter through a functional interaction between the estrogen responsive elements and a promoter proximal region upstream of the TATA box, which is characterized by a high density of binding sites for the transcription factors CTF / NF - 1, C / EBP and HNF3.	estrogen responsive elements,112,140,Gene/Protein	promoter proximal region,147,171,Gene/Protein	TATA box,188,196,Gene/Protein	transcription factors,264,285,Gene/Protein	CTF / NF - 1,286,298,Gene/Protein	C / EBP,300,307,Gene/Protein	HNF3,312,316,Gene/Protein	"[{""token"": ""estrogen responsive elements"", ""start_span"": 112, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""promoter proximal region"", ""start_span"": 147, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 264, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""CTF / NF - 1"", ""start_span"": 286, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""HNF3"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Gene/Protein""}]"	train
Cytokines, IL - 2, IL - 4, IL - 6, IL - 7, IL - 12, and IL - 15 are key regulators of human peripheral blood T and NK cell activation and differentiation but the precise mechanisms that give rise to their differential activities within these cells are not clear.	Cytokines,0,9,Gene/Protein	IL - 2,11,17,Gene/Protein	IL - 4,19,25,Gene/Protein	IL - 6,27,33,Gene/Protein	IL - 7,35,41,Gene/Protein	IL - 12,43,50,Gene/Protein	IL - 15,56,63,Gene/Protein	"[{""token"": ""Cytokines"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}]"	train
Interestingly, tg epsilon26 thymocytes expressed GATA - 3 and TCF - 1, but not LEF - 1 and PEBP - 2alpha, among T cell - specific transcription factors that are involved in early T cell development, indicating that GATA - 3 and TCF - 1 expressed during thymocyte development do not necessarily determine the cell fate into T cell lineage.	GATA - 3,49,57,Gene/Protein	TCF - 1,62,69,Gene/Protein	LEF - 1,79,86,Gene/Protein	PEBP - 2alpha,91,104,Gene/Protein	T cell - specific transcription factors,112,151,Gene/Protein	GATA - 3,215,223,Gene/Protein	TCF - 1,228,235,Gene/Protein	"[{""token"": ""GATA - 3"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PEBP - 2alpha"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific transcription factors"", ""start_span"": 112, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 215, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
However, transactivation of the CD4 promoter by ORFs U86 and U89 is independent of the CRE element, suggesting that additional HHV - 6 ORFs are likely to contribute to CD4 gene activation.	CD4 promoter,32,44,Gene/Protein	ORFs,48,52,Gene/Protein	U86,53,56,Gene/Protein	U89,61,64,Gene/Protein	CRE element,87,98,Gene/Protein	HHV - 6 ORFs,127,139,Gene/Protein	CD4 gene,168,176,Gene/Protein	"[{""token"": ""CD4 promoter"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""U86"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""U89"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CRE element"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""HHV - 6 ORFs"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CD4 gene"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
To circumvent this problem, we developed an alternative procedure which allowed us to show that in neutrophils, LPS and TNFalpha induce a NF - kappaB DNA - binding activity which essentially consists of p50 / RelA dimers, and that IFNgamma promotes the binding of STAT1 homodimers to the IFNgamma response region of the FcgammaRI promoter.	TNFalpha,120,128,Gene/Protein	NF - kappaB,138,149,Gene/Protein	p50 / RelA dimers,203,220,Gene/Protein	IFNgamma,231,239,Gene/Protein	STAT1 homodimers,264,280,Gene/Protein	IFNgamma response region,288,312,Gene/Protein	FcgammaRI promoter,320,338,Gene/Protein	"[{""token"": ""TNFalpha"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""p50 / RelA dimers"", ""start_span"": 203, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 homodimers"", ""start_span"": 264, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma response region"", ""start_span"": 288, ""end_span"": 312, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI promoter"", ""start_span"": 320, ""end_span"": 338, ""type"": ""Gene/Protein""}]"	train
The results suggest that the IL - 4RE of the IL - 4 - inducible gene can accommodate both IL - 4 - and IFN - gamma - activated factors, such as STAT 6 and STAT 1, either in homodimeric or heterodimeric forms and the binding of these different proteins to the respective promoter may play a potential regulatory role in the IL - 4 - inducible gene expression.	IL - 4RE,29,37,Gene/Protein	IL - 4 - inducible gene,45,68,Gene/Protein	IL - 4 - and IFN - gamma - activated factors,90,134,Gene/Protein	STAT 6,144,150,Gene/Protein	STAT 1,155,161,Gene/Protein	homodimeric or heterodimeric forms,173,207,Gene/Protein	IL - 4,323,329,Gene/Protein	"[{""token"": ""IL - 4RE"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - inducible gene"", ""start_span"": 45, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 - and IFN - gamma - activated factors"", ""start_span"": 90, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""STAT 6"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""STAT 1"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""homodimeric or heterodimeric forms"", ""start_span"": 173, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 323, ""end_span"": 329, ""type"": ""Gene/Protein""}]"	train
We have previously shown that NFAT is targeted to inactive calcineurin at a region distinct from the calcineurin active site ( Aramburu, J., Garcia - Cozar, F. J., Raghavan, A., Okamura, H., Rao, A., and Hogan, P. G. ( 1998) Mol. Cell 1, 627 - 637); this region is also involved in NFAT binding to activated calcineurin, since binding is inhibited by an NFAT peptide spanning the calcineurin docking site on NFAT.	NFAT,30,34,Gene/Protein	calcineurin,59,70,Gene/Protein	calcineurin active site,101,124,Gene/Protein	NFAT,282,286,Gene/Protein	calcineurin,308,319,Gene/Protein	calcineurin,380,391,Gene/Protein	NFAT,408,412,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin active site"", ""start_span"": 101, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 282, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 308, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 380, ""end_span"": 391, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 408, ""end_span"": 412, ""type"": ""Gene/Protein""}]"	train
NFAT binding to the calcineurin catalytic domain was inhibited by the calcineurin autoinhibitory domain and the RII substrate peptide, which bind in the calcineurin active site, as well as by the NFAT docking site peptide, which binds to a region of calcineurin distinct from the active site.	NFAT,0,4,Gene/Protein	calcineurin catalytic domain,20,48,Gene/Protein	calcineurin autoinhibitory domain,70,103,Gene/Protein	calcineurin active site,153,176,Gene/Protein	NFAT,196,200,Gene/Protein	calcineurin,250,261,Gene/Protein	active site,280,291,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin catalytic domain"", ""start_span"": 20, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin autoinhibitory domain"", ""start_span"": 70, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin active site"", ""start_span"": 153, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 250, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""active site"", ""start_span"": 280, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Similarly, a kinase - deficient mutant of NIK ( NF - kappaB - inducing kinase), which represents an upstream kinase in the TNF - alpha and IL - 1 signaling pathways leading to IKKalpha and IKKbeta activation, blocks Tax induction of NF - kappaB.	kinase - deficient mutant,13,38,Gene/Protein	NIK,42,45,Gene/Protein	NF - kappaB - inducing kinase,48,77,Gene/Protein	IKKalpha,176,184,Gene/Protein	IKKbeta,189,196,Gene/Protein	Tax,216,219,Gene/Protein	NF - kappaB,233,244,Gene/Protein	"[{""token"": ""kinase - deficient mutant"", ""start_span"": 13, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - inducing kinase"", ""start_span"": 48, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 233, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
Additionally, to determine the impact of RXR for erythroid cell development, dominant interfering mutant RXRs, lacking the transcriptional activator functions AF - 1 and AF - 2, or AF - 2 only, or the entire DNA - binding domain, were introduced into erythroid progenitor cells via recombinant retrovirus vectors and analyzed for RXR - specific effects.	RXR,41,44,Gene/Protein	mutant RXRs,98,109,Gene/Protein	AF - 1,159,165,Gene/Protein	AF - 2,170,176,Gene/Protein	AF - 2,181,187,Gene/Protein	entire DNA - binding domain,201,228,Gene/Protein	RXR,330,333,Gene/Protein	"[{""token"": ""RXR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""mutant RXRs"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""AF - 1"", ""start_span"": 159, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""AF - 2"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""AF - 2"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""entire DNA - binding domain"", ""start_span"": 201, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""RXR"", ""start_span"": 330, ""end_span"": 333, ""type"": ""Gene/Protein""}]"	train
Impairments in the translocation of Rel - B and c - Rel further suggest that the NFKB family members Rel - A, Rel - B and c - Rel are not required for the transcription of IL - 2 in the peripheral T lymphocytes of patients with breast cancer.	Rel - B,36,43,Gene/Protein	c - Rel,48,55,Gene/Protein	NFKB family members,81,100,Gene/Protein	Rel - A,101,108,Gene/Protein	Rel - B,110,117,Gene/Protein	c - Rel,122,129,Gene/Protein	IL - 2,172,178,Gene/Protein	"[{""token"": ""Rel - B"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NFKB family members"", ""start_span"": 81, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Rel - A"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Rel - B"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
We demonstrate in this report that overexpression of an activated form of Rho enhances AP - 1 activity in Jurkat T cells in the presence of phorbol myristate acetate ( PMA), but activated Rho ( V14Rho) has little or no effect on NFAT, Oct - 1, and NF - kappaB enhancer element activities under similar conditions.	Rho,74,77,Gene/Protein	AP - 1,87,93,Gene/Protein	Rho,188,191,Gene/Protein	V14Rho,194,200,Gene/Protein	NFAT,229,233,Gene/Protein	Oct - 1,235,242,Gene/Protein	NF - kappaB enhancer element,248,276,Gene/Protein	"[{""token"": ""Rho"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""V14Rho"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 235, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB enhancer element"", ""start_span"": 248, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
To investigate further, we then purified a number of different kinases, including PKC, PhK, ZAP - 70, ERK, and MEK 1 ( a MKK), and showed that Ro 09 - 2210 was a selective inhibitor of MEK1 in vitro ( IC50 = 59 nM).	PKC,82,85,Gene/Protein	PhK,87,90,Gene/Protein	ZAP - 70,92,100,Gene/Protein	ERK,102,105,Gene/Protein	MEK 1,111,116,Gene/Protein	MKK,121,124,Gene/Protein	MEK1,185,189,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PhK"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""MEK 1"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""MKK"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Epstein - Barr virus - transforming protein latent infection membrane protein 1 activates transcription factor NF - kappaB through a pathway that includes the NF - kappaB - inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.	Epstein - Barr virus - transforming protein,0,43,Gene/Protein	latent infection membrane protein 1,44,79,Gene/Protein	transcription factor NF - kappaB,90,122,Gene/Protein	NF - kappaB - inducing kinase,159,188,Gene/Protein	IkappaB kinases,197,212,Gene/Protein	IKKalpha,213,221,Gene/Protein	IKKbeta,226,233,Gene/Protein	"[{""token"": ""Epstein - Barr virus - transforming protein"", ""start_span"": 0, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""latent infection membrane protein 1"", ""start_span"": 44, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappaB"", ""start_span"": 90, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - inducing kinase"", ""start_span"": 159, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB kinases"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus oncoprotein latent infection membrane protein 1 ( LMP1) is a constitutively aggregated pseudo - tumor necrosis factor receptor ( TNFR) that activates transcription factor NF - kappaB through two sites in its C - terminal cytoplasmic domain.	Epstein - Barr virus oncoprotein,4,36,Gene/Protein	latent infection membrane protein 1,37,72,Gene/Protein	LMP1,75,79,Gene/Protein	pseudo - tumor necrosis factor receptor,112,151,Gene/Protein	TNFR,154,158,Gene/Protein	transcription factor NF - kappaB,175,207,Gene/Protein	C - terminal cytoplasmic domain,233,264,Gene/Protein	"[{""token"": ""Epstein - Barr virus oncoprotein"", ""start_span"": 4, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""latent infection membrane protein 1"", ""start_span"": 37, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""pseudo - tumor necrosis factor receptor"", ""start_span"": 112, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TNFR"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappaB"", ""start_span"": 175, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal cytoplasmic domain"", ""start_span"": 233, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
One site is similar to activated TNFRII in associating with TNFR - associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD.	TNFRII,33,39,Gene/Protein	TNFR - associated factors,60,85,Gene/Protein	TRAF1,86,91,Gene/Protein	TRAF2,96,101,Gene/Protein	TNFRI,137,142,Gene/Protein	TNFRI death domain interacting protein,167,205,Gene/Protein	TRADD,206,211,Gene/Protein	"[{""token"": ""TNFRII"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TNFR - associated factors"", ""start_span"": 60, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TRAF1"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""TNFRI"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""TNFRI death domain interacting protein"", ""start_span"": 167, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Recently, many investigators have been interested in the study on eosinophil biology since genes association with eosinophils such as interleukin - 5 or eosinophil granule proteins ( EPO, ECP, EDN, MBP, and CLC), were isolated.	interleukin - 5,134,149,Gene/Protein	eosinophil granule proteins,153,180,Gene/Protein	EPO,183,186,Gene/Protein	ECP,188,191,Gene/Protein	EDN,193,196,Gene/Protein	MBP,198,201,Gene/Protein	CLC,207,210,Gene/Protein	"[{""token"": ""interleukin - 5"", ""start_span"": 134, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil granule proteins"", ""start_span"": 153, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""ECP"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""EDN"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""CLC"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
The mechanism by which eosinophil - specific genes encoding primary and secondary granule proteins ( e. g. ECP, EDN, EPO, MBP, and CLC) are expressed and regulated during eosinophilopoiesis is also unknown.	eosinophil - specific genes,23,50,Gene/Protein	secondary granule proteins,72,98,Gene/Protein	ECP,107,110,Gene/Protein	EDN,112,115,Gene/Protein	EPO,117,120,Gene/Protein	MBP,122,125,Gene/Protein	CLC,131,134,Gene/Protein	"[{""token"": ""eosinophil - specific genes"", ""start_span"": 23, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""secondary granule proteins"", ""start_span"": 72, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""ECP"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""EDN"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CLC"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
To elucidate the roles of individual GATA factors in erythropoiesis, conditional alleles of GATA - 1, GATA - 2, and GATA - 3 were prepared by fusing each of the factors to the hormone - binding domain of the human estrogen receptor ( ER).	GATA factors,37,49,Gene/Protein	GATA - 1,92,100,Gene/Protein	GATA - 2,102,110,Gene/Protein	GATA - 3,116,124,Gene/Protein	hormone - binding domain,176,200,Gene/Protein	human estrogen receptor,208,231,Gene/Protein	ER,234,236,Gene/Protein	"[{""token"": ""GATA factors"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 3"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""hormone - binding domain"", ""start_span"": 176, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""human estrogen receptor"", ""start_span"": 208, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""ER"", ""start_span"": 234, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
The multiple biological activities of tumor necrosis factor ( TNF) are mediated by two distinct cell surface receptors of 55 kd ( TNFRp55) and 75 kd ( TNFRp75).	tumor necrosis factor,38,59,Gene/Protein	TNF,62,65,Gene/Protein	cell surface receptors,96,118,Gene/Protein	55 kd,122,127,Gene/Protein	TNFRp55,130,137,Gene/Protein	75 kd,143,148,Gene/Protein	TNFRp75,151,158,Gene/Protein	"[{""token"": ""tumor necrosis factor"", ""start_span"": 38, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""cell surface receptors"", ""start_span"": 96, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""55 kd"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TNFRp55"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""75 kd"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""TNFRp75"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
We therefore examined the effects of EC on T cell nuclear factors known to regulate IL - 2 transcription, including c - jun and c - fos - two components of the transcription factor AP - 1, NFAT, and others.	T cell nuclear factors,43,65,Gene/Protein	IL - 2,84,90,Gene/Protein	c - jun,116,123,Gene/Protein	c - fos - two components,128,152,Gene/Protein	transcription factor,160,180,Gene/Protein	AP - 1,181,187,Gene/Protein	NFAT,189,193,Gene/Protein	"[{""token"": ""T cell nuclear factors"", ""start_span"": 43, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""c - fos - two components"", ""start_span"": 128, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 160, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
The levels of GATA - 1, Epo - R and globin mRNA expressed were not affected by a 24 - hour incubation of either cell line with Epo, GM - CSF or interleukin - 3 ( IL - 3).	GATA - 1,14,22,Gene/Protein	Epo - R,24,31,Gene/Protein	globin mRNA,36,47,Gene/Protein	Epo,127,130,Gene/Protein	GM - CSF,132,140,Gene/Protein	interleukin - 3,144,159,Gene/Protein	IL - 3,162,168,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Epo - R"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""globin mRNA"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
For further mapping purposes, a fusion promoter was constructed with the granulocyte / macrophage colony - stimulating factor basic promoter containing 60 base pairs of sequence upstream from the cap site of the mouse granulocyte / macrophage colony - stimulating factor gene and various lengths of the 5 ' upstream sequence of the IL - 4 gene.	fusion promoter,32,47,Gene/Protein	granulocyte / macrophage colony - stimulating factor basic promoter,73,140,Gene/Protein	60 base pairs of sequence,152,177,Gene/Protein	cap site,196,204,Gene/Protein	mouse granulocyte / macrophage colony - stimulating factor gene,212,275,Gene/Protein	5 ' upstream sequence,303,324,Gene/Protein	IL - 4 gene,332,343,Gene/Protein	"[{""token"": ""fusion promoter"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte / macrophage colony - stimulating factor basic promoter"", ""start_span"": 73, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""60 base pairs of sequence"", ""start_span"": 152, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""cap site"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""mouse granulocyte / macrophage colony - stimulating factor gene"", ""start_span"": 212, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream sequence"", ""start_span"": 303, ""end_span"": 324, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 332, ""end_span"": 343, ""type"": ""Gene/Protein""}]"	train
The viral trans - activators appear to target specific DNA binding protein such as NF - kB and Sp1 to cis - acting DNA site and promote lymphokine gene expression without TCR - mediated stimulation.	viral trans - activators,4,28,Gene/Protein	DNA binding protein,55,74,Gene/Protein	NF - kB,83,90,Gene/Protein	Sp1,95,98,Gene/Protein	cis - acting DNA site,102,123,Gene/Protein	lymphokine gene,136,151,Gene/Protein	TCR,171,174,Gene/Protein	"[{""token"": ""viral trans - activators"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding protein"", ""start_span"": 55, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting DNA site"", ""start_span"": 102, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine gene"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
In three unrelated Japanese children with combined pituitary hormone deficiency, we identified three point mutations in the Pit - 1 gene, Pro24Leu, Arg143Gln, and Arg271Trp, located on the major transactivation region, POU - specific domain, and POU - homeodomain, respectively.	Pit - 1 gene,124,136,Gene/Protein	Pro24Leu,138,146,Gene/Protein	Arg143Gln,148,157,Gene/Protein	Arg271Trp,163,172,Gene/Protein	major transactivation region,189,217,Gene/Protein	POU - specific domain,219,240,Gene/Protein	POU - homeodomain,246,263,Gene/Protein	"[{""token"": ""Pit - 1 gene"", ""start_span"": 124, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Pro24Leu"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Arg143Gln"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Arg271Trp"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""major transactivation region"", ""start_span"": 189, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""POU - specific domain"", ""start_span"": 219, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""POU - homeodomain"", ""start_span"": 246, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
Here we have therefore examined the effect of the phorbol ester PMA ( phorbol 12 - myristate 13 - acetate) which stimulates PKC and a combination of the adenosine receptor agonist NECA ( 5 ' - ( N - ethyl) - carboxamido adenosine) and forskolin to raise cAMP, on the levels of c - Fos and Jun and on the binding and transcriptional activity of the transcription factor, activator protein - 1 ( AP - 1).	PKC,124,127,Gene/Protein	adenosine receptor,153,171,Gene/Protein	c - Fos,277,284,Gene/Protein	Jun,289,292,Gene/Protein	transcription factor,348,368,Gene/Protein	activator protein - 1,370,391,Gene/Protein	AP - 1,394,400,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""adenosine receptor"", ""start_span"": 153, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 277, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 289, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 348, ""end_span"": 368, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 370, ""end_span"": 391, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 394, ""end_span"": 400, ""type"": ""Gene/Protein""}]"	train
In spite of its association with p50 in vitro, however, we found a lymphoid cell - specific nuclear factor in vivo that contains c - Rel but not p50 epitopes; this factor, termed IL - 6 kappa B binding factor II, appears to contain the c - Rel homodimer and preferentially recognizes several IL - 6 kappa B - related kappa B motifs.	p50,33,36,Gene/Protein	lymphoid cell - specific nuclear factor,67,106,Gene/Protein	c - Rel,129,136,Gene/Protein	p50 epitopes,145,157,Gene/Protein	IL - 6 kappa B binding factor II,179,211,Gene/Protein	c - Rel homodimer,236,253,Gene/Protein	IL - 6 kappa B - related kappa B motifs,292,331,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""lymphoid cell - specific nuclear factor"", ""start_span"": 67, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""p50 epitopes"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 kappa B binding factor II"", ""start_span"": 179, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel homodimer"", ""start_span"": 236, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 kappa B - related kappa B motifs"", ""start_span"": 292, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	train
The recent definition of a consensus DNA binding sequence for the Ets family of transcription factors has allowed the identification of potential Ets binding sites in the promoters and enhancers of many inducible T - cell genes.	DNA binding sequence,37,57,Gene/Protein	Ets family,66,76,Gene/Protein	transcription factors,80,101,Gene/Protein	Ets binding sites,146,163,Gene/Protein	promoters,171,180,Gene/Protein	enhancers,185,194,Gene/Protein	inducible T - cell genes,203,227,Gene/Protein	"[{""token"": ""DNA binding sequence"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Ets family"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Ets binding sites"", ""start_span"": 146, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 185, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""inducible T - cell genes"", ""start_span"": 203, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
In directing the synthesis of RNA through the intervening DNA and the gene by a tracking and transcription mechanism, the HS2 enhancer may ( i) open up the chromatin structure of a gene domain and ( ii) deliver enhancer binding proteins to the promoter sequence where they may stimulate the transcription of the gene at the cap site.	RNA,30,33,Gene/Protein	DNA,58,61,Gene/Protein	HS2 enhancer,122,134,Gene/Protein	chromatin structure,156,175,Gene/Protein	gene domain,181,192,Gene/Protein	enhancer binding proteins,211,236,Gene/Protein	cap site,324,332,Gene/Protein	"[{""token"": ""RNA"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""DNA"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""HS2 enhancer"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""chromatin structure"", ""start_span"": 156, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""gene domain"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""enhancer binding proteins"", ""start_span"": 211, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""cap site"", ""start_span"": 324, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	train
The KBF1 factor, which binds to the enhancer A located in the promoter of the mouse MHC class I gene H - 2Kb, is indistinguishable from the p50 DNA binding subunit of the transcription factor NF - kappa B, which regulates a series of genes involved in immune and inflammatory responses.	KBF1 factor,4,15,Gene/Protein	enhancer A,36,46,Gene/Protein	promoter,62,70,Gene/Protein	mouse MHC class I gene,78,100,Gene/Protein	H - 2Kb,101,108,Gene/Protein	p50 DNA binding subunit,140,163,Gene/Protein	transcription factor NF - kappa B,171,204,Gene/Protein	"[{""token"": ""KBF1 factor"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""enhancer A"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""mouse MHC class I gene"", ""start_span"": 78, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""H - 2Kb"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""p50 DNA binding subunit"", ""start_span"": 140, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NF - kappa B"", ""start_span"": 171, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
Consistent with this result, these cell lines expressed increased levels of mRNAs encoding the AP - 1 proteins, c - Fos, Fra - 1, c - Jun, JunB, and JunD.	mRNAs,76,81,Gene/Protein	AP - 1 proteins,95,110,Gene/Protein	c - Fos,112,119,Gene/Protein	Fra - 1,121,128,Gene/Protein	c - Jun,130,137,Gene/Protein	JunB,139,143,Gene/Protein	JunD,149,153,Gene/Protein	"[{""token"": ""mRNAs"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 proteins"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
These are prominent enzymes in the endocytic pathway through which soluble protein Ag enter APC, and resistant segments in Ag may, therefore, be expected to contain more T - cell determinants than susceptible segments.	enzymes,20,27,Gene/Protein	soluble protein Ag,67,85,Gene/Protein	APC,92,95,Gene/Protein	resistant segments,101,119,Gene/Protein	Ag,123,125,Gene/Protein	T - cell determinants,170,191,Gene/Protein	susceptible segments,197,217,Gene/Protein	"[{""token"": ""enzymes"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""soluble protein Ag"", ""start_span"": 67, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""resistant segments"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Ag"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""T - cell determinants"", ""start_span"": 170, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""susceptible segments"", ""start_span"": 197, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
We have analyzed the functional domains of the minimal Thy - 1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1, an inverted CCAAT box, and sequences proximal to the transcription start site.	minimal Thy - 1 promoter,47,71,Gene/Protein	dominant promoter elements,90,116,Gene/Protein	multiple binding sites,128,150,Gene/Protein	transcription factor,159,179,Gene/Protein	Sp1,180,183,Gene/Protein	CCAAT box,197,206,Gene/Protein	transcription start site,238,262,Gene/Protein	"[{""token"": ""minimal Thy - 1 promoter"", ""start_span"": 47, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""dominant promoter elements"", ""start_span"": 90, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""multiple binding sites"", ""start_span"": 128, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 159, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT box"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""transcription start site"", ""start_span"": 238, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus DR promoter is located upstream of the PstI repeats, and in addition to the TATA box, it contains an upstream region ( positions - 69 to - 220) responsive to EB1 ( Z) ( the BZLF1 - encoded transcription factor) and an enhancer with two functionally distinct domains, A and B.	Epstein - Barr virus DR promoter,4,36,Gene/Protein	PstI repeats,64,76,Gene/Protein	TATA box,101,109,Gene/Protein	upstream region,126,141,Gene/Protein	BZLF1 - encoded transcription factor,198,234,Gene/Protein	enhancer,243,251,Gene/Protein	B,298,299,Gene/Protein	"[{""token"": ""Epstein - Barr virus DR promoter"", ""start_span"": 4, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""PstI repeats"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""upstream region"", ""start_span"": 126, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1 - encoded transcription factor"", ""start_span"": 198, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 243, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 298, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
The expression of transiently transfected expression vectors under the control of the long terminal repeat ( LTR) of the human immunodeficiency virus ( HIV) or its enhancer sequence and the translocation of the HIV enhancer - binding protein NF - kappa B were analyzed in two human T - cell clones stimulated through their T - cell receptor complex or by tumor necrosis factor or phorbol 12 - myristate 13 - acetate.	long terminal repeat,86,106,Gene/Protein	LTR,109,112,Gene/Protein	enhancer sequence,164,181,Gene/Protein	HIV enhancer - binding protein,211,241,Gene/Protein	NF - kappa B,242,254,Gene/Protein	T - cell receptor complex,323,348,Gene/Protein	tumor necrosis factor,355,376,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 86, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""enhancer sequence"", ""start_span"": 164, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer - binding protein"", ""start_span"": 211, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 242, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor complex"", ""start_span"": 323, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 355, ""end_span"": 376, ""type"": ""Gene/Protein""}]"	train
A novel B - cell - specific transcription factor, BSAP, was identified as a mammalian homolog of the sea urchin protein TSAP, which interacts with the promoters of four tissue - specific late histone H2A - 2 and H2B - 2 genes.	B - cell - specific transcription factor,8,48,Gene/Protein	BSAP,50,54,Gene/Protein	mammalian homolog,76,93,Gene/Protein	sea urchin protein,101,119,Gene/Protein	TSAP,120,124,Gene/Protein	promoters,151,160,Gene/Protein	tissue - specific late histone H2A - 2 and H2B - 2 genes,169,225,Gene/Protein	"[{""token"": ""B - cell - specific transcription factor"", ""start_span"": 8, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""mammalian homolog"", ""start_span"": 76, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""sea urchin protein"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""TSAP"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""tissue - specific late histone H2A - 2 and H2B - 2 genes"", ""start_span"": 169, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
From this and other findings the picture emerges that there are at least three categories of factors which mediate cell - type - specific transcription in B lymphocytes: ( a) cell - specific factors such as Oct - 2A and Oct - 2B that are not expressed in most other cell types: ( b) ubiquitous factors such as NF - kappa B that are constitutively active in B cells but are sequestered in an inactive form in other cells; ( c) ubiquitously active factors, exemplified by the one binding to the E3 sequence motif.	cell - specific factors,175,198,Gene/Protein	Oct - 2A,207,215,Gene/Protein	Oct - 2B,220,228,Gene/Protein	ubiquitous factors,283,301,Gene/Protein	NF - kappa B,310,322,Gene/Protein	ubiquitously active factors,426,453,Gene/Protein	E3 sequence motif,493,510,Gene/Protein	"[{""token"": ""cell - specific factors"", ""start_span"": 175, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2B"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous factors"", ""start_span"": 283, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 310, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitously active factors"", ""start_span"": 426, ""end_span"": 453, ""type"": ""Gene/Protein""}, {""token"": ""E3 sequence motif"", ""start_span"": 493, ""end_span"": 510, ""type"": ""Gene/Protein""}]"	train
Previous transfection studies of HIV LTR constructs linked to the chloramphenicol acetyltransferase gene indicated that multiple regulatory regions including the enhancer, SP1, TATA and TAR regions were important for HIV gene expression.	HIV LTR constructs,33,51,Gene/Protein	chloramphenicol acetyltransferase gene,66,104,Gene/Protein	regulatory regions,129,147,Gene/Protein	enhancer,162,170,Gene/Protein	SP1,172,175,Gene/Protein	TATA,177,181,Gene/Protein	TAR regions,186,197,Gene/Protein	"[{""token"": ""HIV LTR constructs"", ""start_span"": 33, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase gene"", ""start_span"": 66, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""regulatory regions"", ""start_span"": 129, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""SP1"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""TATA"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""TAR regions"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
We investigated the regulation of the promoter ( BMRF1) for this early gene by studying its responsiveness in vitro to two immediate - early viral transactivators, BZLF1 ( Z) and BRLF1 ( R), focusing on the differences in response in lymphoid cells and epithelial cells.	promoter,38,46,Gene/Protein	BMRF1,49,54,Gene/Protein	immediate - early viral transactivators,123,162,Gene/Protein	BZLF1,164,169,Gene/Protein	Z,172,173,Gene/Protein	BRLF1,179,184,Gene/Protein	R,187,188,Gene/Protein	"[{""token"": ""promoter"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early viral transactivators"", ""start_span"": 123, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 172, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""BRLF1"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""R"", ""start_span"": 187, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
The changes in the composition of IL - 2Rs were accompanied by inhibition of IL - 2 - induced tyrosine phosphorylation of the Janus protein - tyrosine kinase 3 ( Jak3) and signal transducers and activators of transcription called Stat3 and Stat5.	IL - 2Rs,34,42,Gene/Protein	IL - 2,77,83,Gene/Protein	Janus protein - tyrosine kinase 3,126,159,Gene/Protein	Jak3,162,166,Gene/Protein	signal transducers and activators of transcription,172,222,Gene/Protein	Stat3,230,235,Gene/Protein	Stat5,240,245,Gene/Protein	"[{""token"": ""IL - 2Rs"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Janus protein - tyrosine kinase 3"", ""start_span"": 126, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 172, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Synergistic induction of the IL - 6 gene by IFN - gamma and TNF - alpha, in monocytic cells, involved cooperation between the IRF - 1 and NF kappa B p65 homodimers with concomitant removal of the negative effect of the retinoblastoma control element present in the IL - 6 promoter.	IL - 6 gene,29,40,Gene/Protein	IFN - gamma,44,55,Gene/Protein	TNF - alpha,60,71,Gene/Protein	IRF - 1,126,133,Gene/Protein	NF kappa B p65 homodimers,138,163,Gene/Protein	retinoblastoma control element,219,249,Gene/Protein	IL - 6 promoter,265,280,Gene/Protein	"[{""token"": ""IL - 6 gene"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B p65 homodimers"", ""start_span"": 138, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""retinoblastoma control element"", ""start_span"": 219, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 promoter"", ""start_span"": 265, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	train
NMR analysis demonstrated the presence of three alpha - helices ( Val10 - Gln22, Glu30 - Leu41 and Phe50 - Tyr65) connected by loop regions ( Ser23 - Ala49 and Leu42 - Pro49).	alpha - helices,48,63,Gene/Protein	Val10 - Gln22,66,79,Gene/Protein	Glu30 - Leu41,81,94,Gene/Protein	Phe50 - Tyr65,99,112,Gene/Protein	loop regions,127,139,Gene/Protein	Ser23 - Ala49,142,155,Gene/Protein	Leu42 - Pro49,160,173,Gene/Protein	"[{""token"": ""alpha - helices"", ""start_span"": 48, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Val10 - Gln22"", ""start_span"": 66, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Glu30 - Leu41"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Phe50 - Tyr65"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""loop regions"", ""start_span"": 127, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Ser23 - Ala49"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Leu42 - Pro49"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Whereas TPCK inhibits phosphorylation of I kappa B and, consequently, activation of NF - kappa B, it markedly enhances the activity of JNK, the MAP kinase - related kinase that phosphorylates the transactivation domain of c - Jun.	TPCK,8,12,Gene/Protein	I kappa B,41,50,Gene/Protein	NF - kappa B,84,96,Gene/Protein	JNK,135,138,Gene/Protein	MAP kinase - related kinase,144,171,Gene/Protein	transactivation domain,196,218,Gene/Protein	c - Jun,222,229,Gene/Protein	"[{""token"": ""TPCK"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase - related kinase"", ""start_span"": 144, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domain"", ""start_span"": 196, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 222, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Triggering of complement receptors CR1 ( CD35) and CR3 ( CD11b / CD18) induces nuclear translocation of NF - kappa B ( p50 / p65) in human monocytes and enhances viral replication in HIV - infected monocytic cells.	complement receptors,14,34,Gene/Protein	CR1,35,38,Gene/Protein	CD35,41,45,Gene/Protein	CR3,51,54,Gene/Protein	CD11b / CD18,57,69,Gene/Protein	NF - kappa B,104,116,Gene/Protein	p50 / p65,119,128,Gene/Protein	"[{""token"": ""complement receptors"", ""start_span"": 14, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""CR1"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""CD35"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""CR3"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 57, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 104, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
This region ( termed the zinc finger protein binding region ( ZIP)) serves as binding site for two differently regulated zinc finger proteins: the constitutively expressed transcription factor Sp1 and the inducible early growth response protein EGR - 1.	zinc finger protein binding region,25,59,Gene/Protein	ZIP,62,65,Gene/Protein	zinc finger proteins,121,141,Gene/Protein	constitutively expressed transcription factor,147,192,Gene/Protein	Sp1,193,196,Gene/Protein	inducible early growth response protein,205,244,Gene/Protein	EGR - 1,245,252,Gene/Protein	"[{""token"": ""zinc finger protein binding region"", ""start_span"": 25, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""ZIP"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger proteins"", ""start_span"": 121, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""constitutively expressed transcription factor"", ""start_span"": 147, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""inducible early growth response protein"", ""start_span"": 205, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 245, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
By using a nucleosome - assembly system derived from Drosophila embryos, we find that the packaging of DNA into chromatin in vitro strongly represses HIV - 1 transcription and that repression can be counteracted efficiently by preincubation of the DNA with LEF - 1 ( or LEF - 1 and Ets - 1) supplemented with fractions containing the promoter - binding protein, Sp1.	nucleosome,11,21,Gene/Protein	chromatin,112,121,Gene/Protein	LEF - 1,257,264,Gene/Protein	LEF - 1,270,277,Gene/Protein	Ets - 1,282,289,Gene/Protein	promoter - binding protein,334,360,Gene/Protein	Sp1,362,365,Gene/Protein	"[{""token"": ""nucleosome"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""chromatin"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 257, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 270, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 282, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""promoter - binding protein"", ""start_span"": 334, ""end_span"": 360, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 362, ""end_span"": 365, ""type"": ""Gene/Protein""}]"	train
A truncation mutant of LEF - 1 ( HMG - 88), which contains the HMG box but lacks the trans - activation domain, did not activate transcription from nucleosomal DNA, indicating that bending of DNA by the HMG domain is not sufficient to activate transcription in vitro.	truncation mutant,2,19,Gene/Protein	LEF - 1,23,30,Gene/Protein	HMG - 88,33,41,Gene/Protein	HMG box,63,70,Gene/Protein	trans - activation domain,85,110,Gene/Protein	nucleosomal DNA,148,163,Gene/Protein	HMG domain,203,213,Gene/Protein	"[{""token"": ""truncation mutant"", ""start_span"": 2, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""HMG - 88"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""HMG box"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""trans - activation domain"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""nucleosomal DNA"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""HMG domain"", ""start_span"": 203, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
The aberrant activation of AP - 1 by gp160 in CD4 positive T cells could result in up - regulation of cytokines containing AP - 1 sites, e. g. interleukin - 3 and granulocyte macrophage colony - stimulating factor, and concurrently lead to T cell unresponsiveness by inhibiting interleukin - 2 secretion.	AP - 1,27,33,Gene/Protein	gp160,37,42,Gene/Protein	cytokines,102,111,Gene/Protein	AP - 1 sites,123,135,Gene/Protein	interleukin - 3,143,158,Gene/Protein	granulocyte macrophage colony - stimulating factor,163,213,Gene/Protein	interleukin - 2,278,293,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sites"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 143, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte macrophage colony - stimulating factor"", ""start_span"": 163, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 278, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
In addition, the Ah receptor complex recognized a DNA binding site for B cell lineage - specific activator protein ( BSAP) in the promoter region of the human CD19 gene which is similar to the consensus Ah receptor DNA binding site.	Ah receptor complex,17,36,Gene/Protein	DNA binding site,50,66,Gene/Protein	B cell lineage - specific activator protein,71,114,Gene/Protein	BSAP,117,121,Gene/Protein	promoter region,130,145,Gene/Protein	CD19 gene,159,168,Gene/Protein	consensus Ah receptor DNA binding site,193,231,Gene/Protein	"[{""token"": ""Ah receptor complex"", ""start_span"": 17, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding site"", ""start_span"": 50, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""B cell lineage - specific activator protein"", ""start_span"": 71, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 130, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CD19 gene"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""consensus Ah receptor DNA binding site"", ""start_span"": 193, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Here we show that the lymphoid - specific transcription factor Oct - 2A plays a critical role in HLA - DRA gene expression in class II - positive B cell lines, and that the high mobility group protein ( HMG) I / Y binds to multiple sites within the DRA promoter, including the Oct - 2A binding site.	lymphoid - specific transcription factor Oct - 2A,22,71,Gene/Protein	HLA - DRA gene,97,111,Gene/Protein	high mobility group protein,173,200,Gene/Protein	HMG,203,206,Gene/Protein	I / Y,208,213,Gene/Protein	DRA promoter,249,261,Gene/Protein	Oct - 2A binding site,277,298,Gene/Protein	"[{""token"": ""lymphoid - specific transcription factor Oct - 2A"", ""start_span"": 22, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRA gene"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""high mobility group protein"", ""start_span"": 173, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""HMG"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""I / Y"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 249, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2A binding site"", ""start_span"": 277, ""end_span"": 298, ""type"": ""Gene/Protein""}]"	train
In lymphoblastoid cell lines, six EBV - encoded nuclear antigens ( EBNA1, 2, 3A, 3B, 3C, - LP), three latent membrane proteins ( LMP1, 2A, 2B), and two nuclear RNAs ( EBERs) are expressed.	EBV - encoded nuclear antigens,34,64,Gene/Protein	latent membrane proteins,102,126,Gene/Protein	LMP1,129,133,Gene/Protein	2A,135,137,Gene/Protein	2B,139,141,Gene/Protein	nuclear RNAs,152,164,Gene/Protein	EBERs,167,172,Gene/Protein	"[{""token"": ""EBV - encoded nuclear antigens"", ""start_span"": 34, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane proteins"", ""start_span"": 102, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""2A"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""2B"", ""start_span"": 139, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""nuclear RNAs"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""EBERs"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Computer analysis of the SM protein sequence showed a C terminal section of SM to be related to genome positional homologues of four other herpesviruses and revealed consensus CKII sites near the N termini of the EBV SM protein, the herpes simplex virus ( HSV) ICP27 protein and the herpesvirus saimiri ( HVS) open reading frame 57 protein.	SM protein,25,35,Gene/Protein	C terminal section,54,72,Gene/Protein	SM,76,78,Gene/Protein	genome positional homologues,96,124,Gene/Protein	consensus CKII sites,166,186,Gene/Protein	N termini,196,205,Gene/Protein	EBV SM protein,213,227,Gene/Protein	"[{""token"": ""SM protein"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""C terminal section"", ""start_span"": 54, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""SM"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""genome positional homologues"", ""start_span"": 96, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""consensus CKII sites"", ""start_span"": 166, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""N termini"", ""start_span"": 196, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""EBV SM protein"", ""start_span"": 213, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	train
OBJECTIVE: To determine whether activation of Epstein - Barr virus ( EBV) replication in tumour cells of AIDS - related non - Hodgkin ' s lymphoma ( ARNHL) is correlated with CD4 + cell counts and influences antibody response to EBV [ anti - Z Epstein - Barr replicative activator ( ZEBRA), anti - early antigen ( EA), anti - viral capsid antigen ( VCA)].	CD4 +,175,180,Gene/Protein	anti - Z Epstein - Barr replicative activator,235,280,Gene/Protein	ZEBRA,283,288,Gene/Protein	anti - early antigen,291,311,Gene/Protein	EA,314,316,Gene/Protein	anti - viral capsid antigen,319,346,Gene/Protein	VCA,349,352,Gene/Protein	"[{""token"": ""CD4 +"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""anti - Z Epstein - Barr replicative activator"", ""start_span"": 235, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""ZEBRA"", ""start_span"": 283, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""anti - early antigen"", ""start_span"": 291, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""EA"", ""start_span"": 314, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""anti - viral capsid antigen"", ""start_span"": 319, ""end_span"": 346, ""type"": ""Gene/Protein""}, {""token"": ""VCA"", ""start_span"": 349, ""end_span"": 352, ""type"": ""Gene/Protein""}]"	train
In order to elucidate the role of c - myb gene in erythroid differentiation of K562 cell induced by hemin ( Hm) and erythropoietin ( Epo), we constructed recombinant plasmid that could produce antisense myb RNA after induction with dexamethasone.	c - myb gene,34,46,Gene/Protein	hemin,100,105,Gene/Protein	Hm,108,110,Gene/Protein	erythropoietin,116,130,Gene/Protein	Epo,133,136,Gene/Protein	recombinant plasmid,154,173,Gene/Protein	antisense myb RNA,193,210,Gene/Protein	"[{""token"": ""c - myb gene"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""hemin"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Hm"", ""start_span"": 108, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 116, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""recombinant plasmid"", ""start_span"": 154, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""antisense myb RNA"", ""start_span"": 193, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Expression and genomic configuration of GM - CSF, IL - 3, M - CSF receptor ( C - FMS), early growth response gene - 1 ( EGR - 1) and M - CSF genes in primary myelodysplastic syndromes.	GM - CSF,40,48,Gene/Protein	IL - 3,50,56,Gene/Protein	M - CSF receptor,58,74,Gene/Protein	C - FMS,77,84,Gene/Protein	early growth response gene - 1,87,117,Gene/Protein	EGR - 1,120,127,Gene/Protein	M - CSF genes,133,146,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF receptor"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""C - FMS"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""early growth response gene - 1"", ""start_span"": 87, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF genes"", ""start_span"": 133, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
Both stimuli induced the appearance of the NF - kappa B components ( c - Rel, p65 ( RelA), and p50 ( NF - kappa B1)) and NF - kappa B DNA binding activity in the nucleus.	NF - kappa B components,43,66,Gene/Protein	c - Rel,69,76,Gene/Protein	p65,78,81,Gene/Protein	RelA,84,88,Gene/Protein	p50,95,98,Gene/Protein	NF - kappa B1,101,114,Gene/Protein	NF - kappa B,121,133,Gene/Protein	"[{""token"": ""NF - kappa B components"", ""start_span"": 43, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
Sequence analyses of pCD41 indicate that there are two potential open reading frames ( ORFs), A and B, which are homologous to the ORFs found in the genomic clone pGD41.	pCD41,21,26,Gene/Protein	open reading frames,65,84,Gene/Protein	ORFs,87,91,Gene/Protein	A,94,95,Gene/Protein	B,100,101,Gene/Protein	ORFs,131,135,Gene/Protein	pGD41,163,168,Gene/Protein	"[{""token"": ""pCD41"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""open reading frames"", ""start_span"": 65, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""A"", ""start_span"": 94, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 100, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""ORFs"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""pGD41"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
To further elucidate the role of this variant octamer motif in the regulation of germline transcription from the unrearranged kappa locus, we have quantitated the relative binding affinity of Oct - 1 and Oct - 2 for the variant octamer motif and determined the functional role of this octamer motif in transcriptional activation.	octamer motif,46,59,Gene/Protein	germline,81,89,Gene/Protein	kappa locus,126,137,Gene/Protein	Oct - 1,192,199,Gene/Protein	Oct - 2,204,211,Gene/Protein	octamer motif,228,241,Gene/Protein	octamer motif,285,298,Gene/Protein	"[{""token"": ""octamer motif"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""kappa locus"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 228, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 285, ""end_span"": 298, ""type"": ""Gene/Protein""}]"	train
Flow cytometry analyses on cultured cells that were treated with tepoxalin or antisense oligonucleotides to the P65 / p50 subunit of NF - kappa B, and then stimulated with PMA, revealed a reduced expression of CD11b / CD18 on monocytic HL60 cells, and endothelial adhesion molecule - 1 ( CD62E) and vascular adhesion molecule - 1 ( CD106) on human umbilical vein endothelial cells.	P65 / p50 subunit,112,129,Gene/Protein	NF - kappa B,133,145,Gene/Protein	CD11b / CD18,210,222,Gene/Protein	endothelial adhesion molecule - 1,252,285,Gene/Protein	CD62E,288,293,Gene/Protein	vascular adhesion molecule - 1,299,329,Gene/Protein	CD106,332,337,Gene/Protein	"[{""token"": ""P65 / p50 subunit"", ""start_span"": 112, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 133, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CD11b / CD18"", ""start_span"": 210, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""endothelial adhesion molecule - 1"", ""start_span"": 252, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""CD62E"", ""start_span"": 288, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""vascular adhesion molecule - 1"", ""start_span"": 299, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 332, ""end_span"": 337, ""type"": ""Gene/Protein""}]"	train
Therefore, to evaluate the mechanism of TPA responsiveness of the SNE motifs and of a related 16 - bp SEE ( SRF / ETS element) motif found in the HCMV and chimpanzee CMV MIE enhancers, we have examined the functional responses and protein binding properties of multimerized wild - type and mutant elements added upstream to the SCMV MIE or simian virus 40 minimal promoter regions in the U - 937, K - 562, HL - 60, THP - 1, and Jurkat cell lines.	SNE motifs,66,76,Gene/Protein	SEE,102,105,Gene/Protein	SRF / ETS element,108,125,Gene/Protein	HCMV and chimpanzee CMV MIE enhancers,146,183,Gene/Protein	multimerized wild - type and mutant elements,261,305,Gene/Protein	SCMV MIE,328,336,Gene/Protein	simian virus 40 minimal promoter regions,340,380,Gene/Protein	"[{""token"": ""SNE motifs"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""SEE"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""SRF / ETS element"", ""start_span"": 108, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""HCMV and chimpanzee CMV MIE enhancers"", ""start_span"": 146, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""multimerized wild - type and mutant elements"", ""start_span"": 261, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""SCMV MIE"", ""start_span"": 328, ""end_span"": 336, ""type"": ""Gene/Protein""}, {""token"": ""simian virus 40 minimal promoter regions"", ""start_span"": 340, ""end_span"": 380, ""type"": ""Gene/Protein""}]"	train
The identification of oriP and the EBNA2 - dependent enhancer as the major positive cis elements involved in regulating Cp activity in LCL suggests that EBNA gene transcription is largely autoregulated by EBNA 1 and EBNA 2.	oriP,22,26,Gene/Protein	EBNA2 - dependent enhancer,35,61,Gene/Protein	cis elements,84,96,Gene/Protein	Cp,120,122,Gene/Protein	EBNA gene,153,162,Gene/Protein	EBNA 1,205,211,Gene/Protein	EBNA 2,216,222,Gene/Protein	"[{""token"": ""oriP"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""EBNA2 - dependent enhancer"", ""start_span"": 35, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""cis elements"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""EBNA gene"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""EBNA 1"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""EBNA 2"", ""start_span"": 216, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
DNase I hypersensitive site ( DHS) mapping revealed that the perforin locus contained six DHS within 7. 0 kb of the 5 ' upstream sequence ( - 7. 0 kb) and two DHS in intron 2.	DNase I hypersensitive site,0,27,Gene/Protein	DHS,30,33,Gene/Protein	perforin locus,61,75,Gene/Protein	DHS,90,93,Gene/Protein	5 ' upstream sequence,116,137,Gene/Protein	DHS,159,162,Gene/Protein	intron 2,166,174,Gene/Protein	"[{""token"": ""DNase I hypersensitive site"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""DHS"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""perforin locus"", ""start_span"": 61, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""DHS"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream sequence"", ""start_span"": 116, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""DHS"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""intron 2"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
Instead, ATF - 2 and Jun proteins bind to the composite kappa 3 / CRE site and NFATp binds to a newly identified second NFAT site centered at - 76 nucleotides relative to the TNF - alpha transcription start site.	ATF - 2,9,16,Gene/Protein	Jun proteins,21,33,Gene/Protein	composite kappa 3 / CRE site,46,74,Gene/Protein	NFATp,79,84,Gene/Protein	NFAT site,120,129,Gene/Protein	- 76 nucleotides,142,158,Gene/Protein	TNF - alpha transcription start site,175,211,Gene/Protein	"[{""token"": ""ATF - 2"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""Jun proteins"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""composite kappa 3 / CRE site"", ""start_span"": 46, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NFAT site"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""- 76 nucleotides"", ""start_span"": 142, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha transcription start site"", ""start_span"": 175, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Gel mobility shift and immunoprecipitation analyses revealed that in addition to activating STAT3 ( signal transducer and activator of transcription - 3) and STAT5, IL - 2 induced tyrosine and serine phosphorylation of STAT1 alpha, which formed IFN - gamma - activated sequence - binding complexes by itself and with STAT3.	STAT3,92,97,Gene/Protein	signal transducer and activator of transcription - 3,100,152,Gene/Protein	STAT5,158,163,Gene/Protein	IL - 2,165,171,Gene/Protein	STAT1 alpha,219,230,Gene/Protein	IFN - gamma - activated sequence - binding complexes,245,297,Gene/Protein	STAT3,317,322,Gene/Protein	"[{""token"": ""STAT3"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription - 3"", ""start_span"": 100, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma - activated sequence - binding complexes"", ""start_span"": 245, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 317, ""end_span"": 322, ""type"": ""Gene/Protein""}]"	train
Therefore, we analyzed the expression, DNA binding, and transcriptional activity of the endogenous RA and VitD3 receptors [ retinoic acid receptors ( RARs), retinoid X receptors ( RXRs), and VitD3 receptor ( VDR)] in the U - 937 cell line, in which RA and VitD3 induce distinct monocytic differentiation pathways.	endogenous RA and VitD3 receptors,88,121,Gene/Protein	retinoic acid receptors,124,147,Gene/Protein	RARs,150,154,Gene/Protein	retinoid X receptors,157,177,Gene/Protein	RXRs,180,184,Gene/Protein	VitD3 receptor,191,205,Gene/Protein	VDR,208,211,Gene/Protein	"[{""token"": ""endogenous RA and VitD3 receptors"", ""start_span"": 88, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptors"", ""start_span"": 124, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""VitD3 receptor"", ""start_span"": 191, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""VDR"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Two explanations for hyporesponsiveness of the human iNOS promoter to LPS + / - IFN - gamma were found: ( 1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS / IFN - gamma induced expression of the mouse iNOS gene; and ( 2) and absence of one or more nuclear factors in human macrophages ( e. g., an LPS - inducible nuclear factor - kappa B / Rel complex), that is ( are) required for maximal expression of the gene.	human iNOS promoter,47,66,Gene/Protein	IFN - gamma,80,91,Gene/Protein	enhancer element,188,204,Gene/Protein	IFN - gamma,243,254,Gene/Protein	mouse iNOS gene,281,296,Gene/Protein	nuclear factors,334,349,Gene/Protein	LPS - inducible nuclear factor - kappa B / Rel complex,383,437,Gene/Protein	"[{""token"": ""human iNOS promoter"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""enhancer element"", ""start_span"": 188, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 243, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""mouse iNOS gene"", ""start_span"": 281, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 334, ""end_span"": 349, ""type"": ""Gene/Protein""}, {""token"": ""LPS - inducible nuclear factor - kappa B / Rel complex"", ""start_span"": 383, ""end_span"": 437, ""type"": ""Gene/Protein""}]"	train
CD40 signaling activates downstream effectors, including the tyrosine protein kinase, Lyn, the phosphatidylinositol - 3 - kinase ( PI - 3 kinase), and the transcription factor, NF - kappa B.	CD40,0,4,Gene/Protein	downstream effectors,25,45,Gene/Protein	tyrosine protein kinase,61,84,Gene/Protein	Lyn,86,89,Gene/Protein	phosphatidylinositol - 3 - kinase,95,128,Gene/Protein	PI - 3 kinase,131,144,Gene/Protein	NF - kappa B,177,189,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""downstream effectors"", ""start_span"": 25, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine protein kinase"", ""start_span"": 61, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Lyn"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol - 3 - kinase"", ""start_span"": 95, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""PI - 3 kinase"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
STAT1 activity was evident on the STAT binding sequences ( SBE) present in the promoters of genes which are up - regulated during monocyte to macrophage maturation such as FcgammaRI and ICAM - 1, and in the promoter of the transcription factor IFN regulatory factor - 1.	STAT1,0,5,Gene/Protein	STAT binding sequences,34,56,Gene/Protein	SBE,59,62,Gene/Protein	promoters,79,88,Gene/Protein	FcgammaRI,172,181,Gene/Protein	ICAM - 1,186,194,Gene/Protein	transcription factor IFN regulatory factor - 1,223,269,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""STAT binding sequences"", ""start_span"": 34, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""SBE"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""FcgammaRI"", ""start_span"": 172, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor IFN regulatory factor - 1"", ""start_span"": 223, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
As2O3 induced PML ( promyelocytic leukemia) protein degradation but did not modulate expression of cell cycle - related proteins, including c - myc, retinoblastoma protein, cyclin - dependent kinase 4, cyclin D1, and p53, or expression of differentiation - related antigens.	cell cycle - related proteins,99,128,Gene/Protein	c - myc,140,147,Gene/Protein	retinoblastoma protein,149,171,Gene/Protein	cyclin - dependent kinase 4,173,200,Gene/Protein	cyclin D1,202,211,Gene/Protein	p53,217,220,Gene/Protein	differentiation - related antigens,239,273,Gene/Protein	"[{""token"": ""cell cycle - related proteins"", ""start_span"": 99, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""retinoblastoma protein"", ""start_span"": 149, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinase 4"", ""start_span"": 173, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D1"", ""start_span"": 202, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""differentiation - related antigens"", ""start_span"": 239, ""end_span"": 273, ""type"": ""Gene/Protein""}]"	train
However, binding of SHP2 to SIT is not required for inhibition of NF - AT induction, suggesting that SIT not only regulates NF - AT activity but also controls NF - AT unrelated pathways of T cell activation involving SHP2.	SHP2,20,24,Gene/Protein	SIT,28,31,Gene/Protein	NF - AT,66,73,Gene/Protein	SIT,101,104,Gene/Protein	NF - AT,124,131,Gene/Protein	NF - AT,159,166,Gene/Protein	SHP2,217,221,Gene/Protein	"[{""token"": ""SHP2"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""SIT"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""SIT"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""SHP2"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
However, CD80 and CD86 also induce distinct signal transduction pathways including the tyrosine phosphorylation of CD28 and phospholipase Cgamma1 and the SH2 - dependent association of phosphoinositide 3 - kinase with CD28.	CD80,9,13,Gene/Protein	CD86,18,22,Gene/Protein	CD28,115,119,Gene/Protein	phospholipase Cgamma1,124,145,Gene/Protein	SH2,154,157,Gene/Protein	phosphoinositide 3 - kinase,185,212,Gene/Protein	CD28,218,222,Gene/Protein	"[{""token"": ""CD80"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase Cgamma1"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""SH2"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""phosphoinositide 3 - kinase"", ""start_span"": 185, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
The functional contribution of the kappaB - Sp1 composite site in P / I - inducible fas promoter activation was verified by using kappaB - Sp1 concatamers ( - 295 to - 286) in a thymidine kinase promoter - driven reporter construct and native promoter constructs in Jurkat cells overexpressing IkappaB - alpha.	kappaB - Sp1 composite site,35,62,Gene/Protein	P / I - inducible fas promoter,66,96,Gene/Protein	Sp1,139,142,Gene/Protein	- 295 to - 286,157,171,Gene/Protein	thymidine kinase promoter - driven reporter construct,178,231,Gene/Protein	native promoter constructs,236,262,Gene/Protein	IkappaB - alpha,294,309,Gene/Protein	"[{""token"": ""kappaB - Sp1 composite site"", ""start_span"": 35, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""P / I - inducible fas promoter"", ""start_span"": 66, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""- 295 to - 286"", ""start_span"": 157, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase promoter - driven reporter construct"", ""start_span"": 178, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""native promoter constructs"", ""start_span"": 236, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 294, ""end_span"": 309, ""type"": ""Gene/Protein""}]"	train
RESULTS: We identified peptides derived from EWS / FLI - 1 fusion protein and from mutated K - RAS protein ( encompassing respectively the fusion point and the mutation at position 12) that showed binding motif for HLA - Cw * 0702 and HLA - A3 respectively.	EWS / FLI - 1 fusion protein,45,73,Gene/Protein	mutated K - RAS protein,83,106,Gene/Protein	fusion point,139,151,Gene/Protein	position 12,172,183,Gene/Protein	binding motif,197,210,Gene/Protein	HLA - Cw * 0702,215,230,Gene/Protein	HLA - A3,235,243,Gene/Protein	"[{""token"": ""EWS / FLI - 1 fusion protein"", ""start_span"": 45, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""mutated K - RAS protein"", ""start_span"": 83, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""fusion point"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""position 12"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""binding motif"", ""start_span"": 197, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""HLA - Cw * 0702"", ""start_span"": 215, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""HLA - A3"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
A threonine residue at position 234, previously shown to be important for CD40 association with TNF receptor - associated factor 2 ( TRAF2), TRAF3, and TRAF5, was not required for NF - kappa B activation.	position 234,23,35,Gene/Protein	CD40,74,78,Gene/Protein	TNF receptor - associated factor 2,96,130,Gene/Protein	TRAF2,133,138,Gene/Protein	TRAF3,141,146,Gene/Protein	TRAF5,152,157,Gene/Protein	NF - kappa B,180,192,Gene/Protein	"[{""token"": ""position 234"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""TNF receptor - associated factor 2"", ""start_span"": 96, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""TRAF5"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Treatment of cells expressing the chimeric receptor kit / IL - 4R alpha with SCF induces activation of the IL - 4R alpha - associated kinase JAK - 1 and the transcription factor STAT6.	chimeric receptor,34,51,Gene/Protein	kit / IL - 4R alpha,52,71,Gene/Protein	SCF,77,80,Gene/Protein	IL - 4R alpha - associated kinase,107,140,Gene/Protein	JAK - 1,141,148,Gene/Protein	transcription factor,157,177,Gene/Protein	STAT6,178,183,Gene/Protein	"[{""token"": ""chimeric receptor"", ""start_span"": 34, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""kit / IL - 4R alpha"", ""start_span"": 52, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha - associated kinase"", ""start_span"": 107, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""JAK - 1"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Clonal analysis revealed individual responses to the two immediate early proteins BZLF1 and BRLF1, and to three ( BMLF1, BMRF1, and BALF2) of the six early proteins tested.	immediate early proteins,57,81,Gene/Protein	BZLF1,82,87,Gene/Protein	BRLF1,92,97,Gene/Protein	BMLF1,114,119,Gene/Protein	BMRF1,121,126,Gene/Protein	BALF2,132,137,Gene/Protein	early proteins,150,164,Gene/Protein	"[{""token"": ""immediate early proteins"", ""start_span"": 57, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""BZLF1"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""BRLF1"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""BMLF1"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""BALF2"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""early proteins"", ""start_span"": 150, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
c - Fos protein was shown essential for an optimal transactivation of the HIV - 1 long terminal repeat ( LTR) by Tat: incubation of Jurkat cells with antisense, but not sense, c - fos oligonucleotides significantly reduced either the Tat - enhanced expression of an LTR - CAT reporter construct or the levels of gag p24 in the culture supernatants of Jurkat cells and PBMC acutely infected with HIV - 1.	c - Fos,0,7,Gene/Protein	long terminal repeat,82,102,Gene/Protein	LTR,105,108,Gene/Protein	Tat,113,116,Gene/Protein	Tat,234,237,Gene/Protein	LTR - CAT reporter construct,266,294,Gene/Protein	gag p24,312,319,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""LTR - CAT reporter construct"", ""start_span"": 266, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""gag p24"", ""start_span"": 312, ""end_span"": 319, ""type"": ""Gene/Protein""}]"	train
The interaction of Tax1 with NF - YB was specific in that NF - YB did not interact with a variety of other transcription factors, including human immunodeficiency virus Tat, human papillomavirus E6, and Bicoid, or with the M7 ( amino acids 29CP - AS) Tax1 mutant.	Tax1,19,23,Gene/Protein	NF - YB,29,36,Gene/Protein	NF - YB,58,65,Gene/Protein	transcription factors,107,128,Gene/Protein	human immunodeficiency virus Tat,140,172,Gene/Protein	human papillomavirus E6,174,197,Gene/Protein	Bicoid,203,209,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""NF - YB"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""NF - YB"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 107, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""human immunodeficiency virus Tat"", ""start_span"": 140, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""human papillomavirus E6"", ""start_span"": 174, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Bicoid"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
In order to evaluate the conditions for optimal expression and immunogenicity of varicella - zoster virus ( VZV) proteins in a herpes simplex virus - 1 ( HSV - 1) vector, we selected the VZV glycoprotein E ( gE), encoded by ORF 68 and the VZV product of ORF 62, an immediate - early major tegument protein ( IE62).	VZV glycoprotein E,187,205,Gene/Protein	gE,208,210,Gene/Protein	ORF 68,224,230,Gene/Protein	VZV product,239,250,Gene/Protein	ORF 62,254,260,Gene/Protein	immediate - early major tegument protein,265,305,Gene/Protein	IE62,308,312,Gene/Protein	"[{""token"": ""VZV glycoprotein E"", ""start_span"": 187, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""gE"", ""start_span"": 208, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""ORF 68"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""VZV product"", ""start_span"": 239, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""ORF 62"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early major tegument protein"", ""start_span"": 265, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""IE62"", ""start_span"": 308, ""end_span"": 312, ""type"": ""Gene/Protein""}]"	train
When introduced into interleukin 3 ( IL - 3) - dependent mouse pro - B lymphocytes, E2A - HLF prevents apoptosis induced by growth factor deprivation, suggesting that IL - 3 mediates cell survival through activation of a transcription factor whose activity can be constitutively replaced by the chimeric oncoprotein.	interleukin 3,21,34,Gene/Protein	IL - 3,37,43,Gene/Protein	E2A - HLF,84,93,Gene/Protein	growth factor,124,137,Gene/Protein	IL - 3,167,173,Gene/Protein	transcription factor,221,241,Gene/Protein	chimeric oncoprotein,295,315,Gene/Protein	"[{""token"": ""interleukin 3"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""growth factor"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 221, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""chimeric oncoprotein"", ""start_span"": 295, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
The gene encodes an 85 - kDa protein, designated BASH ( B cell adaptor containing SH2 domain), that contains N - terminal acidic domains with SH2 domain - binding phosphotyrosine - based motifs, a proline - rich domain, and a C - terminal SH2 domain.	85 - kDa protein,20,36,Gene/Protein	BASH,49,53,Gene/Protein	B cell adaptor containing SH2 domain,56,92,Gene/Protein	N - terminal acidic domains,109,136,Gene/Protein	SH2 domain - binding phosphotyrosine - based motifs,142,193,Gene/Protein	proline - rich domain,197,218,Gene/Protein	C - terminal SH2 domain,226,249,Gene/Protein	"[{""token"": ""85 - kDa protein"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""BASH"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""B cell adaptor containing SH2 domain"", ""start_span"": 56, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal acidic domains"", ""start_span"": 109, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain - binding phosphotyrosine - based motifs"", ""start_span"": 142, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""proline - rich domain"", ""start_span"": 197, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal SH2 domain"", ""start_span"": 226, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
These studies revealed that the major protein in extracts of PMN activated by G - CSF to bind the high - affinity serum - inducible element ( hSIE) is a 72 - kDa protein that cross - reacts with Stat3 monoclonal antibody, which we have designated Stat3gamma.	major protein,32,45,Gene/Protein	G - CSF,78,85,Gene/Protein	high - affinity serum - inducible element,98,139,Gene/Protein	hSIE,142,146,Gene/Protein	72 - kDa protein,153,169,Gene/Protein	Stat3 monoclonal antibody,195,220,Gene/Protein	Stat3gamma,247,257,Gene/Protein	"[{""token"": ""major protein"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity serum - inducible element"", ""start_span"": 98, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""hSIE"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""72 - kDa protein"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Stat3 monoclonal antibody"", ""start_span"": 195, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""Stat3gamma"", ""start_span"": 247, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
These motifs are regulatory sequences within the so - called AU - rich elements ( AREs) often found in 3 ' untranslated regions of genes such as cytokines, proto - oncogenes, and transcription factors.	regulatory sequences,17,37,Gene/Protein	AU - rich elements,61,79,Gene/Protein	AREs,82,86,Gene/Protein	3 ' untranslated regions,103,127,Gene/Protein	cytokines,145,154,Gene/Protein	proto - oncogenes,156,173,Gene/Protein	transcription factors,179,200,Gene/Protein	"[{""token"": ""regulatory sequences"", ""start_span"": 17, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""AU - rich elements"", ""start_span"": 61, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""AREs"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""3 ' untranslated regions"", ""start_span"": 103, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogenes"", ""start_span"": 156, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 179, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
p130, predominantly in Form 1, and hypophosphorylated pRb bind an E2F DNA binding site; p130 complexes E2F - 4, whereas pRb binds both E2F - 4 and E2F - 1.	p130,0,4,Gene/Protein	hypophosphorylated pRb,35,57,Gene/Protein	E2F DNA binding site,66,86,Gene/Protein	p130,88,92,Gene/Protein	E2F - 4,103,110,Gene/Protein	pRb,120,123,Gene/Protein	E2F - 1,147,154,Gene/Protein	"[{""token"": ""p130"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""hypophosphorylated pRb"", ""start_span"": 35, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""E2F DNA binding site"", ""start_span"": 66, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 4"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
The effect of Rho on AP - 1 is independent of the mitogen - activated protein kinase pathway, as a dominant - negative MEK and a MEK inhibitor ( PD98059) did not affect Rho - induced AP - 1 activity.	Rho,14,17,Gene/Protein	AP - 1,21,27,Gene/Protein	mitogen - activated protein kinase,50,84,Gene/Protein	dominant - negative MEK,99,122,Gene/Protein	MEK,129,132,Gene/Protein	Rho,169,172,Gene/Protein	AP - 1,183,189,Gene/Protein	"[{""token"": ""Rho"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 50, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""dominant - negative MEK"", ""start_span"": 99, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Dominant negative mutants of NIK, IKKalpha, or IKKbeta substantially inhibited NF - kappaB activation by LMP1 or by each of its effector sites.	Dominant negative mutants,0,25,Gene/Protein	NIK,29,32,Gene/Protein	IKKalpha,34,42,Gene/Protein	IKKbeta,47,54,Gene/Protein	NF - kappaB,79,90,Gene/Protein	LMP1,105,109,Gene/Protein	effector sites,128,142,Gene/Protein	"[{""token"": ""Dominant negative mutants"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""effector sites"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
MyD88, originally isolated as a myeloid differentiation primary response gene, is shown to act as an adaptor in interleukin - 1 ( IL - 1) signaling by interacting with both the IL - 1 receptor complex and IL - 1 receptor - associated kinase ( IRAK).	MyD88,0,5,Gene/Protein	primary response gene,56,77,Gene/Protein	interleukin - 1,112,127,Gene/Protein	IL - 1,130,136,Gene/Protein	IL - 1 receptor complex,177,200,Gene/Protein	IL - 1 receptor - associated kinase,205,240,Gene/Protein	IRAK,243,247,Gene/Protein	"[{""token"": ""MyD88"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""primary response gene"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor complex"", ""start_span"": 177, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor - associated kinase"", ""start_span"": 205, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""IRAK"", ""start_span"": 243, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
Somewhat unexpectedly, the constitutive p21ras activity did not cause an increased DNA binding of transcription factors PEA1 ( AP1), PEA3, Oct - 2 or NF - kB	p21ras,40,46,Gene/Protein	transcription factors,98,119,Gene/Protein	PEA1,120,124,Gene/Protein	AP1,127,130,Gene/Protein	PEA3,133,137,Gene/Protein	Oct - 2,139,146,Gene/Protein	NF - kB,150,157,Gene/Protein	"[{""token"": ""p21ras"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 98, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""PEA1"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""PEA3"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
Little effect was observed with 50 - kDa forms of p105 NF - kappa B or rel, in combination with p65 or full - length c - rel, which do not stimulate the HIV enhancer in these cells.	50 - kDa forms,32,46,Gene/Protein	p105,50,54,Gene/Protein	NF - kappa B,55,67,Gene/Protein	rel,71,74,Gene/Protein	p65,96,99,Gene/Protein	full - length c - rel,103,124,Gene/Protein	HIV enhancer,153,165,Gene/Protein	"[{""token"": ""50 - kDa forms"", ""start_span"": 32, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""rel"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""full - length c - rel"", ""start_span"": 103, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HIV enhancer"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Furthermore, an antiserum against KBF1 ( identical to 50 kDa NF - kappa B protein) reacted with the p50 of NF - GM2, indicating that the NF - GM2 polypeptide can not be immunologically differentiated from the 50 kDa subunit of NF - kappa B.	KBF1,34,38,Gene/Protein	50 kDa NF - kappa B protein,54,81,Gene/Protein	p50,100,103,Gene/Protein	NF - GM2,107,115,Gene/Protein	NF - GM2 polypeptide,137,157,Gene/Protein	50 kDa subunit,209,223,Gene/Protein	NF - kappa B,227,239,Gene/Protein	"[{""token"": ""KBF1"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""50 kDa NF - kappa B protein"", ""start_span"": 54, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""NF - GM2 polypeptide"", ""start_span"": 137, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""50 kDa subunit"", ""start_span"": 209, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 227, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
When the human epsilon - or beta - globin genes driven by the dominant control region ( DCR) are introduced into this system, the human epsilon - globin gene, in contrast to the beta - globin gene, is not deregulated by the presence of the DCR and is expressed strictly as an embryonic gene.	human epsilon - or beta - globin genes,9,47,Gene/Protein	dominant control region,62,85,Gene/Protein	DCR,88,91,Gene/Protein	human epsilon - globin gene,130,157,Gene/Protein	beta - globin gene,178,196,Gene/Protein	DCR,240,243,Gene/Protein	embryonic gene,276,290,Gene/Protein	"[{""token"": ""human epsilon - or beta - globin genes"", ""start_span"": 9, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""dominant control region"", ""start_span"": 62, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""DCR"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""human epsilon - globin gene"", ""start_span"": 130, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin gene"", ""start_span"": 178, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""DCR"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""embryonic gene"", ""start_span"": 276, ""end_span"": 290, ""type"": ""Gene/Protein""}]"	train
IBR is a 503 - amino - acid - long acidic protein which is 99. 0% identical to the recently reported human NRF - 1 / alpha - Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG).	IBR,0,3,Gene/Protein	503 - amino - acid - long acidic protein,9,49,Gene/Protein	human NRF - 1 / alpha - Pal factor,101,135,Gene/Protein	transcription factors,175,196,Gene/Protein	P3A2,197,201,Gene/Protein	erected wing gene product,206,231,Gene/Protein	EWG,234,237,Gene/Protein	"[{""token"": ""IBR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""503 - amino - acid - long acidic protein"", ""start_span"": 9, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""human NRF - 1 / alpha - Pal factor"", ""start_span"": 101, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 175, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""P3A2"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""erected wing gene product"", ""start_span"": 206, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""EWG"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
This death - promoting activity of Bik can be suppressed by coexpression of Bcl - 2, Bcl - XL, EBV - BHRF1 and E1B - 19 kDa proteins suggesting that Bik may be a common target for both cellular and viral anti - apoptotic proteins.	Bik,35,38,Gene/Protein	Bcl - 2,76,83,Gene/Protein	Bcl - XL,85,93,Gene/Protein	EBV - BHRF1,95,106,Gene/Protein	E1B - 19 kDa,111,123,Gene/Protein	Bik,149,152,Gene/Protein	cellular and viral anti - apoptotic proteins,185,229,Gene/Protein	"[{""token"": ""Bik"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - XL"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""EBV - BHRF1"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""E1B - 19 kDa"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Bik"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""cellular and viral anti - apoptotic proteins"", ""start_span"": 185, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
